Page last updated: 2024-08-26

fibrinogen and Cardiovascular Stroke

fibrinogen has been researched along with Cardiovascular Stroke in 870 studies

Research

Studies (870)

TimeframeStudies, this research(%)All Research%
pre-1990388 (44.60)18.7374
1990's204 (23.45)18.2507
2000's193 (22.18)29.6817
2010's73 (8.39)24.3611
2020's12 (1.38)2.80

Authors

AuthorsStudies
Duan, Z; Fu, B; Han, D; Luo, C1
Božič Mijovski, M; Jug, B; Košuta, D; Novaković, M1
Ji, W; Li, Z; Sun, H; Teng, T; Yang, Q; Yu, Y; Zeng, S; Zhang, C; Zhou, X1
Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P1
Hou, XG; Ma, YT; Wu, TT; Xie, X; Yang, HT; Yang, Y; Zheng, YY1
Calderón, JM; Carratalá, A; Pozo, A; Rodríguez, E; Sanchis, J1
Bao, J; Gao, Z; Hu, Y; Liu, W; Wang, L; Ye, L1
Punjabi, PP1
Chen, YY; Dong, Y; Duan, L; He, XH; Liu, YM; Ma, RF; Wang, J; Wu, GJ; Yang, XC; Zhang, Y1
He, D; Li, Z; Song, J; Sun, Z; Yu, T1
Choe, CU; Jensen, M; Müller, C; Schwedhelm, E; Zeller, T1
Burns, JC; El-Said, H; Friedman, K; Gordon, JB; Newburger, JW; Tremoulet, AH1
Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S1
Cui, CJ; Dong, Q; Du, Y; Gao, Y; Guo, YL; Li, JJ; Li, S; Li, XL; Qing, P; Sun, J; Wu, NQ; Xu, RX; Yang, SH; Zhang, Y; Zhu, CG1
Burke, DL; Jackson, D; Kirkham, J; Price, M; Riley, RD; Salanti, G; White, IR1
Ahluwalia, J; Das, R; Dogra, RK; Jamwal, M; Rohit, MK; Sharma, P; Vishwajeet, V1
Battah, A; El-Fattah, AAA; Nabil, M; Sadik, NAH; Sedrak, H1
Aguilar, E; Altes, P; Álvarez, LR; Esteban, C; García-Díaz, AM; Jiménez, PE; Monreal, M; Perez, P; Sahuquillo, JC; Sánchez Muñoz-Torrero, JF1
Kvaløy, JT; Midttun, Ø; Mjelva, ØR; Nilsen, DWT; Nordrehaug, JE; Nygård, O; Pedersen, EKR; Seifert, R; Svingen, GFT; Ueland, PM1
Jung, JM; Kim, SU; Kwon, DY; Park, JW; Park, MH1
Bugert, P; González Maldonado, S; Grafetstätter, M; Groß, ML; Hüsing, A; Johnson, T; Kaaks, R; Kloss, M; Kühn, T; Pletsch-Borba, L; Sookthai, D1
Bundred, PE; Kasielska-Trojan, A; Manning, JT; Mason, L; Smith-Straney, T1
Becker, DM; Becker, LC; Bielak, LF; Bielinski, SJ; Boerwinkle, E; Bowden, J; Brody, JA; Chasman, DI; Chen, YI; Davey Smith, G; de Maat, MPM; de Vries, PS; Dehghan, A; Delgado, G; Dörr, M; Franco, OH; Fu, YP; Giulianini, F; Groß, S; Guo, X; Hartwig, FP; Hemani, G; Huffman, JE; Johnson, AD; Jukema, JW; Kacprowski, T; Kardia, SLR; Kleber, ME; Koenig, W; März, W; Mathias, RA; McKnight, B; Meitinger, T; Morrison, AC; Müller-Nuraysid, M; O'Donnell, CJ; Pankratz, N; Peters, A; Petersman, A; Peyser, PA; Psaty, BM; Ridker, PM; Rotter, JI; Sattar, N; Smith, JA; Smith, NL; Song, C; Strauch, K; Tang, W; Taylor, KD; Tracy, R; Trompet, S; Uitterlinden, AG; Waldenberger, M; Ward-Caviness, CK; Wiggins, KL; Yanek, LR; Yao, J1
Braekkan, SK; Evensen, LH; Gabrielsen, ME; Hansen, JB; Hveem, K; Mathiesen, EB; Morelli, VM; Njølstad, I; Rinde, LB; Rosendaal, FR; Småbrekke, B1
Bacci, S; De Cosmo, S; Pacilli, A; Trischitta, V1
Fukui, T; Sasaki, K; Tabata, M; Takanashi, S1
Ajello, L; Assennato, P; Caruso, M; Castellano, F; Iacona, R; La Franca, E; Mancuso, D; Novo, S; Sansone, A1
Abdel Gader, AG; Al Aseri, Z; Habib, SS; Kurdi, MI; Suriya, MO1
Kofidis, T; Nithya, V; Plotkin, M; Rufaihah, AJ; Seliktar, D; Shen, J; Vaibavi, SR; Wang, J1
Gorczyca-Michta, I; Górska, R; Wożakowska-Kapłon, B; Włosowicz, M1
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T1
Badimon, L; Cubedo, J; Martin-Yuste, V; Padró, T; Ramaiola, I; Sabate-Tenas, M1
Gu, L; Huang, G; Liang, B; Liu, W; Su, L; Tan, J; Wu, G; Yan, Y1
Brunetti, ND; Correale, M; Cuculo, A; De Gennaro, L; Di Biase, M; Pellegrino, PL1
Baci, D; Bearzi, C; Condorelli, G; Fortunato, O; Gargioli, C; Kossover, O; Latronico, MV; Rizzi, R; Seliktar, D; Shapira-Schweitzer, K1
Dai, W; Li, Y; Lv, YN; Wei, CD; Zheng, HY1
Kim, EK; Kim, NY; Kwak, YL; Shim, JK; Song, JW1
Alwi, I; Atmakusumah, D; Aziz, A; Inggriani, S; Irawan, C; Kosasih, A; Lison, L; Reksodiputro, AH; Santoso, T; Saputra, A; Sudoyo, AW; Wintery, M1
Abbate, R; Bani, D; Becatti, M; Bruschi, G; Fiorillo, C; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Taddei, N1
Chasman, DI; Elias, JA; Loscalzo, J; Ridker, PM; Rose, L1
Alonso-Orgaz, S; Barderas, MG; de la Cuesta, F; García, Á; González-Juanatey, JR; Grigorian-Shamagian, L; Guitián, E; Moreu, J; Ocaranza-Sánchez, R; Parguiña, AF; Rosa, I; Vélez, P1
Badimon, L; Cubedo, J; Juan-Babot, O; Martin-Yuste, V; Padró, T; Peña, E; Ramaiola, I; Sabate, M1
Bojiang, L; Li, J; Tong, L; Wenjin, P; Xiaomin, H; Xin, L; Yingwu, L; Yu, W; Yunyun, W1
Ádány, R; Balogh, E; Balogh, L; Bereczky, Z; Czuriga, I; Édes, I; Fiatal, S; Gindele, R; Katona, É; Mezei, ZA; Muszbek, L1
Averett, RD; Fan, NK; Keegan, PM; Platt, MO1
Assennato, P; Bellia, C; Bonomo, V; Ciaccio, M; Dieli, F; Fiore, M; Giovino, M; Meraviglia, S; Novo, G; Novo, S; Pugliesi, M; Sasso, BL1
Allouche, N; Derbali, F; Ellefi, H; Gammoudi, A; Gharsallah, N; Hajji, R; Kadri, A; Khabbabi, G; Mnafgui, K1
Barsova, RM; Favorov, AV; Favorova, OO; Karamova, IM; Kukava, NG; Kulakova, OG; Lvovs, D; Matveeva, NA; Mustafina, OE; Nasibullin, TR; Osmak, GJ; Ruda, MY; Shakhnovich, RM; Sukhinina, TS; Titov, BV; Tsareva, EY1
Forssell, H; Freitag, M; Halling, A; Lindblad, U; Odeberg, H; Odeberg, J; Persson, ML; Råstam, L; Vaara, I1
Ang, L; Behnamfar, O; Enright, K; Huynh, A; Kaushal, K; Li, S; Lin, F; Mahmud, E; Palakodeti, S; Patel, M; Ramsis, M; Reeves, R; Teh, P1
Cheng, WC; Cheow, ES; de Kleijn, D; Lee, CN; Sorokin, V; Sze, SK1
Bilecen, S; Brandon Bravo Bruinsma, GJ; de Groot, JA; Kalkman, CJ; Moons, KG; Nierich, AP; Spanjersberg, AJ1
Amouyel, P; Arveiler, D; Bingham, A; Canoui-Poitrine, F; Ducimetiere, P; Empana, JP; Evans, A; Ferrieres, J; Haas, B; Juhan-Vague, I; Luc, G; Montaye, M; Morange, P; Ruidavets, JB1
Applegate, RJ; Ketch, TR; Kutcher, MA; Lingle, KC; Sacrinty, MT; Sane, DC; Turner, SJ1
Fefer, P; Hod, H; Matetzky, S; Savion, N; Shenkman, B; Varon, D1
Antoniades, C; Bellander, T; Chalamandaris, AG; Greven, S; Jacquemin, B; Koenig, W; Müller, M; Nyberg, F; Peters, A; Pistelli, R; Plana, E; Salomaa, V; Sunyer, J1
Ahmad-Nejad, P; Borggrefe, M; Elmas, E; Neumaier, M; Weiss, C1
Landoni, G1
Criado Jimenez, A; Moreno Gomez Limon, I; Palomero Rodríguez, MA; Suarez Gonzalo, L; Varela Crespo, C; Villar Alvarez, F1
Gu, DF; Huang, JF; Lu, XF; Wang, LY; Yu, HJ; Zhou, XY1
Assad, JA; Buja, LM; Coulter, S; Fernandes, MR; Perin, EC; Silva, GV; Sousa, AL; Vela, DC; Willerson, JT1
Baum, SR; Baum, VA; Nikitin, YP; Polonskaya, YV; Ragino, YI; Sadovski, EV1
Baldari, F; Bellander, T; Breitner, S; Chrysohoou, C; Greven, S; Heid, IM; Illig, T; Jacquemin, B; Koenig, W; Lanki, T; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Rückerl, R; Schneider, A; Stefanadis, C; Sunyer, J; Wichmann, HE1
Algra, A; Rosendaal, FR; Siegerink, B1
Amoroso, GR; Assennato, P; Balistreri, CR; Caruso, C; Caruso, M; Coppola, G; Fazio, G; Hoffmann, E; Novo, G; Novo, S; Rotolo, A; Turturici, C1
Baccarelli, A1
Fountoulaki, K; Gialeraki, A; Kremastinos, DT; Lekakis, I; Politou, M; Rallidis, LS; Sourides, V; Travlou, A1
Agewall, S; Henareh, L; Jogestrand, T1
Blauw, GJ; Buckley, BM; Cobbe, S; de Craen, AJ; Ford, I; Jukema, JW; Lowe, GD; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG1
Aktoz, M; Ozcelik, F; Tatli, E1
Abd el-Kader, SS; Abu el-Makrem, MA; Ghazaly, T; Mahmoud, YZ; Matta, R; Nassef, NM; Sayed, D; Zakhary, M1
Bellander, T; de Faire, U; Leander, K; Ljungman, P; Nyberg, F; Panasevich, S; Pershagen, G; Rosenlund, M1
Eshraghian, A; Izadi, HR; Naghshvar, F; Pourahmad, M; Shojaie, M1
Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC1
Bellander, T; Breitner, S; Forastiere, F; Hampel, R; Illig, T; Jacquemin, B; Katsouyanni, K; Koenig, W; Lanki, T; Ljungman, P; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Pitsavos, C; Rosenqvist, M; Schneider, A; Sunyer, J; von Klot, S1
Baum, SR; Baum, VA; Nikitin, IuP; Polonskaia, IaV; Ragino, IuI1
Chakravarti, A; Couper, DJ; Folsom, AR; Kucharska-Newton, AM; Pankow, JS; Prineas, RJ; Rea, TD; Rosamond, WD; Siscovick, DS; Sotoodehnia, N1
Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC1
Grønbaek, M; Nordestgaard, BG; Tolstrup, JS1
Carru, C; Deiana, L; Franconi, F; Maoddi, I; Mureddu, G; Musino, L; Partenza, A; Pilo, P; Rossi, R; Spazzafumo, L; Zinellu, A1
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP1
Deev, AD; Metel'skaia, VA; Perova, NV; Ratnikova, LA; Shal'nova, SA; Shkol'nikov, VM; Shkol'nikova, MA1
Barbieri, M; Boccardi, V; Esposito, A; Marfella, R; Paolisso, G; Papa, M; Portoghese, M; Rizzo, MR1
Abbas, CC; Begré, S; Haeberli, A; Saner, H; Schmid, JP; Stutz, M; von Känel, R1
Sinkovic, A1
Ahn, Y; Cho, JS; Hong, YJ; Jeong, MH; Kim, W1
Arbel, Y; Banai, S; Berliner, S; Chundadze, T; Finkelstein, A; Halkin, A; Keren, G; Leshem-Rubinow, E; Rogowski, O; Steinvil, A1
Beer, JH1
Dennis, M; Jackson, C; Lewis, S; Lowe, G; Rumley, A; Sandercock, P; Sudlow, C; Wardlaw, J; Whiteley, W1
Avellone, G; Campisi, D; Di Garbo, V; Guarnotta, V; Parrinello, G; Purpura, L; Scaglione, R; Torres, D1
Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V1
Androulakis, E; Antoniades, C; Briasoulis, A; Papageorgiou, N; Stefanadis, C; Tousoulis, D1
Arbel, G; Aronson, D; Caspi, O; Gepstein, A; Gepstein, L; Habib, M; Seliktar, D; Shapira-Schweitzer, K1
Frikke-Schmidt, R; Grande, P; Haase, CL; Hornstrup, LS; Nordestgaard, BG; Sillesen, H; Tybjærg-Hansen, A1
Caulfield, MJ; Kiechl, S; Morris, GE; Motterle, A; Pender, SL; Willeit, J; Xiao, Q; Ye, S1
Chen, Y; Jin, Z; Li, H; Lv, S; Song, X; Xu, F; Yuan, F; Zhou, Y1
Baumert, J; Greven, S; Karakas, M; Koenig, W; Peters, A; Rückerl, R1
Figueras, J; Garcia-Dorado, D; Lidón, RM; Monasterio, J; Sambola, A1
Bongo, AS; Colli, E; Ferraro, S; Galvani, M; Maffé, S; Marano, G; Panteghini, M; Rossi, L; Santagostino, M; Vendramin, C1
Doğan, A; Erdogan, D; Icli, A; Varol, E1
Kacprzak, M; Kidawa, M; Zielińska, M1
Bakhshaliev, AB; Gadzhiev, RF; Gamidova, ÉS; Kerimova, KN1
Gong, YJ; Huo, Y; Li, JP; Liu, ZP; Momin, M; Wang, CY; Wang, XG; Zhang, Y; Zheng, B1
Chu, JY; Huang, XQ; Li, JM; Lin, KQ; Qi, L; Sun, H; Yang, ZQ1
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J1
Dincić, D; Gligić, B; Jovelić, A; Obradović, S; Ratković, N; Vukotić, S1
Filipiak, KJ; Kołtowski, L; Opolski, G; Rdzanek, A; Stępień, V; Tarchalska-Kryńska, B1
Bova, M; Caruso, C; Caruso, M; Forte, GI; Lio, D; Massenti, MF; Novo, S; Palmeri, M; Scola, L; Vaccarino, L; Vitale, F; Vitale, S1
Ang, L; Ilapakurti, M; Lee, MS; Mahmud, E; Palakodeti, V; Thani, KB1
Chavance, M; Marti, H1
Almenar Bonet, L; Arnau Vives, MA; Martínez Dolz, LV; Morillas Blasco, P; Osa Sáez, A; Osca Asensi, J; Palencia Pérez, MA; Quesada Carmona, A; Rueda Soriano, J; Sanjuán Máñez, R1
Aggarwal, A; Gennari, FJ; Kabbani, SS; Rimmer, JM; Schneider, DJ; Sobel, BE; Taatjes, DJ1
Borrás Pallé, S; Campos Ferrer, C; Gómez Martínez, E; Molina, E; Romero Rodrigo, A; Valentín Segura, V1
Angelino, P; Aruta, E; Bigi, R; Figura, N; Gai, V; Gandolfo, N; Parravicini, PP; Pellicano, R; Ponzetto, A; Rizzetto, M1
Blasco, ML; Bodí, V; Chorro, FJ; Facila, L; Gómez-Aldaraví, R; Insa, L; Llácer, A; Mainar, L; Monmeneu, JV; Núñez, J; Sanchis, J; Sanjuan, R1
Dimcevski, G; Helleberg, I; Holm, J; Kristensen, L; Montvilas, P; Mouritsen, E; Suciu, G; von Eyben, FE; von Eyben, R1
De Faire, U; Falk, G; Hallqvist, J; Leander, K; Wiman, B1
Büttcher, E; Ehlers, R; Eltzschig, HK; Helber, U; Hoffmeister, HM; Kazmaier, S; Szabo, S1
Franz, IW; Hopfenmüller, W; Müller, JF; Röcker, L; Tönnesmann, U; Van Der Meyden, J1
Cui, X; Dang, Q; Huang, F; Ji, M; Jiang, Y; Li, J; Liu, R; Mu, H; Wang, Y1
Amouyel, P; Arveiler, D; Dos Santos, C; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY1
Antonova, OA; Dudnik, OA; Khaspekova, SG; Mazurov, AV; Pevzner, DV; Ruda, MIa; Samko, AN; Semenov, AV; Staroverov, II; Vlasik, TN1
Browett, PJ; Cooke, G; French, JK; Gao, W; Goldschmidt-Clermont, P; Liu-Stratton, Y; Lund, M; McDowell, J; Pohorence, J; Sutton, TM; Szymanski, D; Van de Water, NS; White, HD1
Bell, WR1
Aliev, OI; Maslov, MJ; Plotnikov, MB; Tjukavkina, NA; Vasiliev, AS1
Grip, L; Linder, R; Nørgaard, BL; Oldgren, J; Siegbahn, A; Wallentin, L1
Bartosik-Baschton, A; Baschton, M; Spyra, J; Szczesny, S; Szyguła, J; Słowińska, L; Turczyński, B; Wodniecki, J1
Amouyel, P; Arveiler, D; Bard, JM; Ducimetiere, P; Evans, A; Ferrieres, J; Fruchart, JC; Juhan-Vague, I; Luc, G1
Grant, PJ1
Jaeger, BR1
Liu, Q; Ma, X; Wang, Y; Yuan, Z; Zhu, J1
Bennermo, M; Ericsson, CG; Hamsten, A; Hansson, LO; Held, C; Strandberg, LE; Tornvall, P1
GILCHRIST, E; TULLOCH, JA1
LOSNER, S; VOLK, BW; WILENSKY, ND1
LINKO, E; WARIS, E1
CRASTNOPOL, P; LOSNER, S; VOLK, BW2
FRADKINA, VE1
HOLGER-MADSEN, T1
PHEAR, D; STIRLAND, R1
RECHENBERGER, J1
LASCH, F; THEINL, K1
GILLUM, GN; GORENSTEIN, I; GRAHAM, WK; HAMILTON, A; STEINBERG, MS1
KOZLOVA, VN; SANDLER, RI1
DJORDJEVIC, BS; STRASER, T1
RAEVSKAIA, GA1
KOZHEVNIKOVA, TL1
IRANI, MA1
BRITOV, AN1
BAYLES, TB; FINKELSTEIN, AE; LEVINE, HD; SMITH, JC; WOERNER, TE1
HELLE, I1
EASTHAM, RD; MORGAN, EH1
JAROSCHEWSKI, AJ; SHAWORONKOWA, EK1
FREMONT, RE1
DOBROVOLSKAIA, TI1
IAROSHEVSKII, AIa; ZHAVORONKOVA, EK1
VONKAULLA, E; VONKAULLA, KN1
COTTON, RC; WADE, EG1
KISELEVA, EN; PETROVA, TR1
HUME, R1
FULLERTON, HW; OGSTON, D1
Cesar, LA; Lemos, PA; Mansur, AP; Maranhão, RC; Ramires, JA; Sposito, AC1
Jaeger, BR; Labarrere, CA1
Elikowski, W; Kwaśnikowski, P; Lewandowski, K; Zawilska, K1
Lowe, GD; Morrison, CE; Nieuwenhuizen, W; Rumley, A; Woodward, M1
Brennan, SO; George, PM; Maghzal, GJ1
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L; Tydén, P1
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L2
Bal dit Sollier, C; Choussat, R; Collet, JP; Dalby, M; Drobinski, G; Drouet, L; Gallois, V; Montalescot, G; Soulat, T; Thomas, D; Vicaut, E1
Aznar, J; Contreras, MT; Corella, D; Falcó, C; Martínez-Sales, V; Réganon, E; Vayá, A; Vila, V1
Abrams, CS; Cines, DB1
Martin, F; Martin-Luengo, C; Morinigo, JL; Pabon, P; Palacios, IF; Piedra, I; Sanchez, PL1
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Sabeti, S; Schillinger, M; Schlager, O; Wagner, O1
Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB1
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Muellner, M; Rumpold, H; Sabeti, S; Schillinger, M; Wagner, O1
Basili, S; Bertazzoni, G; Di Francoi, M; Diurni, V; Ferroni, P; Rosa, A; Scarpellini, MG1
Benes, M; Hermens, WT; Richter, R; Speijer, H1
Byrne, CE; Cannon, CP; Fitzgerald, A; Fitzgerald, DJ; Shields, DC1
Engström, G; Hedblad, B; Janzon, L; Jonsson, S; Lind, P; Lindgärde, F; Stavenow, L1
Fujii, A; Funabiki, M; Morikawa, Y; Nishida, Y; Nishizaki, K; Seki, T1
Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A1
Bergovec, M; Mirat, J; Raguz, M; Raos, V; Romić, Z; Sikić-Vagić, J1
Aznar, J; Breña, S; Contreras, MT; Corella, D; Martinez-Sales, V; Réganon, E; Vayá, A; Vila, V; Zorio, E1
Dedobbeleer, C; Melot, C; Renard, M1
Longstaff, C; Whitton, CM1
Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H1
Algra, A; Clark, TG; Gutnikov, SA; Howard, SC; Murphy, MF; Power, DA; Rothwell, PM; van Gijn, J; Warlow, CP1
Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A1
Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S1
Mazurov, AV; Voskoboĭ, IV1
Alonso-Orgaz, S; Burgos, ME; Carrasco, C; de Andrés, R; Farré, J; García-Méndez, A; Gómez, J; Granizo, JJ; López Farré, A; Macaya, C; Mateos-Cáceres, PJ; Núñez, A; Rico, LA1
Agache, I; Bobescu, E; Rădoi, M1
Chudakova, DA; Minushkina, LO; Nosik, VV; Zateĭshchikov, DA1
Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J1
Cavallini, C; Doggen, CJ; Mannucci, PM; Martini, CH; Rosendaal, FR1
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Sanchis, J1
Dimcevski, G; Holm, J; Kristensen, LL; Montvilas, P; Mouritsen, EA; Rasmussen, IH; Suciu, G; Von Eyben, FE; Von Eyben, R1
Kirbis, J; Milutinović, A; Poglajen, G1
Ahn, YK; Cho, JG; Hong, SN; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, DG; Kang, JC; Kim, JH; Kim, KB; Kim, KH; Kim, W; Lee, SH; Lee, YS; Lim, SY; Park, HW; Park, JC; Yun, KH1
Boquist, S; Ericsson, CG; Eriksson, P; Hamsten, A; Lundman, P; Mannila, MN; Samnegård, A; Silveira, A; Tornvall, P1
Duarte, Eda R; Pellanda, LC; Portal, VL1
Battler, A; Ben-Dor, I; Haim, M; Harell, D; Hasdai, D; Iakobishvili, Z; Murininkas, D; Nahon, M; Porter, A; Rechavia, E; Scapa, E1
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Ruiz, V; Sanchis, J1
Demircan, S; Durna, K; Sahin, M; Yazici, M1
Abrignani, MG; Braschi, A; Braschi, G; Coppola, G; Corrado, E; Di Girolamo, A; Novo, S; Rizzo, M1
Dinesen, B; Eliasson, M; Lundblad, D; Rautio, A; Røder, ME1
Evers, S; Hennersdorf, M; Jax, T; Schwalen, A; Steiner, S; Strauer, BE1
Bibis, GP; Cokkinos, DV; Foussas, SG; Glyptis, MP; Kardoulas, AD; Lyras, AG; Makrygiannis, SS; Patsourakos, NG; Prekates, AA; Zairis, MN1
Grønbaek, M; Jensen, MK; Manson, JE; Mukamal, KJ; Pischon, T; Rimm, EB; Stampfer, MJ1
Gardemann, A; Haberbosch, W1
Albertini, F; Archetti, S; Assanelli, D; Galeazzi, G; Grassi, M; Mozzini, C; Negrini, R; Pezzini, A; Salvadori, G1
Amouyel, P; Arocha-Piñango, CL; Arveiler, D; Assmann, G; Bauer, KA; Ben-Shlomo, Y; Benderly, M; Bingham, A; Brunner, E; Campos, G; Cantin, B; Collins, R; Cooper, JA; Cremer, P; Curb, JD; Cushman, M; D'Agostino, R; Dagenais, GR; Danesh, J; Davey Smith, G; de Maat, MP; De Stavola, B; Després, JP; Dickinson, A; Diez-Ewald, MP; Ducimetiere, P; Elwood, PC; Eriksson, H; Espinosa, R; Evans, AE; Fernandez, V; Ferrieres, J; Feskens, EJ; Folsom, AR; Ford, I; Fowkes, FG; Goldbourt, U; Harald, K; Haverkate, F; Hedblad, B; Ireland, B; Jousilahti, P; Juhan-Vague, I; Juzwishin, K; Kannel, WB; Kaptoge, S; Kiechl, S; Kitamura, A; Knottenbelt, C; Koenig, W; Kostis, JB; Kromhout, D; Lamarche, B; Lappas, G; Lee, AJ; Lewington, S; Lind, P; Loewel, H; Lowe, GD; Marchioli, R; Meade, TW; Memon, A; Mijares, M; Miller, GJ; Nagel, D; Nagy, E; Naito, Y; Nyyssönen, K; Palmieri, V; Palosuo, T; Pekkanen, J; Psaty, BM; Rasi, R; Ridker, P; Robertson, M; Rodeghiero, F; Rodriguez, B; Rodriguez-Larralde, A; Rodriquez-Roa, E; Rosenberg, RD; Rosengren, A; Rudnicka, A; Ryder, E; Salomaa, V; Salonen, JT; Sarwar, N; Sato, S; Schulte, H; Shepherd, J; Shipley, M; Smith, FB; Sweetnam, PM; Thompson, SG; Tofler, G; Torres, E; Tosetto, A; Tracy, RP; Tunstall-Pedoe, H; Tuomainen, TP; Tybjaerg-Hansen, A; Vahtera, E; Valagussa, F; Walker, M; Wheeler, J; White, I; Wilhelmsen, L; Willeit, J; Wilson, AC; Wilson, PW; Wood, A; Woodward, M; Wu, K; Yano, K; Yarnell, JW; Yeh, JL1
Aloui, H; Annabi, N; Ben Khalfallah, A; Naffeti, S; Ousji, M; Sanaa, I1
Ginsburg, D1
Brovkin, AN; Chudakova, DA; Dankovtseva, EN; Gaĭdukova, NV; Koroleva, OS; Nosikov, VV; Sidorenko, BA; Tishchenko, VA; Zateĭshchikov, DA1
Bertina, RM; DE Visser, MC; Doggen, CJ; Rosendaal, FR; Uitte DE Willige, S1
Bella, JN; Best, LG; Devereux, RB; Kizer, JR; Lee, ET; Liu, JE; Palmieri, V; Roman, MJ1
Pavlova, TV1
Suggs, L; Wang, X; Wang, Z; Zhang, G; Zhang, J1
Ericsson, CG; Eriksson, P; Hamsten, A; Mannila, MN; Silveira, A1
Stepien, E; Szczeklik, A; Tracz, W; Undas, A1
Petzelbauer, P; Reingruber, S; Zacharowski, K; Zacharowski, P1
Adler, Y; Behar, S; Benderly, M; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R1
Adler, Y; Behar, S; Benderly, M; Boyko, V; Esper, RJ; Fisman, EZ; Matas, Z; Tanne, D; Tenenbaum, A1
Balion, C; Bickel, C; Blankenberg, S; Cambien, F; Gerstein, H; Lonn, E; McQueen, MJ; Münzel, T; Pogue, J; Rupprecht, HJ; Smieja, M; Tiret, L; Yusuf, S1
Allali, Y; Ankri, A; Blanchet, B; Collet, JP; Dumaine, R; Gianetti, J; Lesty, C; Montalescot, G; Payot, L; Silvain, J; Tanguy, ML; Weisel, JW1
Osadnik, T; Poloński, L; Wasilewski, J1
Bodanese, LC; Carrion, LJ; Guaragna, JC; Jaeger, CP; Kalil, RA; Petracco, JB1
Armaganijan, D; Batlouni, M; de Quateli Doi, S; Hirata, MH; Hirata, RD; Luchessi, AD; Picciotti, R; Sampaio, MF; Santos, FC1
Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, KJ; Lubos, E; Messow, CM; Münzel, T; Rupprecht, HJ; Schnabel, R; Sinning, JM; Tiret, L1
de Faire, U; Eriksson, P; Hamsten, A; Leander, K; Mannila, MN; Silveira, A; Wiman, B1
Adány, R; Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Kárpáti, L; Katona, E; Muszbek, L; Pocsai, Z; Széles, G1
Eriksson, P; Farrell, DH; Hamsten, A; Kazmierczak, SC; Lovely, RS; Mannila, MN; Samnegård, A; Silveira, A1
Horstkotte, D; Jaster, M; Knie, W; Pauschinger, M; Rauch, U; Schultheiss, HP; Spencker, S; Stellbaum, C; Willich, T1
Cruz-Flores, S1
Boehm, O; Emeis, JJ; Friedl, P; Henning, R; Koch, A; Mastan, P; Petzelbauer, P; Reingruber, S; Rother, RP; Zacharowski, K; Zacharowski, PA1
Hu, Q; Nakamura, Y; Suggs, LJ; Wang, X; Zhang, G; Zhang, J1
Bennermo, M; Ekström, M; Eriksson, P; Silveira, A; Tornvall, P1
Ehlert, U; Emini, L; Groessbauer, S; Rüdisüli, K; von Känel, R; Wirtz, PH1
Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Kárpáti, L; Katona, E; Muszbek, L; Shemirani, AH1
Aalto, P; Antoniades, C; Bellander, T; Berglind, N; Chrysohoou, C; Forastiere, F; Greven, S; Jacquemin, B; Koenig, W; Küchenhoff, H; Lanki, T; Ljungman, P; Pekkanen, J; Perucci, CA; Peters, A; Rückerl, R; Schneider, A; Sunyer, J; von Klot, S1
Baskot, B; Djenić, N; Gligić, B; Miailović, Z; Obradović, S; Orozović, V; Rafajlovski, S; Ratković, N1
Boothroyd, D; Fortmann, SP; Go, AS; Hlatky, MA; Iribarren, C; Itakura, H; Leung, LL; Quertermous, T; Sobel, BE1
Algra, A; Howard, SC; Rothwell, PM1
MEYERS, L1
Crawley, JT; Lane, DA; Lowe, GD; Rumley, A; Woodward, M1
Biele, J; Hoppmann, P; Kastrati, A; Koch, W; Mueller, JC; Schömig, A1
Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A1
Coma-Canella, I; Martínez de Sizarrondo, S; Orbe, J; Páramo, JA; Rodríguez, JA; Serrano, R; Zudaire, M1
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J1
Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD1
Billing, E; Held, C; Karlsson, MR; Plüss, CE; Wallen, N1
Bellander, T; Jacquemin, B; Katsouyanni, K; Koenig, W; Lanki, T; Löwel, H; Panagiotakos, D; Peters, A; Picciotto, S; Schneider, A; Stafoggia, M1
Arizo, D; Corella, D; Murado, J; Rueda, J; Simó, M; Vayá, A; Zorio, E1
Bang, HO; Ditzel, J; Thorsen, N2
Cepelák, V; Cepeláková, H; Dvorák, J1
Bell, WR; Reiner, AP1
Harenberg, J; Weber, E; Zimmermann, R1
Blömer, H; Keisel, I; Theiss, W; Volger, E; Wirtzfeld, A1
Burridge, DJ; Maskill, MR; O'Connor, JF; O'Malley, BP; Simmonds, JP1
Ikkala, E; Rasi, V; Torstila, I1
Brunetti, A; Cafiero, F; de Zio, A; Girolami, A; Gribaldo, A; Patrassi, GM1
Cannon, PJ; Kaplan, KL; Nichols, AB; Nossel, HL; Owen, J; Sciacca, RR1
Dormandy, J; Ernst, E; Flute, PT; Matrai, A1
Douglas, JT; Forbes, CD; Lowe, GD; Prentice, CR1
Bertina, R; Briët, E; Kolff, J; van der Laarse, A; van Hulsteijn, H1
Goldenberg, E; Haines, AP; Howarth, D; Meade, TW; Millar Craig, MW; North, WR; Raftery, EB; Stirling, Y1
Movshovich, BL1
Goodnough, LT; Ratnoff, OD; Saito, H1
Dormandy, JA3
Hladovec, J; Prerovský, I1
Cristea, A; Cucuianu, MP; Missits, I; Pechet, L; Roman, S; Rus, H1
Drexler, M; Erbel, R; Kasper, W; Meinertz, T; Meyer, J; Pop, T; Prellwitz, W; Rückel, A1
Godal, HC; Holm, B2
Biland, L; Christe, M; Delley, A; Duckert, F; Marbet, GA1
Buchbinder, N; Charuzi, Y; Fishbein, MC; Ganz, W; Kass, R; Maddahi, J; Marcus, H; Miyamoto, A; Mondkar, A; O'Connor, L; Shell, W; Swan, HJ1
Barbakar', NG; Mazaev, AV; Suvorova, LA1
Brayden, GP; Ferguson, DW; Kelly, KJ; Kioschos, JM; Marcus, ML; Schwartz, JL; White, CW1
Beiküfner, P; Panzram, G; Schmechel, H1
Deriagina, GP1
Bergmann, SR; Collen, D; de Geest, H; Fox, KA; Ludbrook, PA; Sobel, BE; Tiefenbrunn, AJ; Van de Werf, F; Verstraete, M1
Fallon, JT; Gold, HK; Grossbard, E; Guerrero, JL; Hoyng, CF; Khaw, BA; Leinbach, RC; Newell, JB; Vislosky, FM; Yasuda, T1
Neidhardt, B; Schricker, KT; Weniger, J1
Godal, HC; Holm, B; Kierulf, P1
Babu, NS; Dixon, J; Frederiksen, R; Kaiser, AB; Kaplan, P; Page, HL; Roach, A; Tacogue, L; Tennant, SN; Venable, TC1
Krosch, H; Schäbitz, J2
Bar-Ilan, I; Cristal, N; Hart, A; Slonim, A1
Gopal, R; Gupta, B; Prasad, DN; Saxena, KK; Srivastava, RK; Srivastava, SS1
Acciavatti, A; Del Bigo, C; Di Perri, T; Forconi, S; Galigani, C; Guerrini, M; Pieragalli, D1
Arrigo, F; Barbera, CM; Consolo, F; Giannetto, M1
Assennato, P; Caimi, G; Raineri, A; Sarno, A1
Haeberli, A; Im Hof, V; Mombelli, G; Straub, PW1
Ganz, W; Geft, IL; Lew, AS; Neer, T; Rodriguez, L; Shah, PK1
Korsan-Bengtsen, K; Larsson, B; Svärdsudd, K; Tibblin, G; Welin, L; Wilhelmsen, L1
Amtorp, O; Gormsen, J; Knudsen, JB; Skagen, K1
Abbate, R; Favilla, S; Gensini, GF; Neri Serneri, GG1
Cucuianu, MP; Missits, I; Olinic, N; Roman, S1
Cowley, MJ; Fisher, LM; Garrett, R; Hastillo, A; Hess, ML; Vetrovec, GW1
Barker, AF1
Caprissi, LF; Castellanos, H; de Caprissi, ES; Ruggiero, HA; Ruggiero, LH1
Haas, R; Harenberg, J; Zimmermann, R2
Davies, MJ; Woolf, N1
Gofferje, H; Horbach, L; Ollenschläger, G; Prestele, H; Schultis, K1
Caimi, G; Raineri, A; Sarno, A1
Cristal, N; Hagay, Z; Hart, A; Ronen, M; Silverman, C; Slonim, A1
Baughman, DJ; Kostis, JB; Kuo, PT1
Caprissi, ES; Caprissi, LF; Castellanos, H; Ruggiero, HA1
Descovich, GC; Gaddi, A; Lenzi, S1
Carvalho, A; Gold, HK; Haber, E; Khaw, BA; Locke, E; Strauss, HW1
Gopal, R; Gupta, B; Prasad, DN; Saxena, KK; Singh, RC; Srivastava, RK; Srivastava, SS1
de Boer, AC; den Ottolander, GJ; Jonker, JJ; Peters, SH1
Löfmark, R1
Alkjaersig, N; Fletcher, AP1
Assennato, P; Caimi, G; Catania, A; Raineri, A; Sarno, A1
Bolińska, H; Judkiewicz, L; Khawam, E; Niewiarowska, J; Wasiak-Radzikowska, M1
Geissler, D; Hörtnagl, H; Kunz, F; Zwierzina, WD1
Allen, J; Bennett, ED; Boyd, MJ; Dodds, AJ; Dormandy, JA; Flute, PT1
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A2
Ames, PR; Brancaccio, V; Iannaccone, L; Pyke, S1
Torbet, J1
Agnelli, G; Callegari, P; Hauert, J; Iorio, A; Parise, P1
Beier, H; Cohen, AF; Günzler, WA; Hopkins, GR; Koster, RW; van der Wouw, PA1
Barrios, L; Benit, E; Collen, D; De Man, F; Hermans, L; Kerdsinchai, P; Muyldermans, L; Van den Heuvel, P; Vanderschueren, S; Vrolix, M1
Bozzoli, C; D'Atena, T; Legnani, C; Massarelli, G; Mazzuca, A; Miniero, R; Muscari, A; Palareti, G; Puddu, GM; Toscano, V1
Lichtlen, PR; Wolf, R1
Deutsch, M; Fischer, M; Halbmayer, WM; Haushofer, A; Radek, J; Schön, R1
Crook, M; Haq, M; Haq, S; Tutt, P1
Baller, D; Gleichmann, U; Mannebach, H; Miche, E; Prohaska, W; Schmidt, H1
Chew, CY; Choo, M; Koh, SC; Ratnam, SS; Viegas, OA1
Koenig, W1
Baller, D; Gleichmann, U; Mannebach, H; Miche, E; Seggewiss, H1
Barasch, E; Behar, S; Benderly, M; Caspi, A; Goldbourt, U; Graff, E; Pelled, B; Reicher-Reiss, H; Reisin, L; Roguin, N1
Martin, M1
de Groote, P; Decoulx, E; Ducloux, G; Leroy, O; Millaire, A1
Meade, TW1
Fowkes, FG1
Haverkate, F; Kienast, J; Pyke, SD; Thompson, SG; van de Loo, JC1
Bennett, GM; Meade, TW; Ross-Murphy, SB; Scrutton, MC; Stirling, Y1
Arveiler, D; Bara, L; Cambien, F; Cambou, JP; Evans, AE; Luc, G; Nicaud, V; Scarabin, PY1
Stringer, KA1
Agraou, B; Asseman, P; Bauters, C; Cosson, A; Devos, P; Jude, B; Lepelley, P; McFadden, EP; Susen, S; Vanhaesbroucke, C1
Clark, P; Cockburn, F; Cowan, RA; Czapla, K; Dunnigan, MG; Farish, E; Hughes, E1
Cremer, P; Elster, H; Labrot, B; Mann, H; Muche, R; Nagel, D; Seidel, D1
Brügemann, J; de Graeff, PA; Hillege, HL; Lie, KI; van Boven, AJ; van der Meer, J; van Doormaal, JJ1
Chandler, WL; Stratton, JR1
Bara, L; Cambien, F; Nicaud, V; Samama, MM; Tiret, L1
Agostoni, P; Grazi, S; Guazzi, MD; Marenzi, GC; Salvioni, A1
Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS1
Kessler, P; Kubícková, M1
Cimminiello, C1
Cesnik, H; Lechner, H; Lechner, P; Walzl, B; Walzl, M1
Harris, S; Hill, RD; Kleiman, NS; Puleo, P; Roberts, R; Schaaff, LJ; Tracy, RP1
Abe, S; Goto, S; Handa, S; Hori, S; Ikeda, Y; Kawai, Y; Ogawa, S; Takahashi, E; Watanabe, K1
Blombäck, M; Green, F; Hamsten, A; Humphries, S1
Aznar, J; Lacueva, V; Martinez, V; Reganon, E; Ruano, M; Vila, V1
Bode, C; Freitag, M; Kreuzer, J; Pestel, E; von Hodenberg, E1
Angós, JA; Cornudella, R; Gálvez, M; Gutiérrez, M; Moreno, JA; Romero, S1
Creamer, JE; Durrington, PN; Hunt, L; Mackness, MI; MBewu, AD; Turkie, WH1
Campbell, S; Gunn, J; Rowlands, L; Trudgill, NJ; Tsikaderis, D; Violaris, AG1
Bergström, K; Chen, J; Hagerman, I; Karlberg, KE; Saldeen, T; Sylvén, C; Wallin, R1
Jespersen, J; Juhan-Vague, I; Thompson, SG1
Anderson, JL; Karagounis, LA; Moreno, FL; Sorensen, SG1
Hummel, L1
Douglas, JT; Dunn, FG; Gemmill, JD; Hillis, WS; Hogg, KJ; Lowe, GD; Rae, AP1
Beamer, N; Coull, BM; de Garmo, P; Knox, R; Seaman, G; Sexton, G1
Allen, A; Anderson, JL; Gomez, MA; Karagounis, LA1
Kinane, DF; Kweider, M; Lowe, GD; McGowan, DA; Murray, GD1
Bartholomeus, I; Bonnier, JJ; Hoffmann, JJ; Melman, PG1
Friesewinkel, O; Marbet, GA; Ritz, R1
Eriksen, UH; Ingerslev, J; Nielsen, TT1
Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M1
Dimitri, G; Graziani, MS; Menegatti, G; Modena, N; Nicoli, M; Righetti, G; Vassanelli, C; Zanolla, L1
Hoegee-de Nobel, E; Nieuwenhuizen, W; Oethinger, M; Seifried, E; Tanswell, P1
Arveiler, D; Bara, L; Cambien, F; Cambou, JP; Evans, AE; Luc, G; Poirier, O; Ricard, S; Samama, MM; Scarabin, PY1
Lowe, GD1
Ho, CH; Jap, TS; Wang, SP1
Jounela, A; Peuhkurinen, K; Risteli, J; Risteli, L1
Arveiler, D; Bara, L; Behague, I; Cambien, F; Cambou, JP; Evans, A; Green, F; Luc, G; Nicaud, V; Poirier, O; Scarabin, PY1
de Faire, U; Ericsson, CG; Grip, L; Hamsten, A; Nilsson, J; Svane, B1
Becker, DJ; Ellis, D; Kuller, LH; Lloyd, CE; Orchard, TJ; Wing, RR1
Amudha, B; Maheswari, RU; Muthu, R; Padma, P; Sathyaraj, D; Shanmugasundaram, KR; Sharada, V; Srinivas, K; Sundaram, P; Veeraraghavan, V1
Bobins, M; Bukowska, H; Chełstowski, K; Jastrzebska, M; Klinke, M; Naruszewicz, M1
Bergström, K; Chen, J; Eneroth, P; Hagerman, I; Karlberg, KE; Saldeen, T; Sylvén, C; Wallin, R1
Assmann, G; Cullen, P; Heinrich, J; Schulte, H1
Marian, AJ; Roberts, R; Safavi, F; Yu, Q1
Becker, RC; Bovill, EG; Braunwald, B; Cannon, CP; Knatterud, GL; Randall, A; Thompson, B; Tracy, RP1
Davies, MJ1
Giraldi, F; Grazi, S; Guazzi, MD; Lauri, G; Marenzi, G; Perego, GB; Salvioni, A1
Arima, T; Harubyu, N; Miyahara, K; Miyauchi, T; Nagata, H; Sanada, J; Sonoda, M; Uenomachi, H1
Blümchen, G; Brestrich, M; Claus, J1
Iida, M; Iso, H; Kitamura, A; Kiyama, M; Kobayashi, T; Komachi, Y; Naito, Y; Sato, S1
Chiaranda, G; Ferlito, S; Gallina, M; Mangiameli, S1
Alessi, MC; Haverkate, F; Jespersen, J; Juhan-Vague, I; Pyke, SD; Thompson, SG1
Andreotti, F; Davies, GJ; Haider, AW; Kluft, C; Maseri, A; Thompson, GR1
Blombäck, M; Fatah, K; Hamsten, A; Karpe, F; Silveira, A; Tornvall, P1
Apostolopoulos, T; Bosinakou, E; Kyriakides, M; Tentolouris, C; Tousoulis, D; Toutouzas, P1
Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A1
Kántor, M; Lestyán, K; Márk, L; Orosz, I; Wolf, I1
Cremer, P; Elster, H; Labrot, B; Mann, H; Müller-Berninger, R; Nagel, D; Seidel, D1
Barradell, LB; Goa, KL; Plosker, GL1
Eberbach, A; Gardemann, A; Haberbosch, W; Hehrlein, FW; Katz, N; Schwartz, O; Tillmanns, H; Waas, W; Weiss, T1
Collen, D; De Man, F; Dens, J; Desmet, W; Hermans, L; Kerdsinchai, P; Van de Werf, F; Van den Heuvel, P; Vanderschueren, S; Vrolix, M1
Carter, AM; Grant, PJ; Ossei-Gerning, N; Wilson, IJ1
Bach, D; Dieplinger, H; Grabensee, B; Koch, M; Kronenberg, F; Kutkuhn, B; Trenkwalder, E1
Haas, A; Walzl, B; Walzl, M1
Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L1
Amore, C; D'Orazio, A; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Zito, F1
Bovill, EG; Brown, RG; Cannon, CP; Collen, D; Kleiman, NS; Mahan, E; Mann, KG; Rogers, WJ; Sopko, G; Stump, DC; Thompson, B; Tracy, RP; Williams, DO; Zaret, BL1
Carter, A; Grant, PJ; Kohler, HP; Mikkola, H; Ossei-Gerning, N; Stickland, MH1
Carter, AM; Grant, PJ; Kohler, HP; Stickland, MH1
Pileggi, N; Qi Wu, H; Sobel, JH; Trakht, I1
Bosinakou, E; Davies, G; Tentolouris, C; Tousoulis, D; Toutouzas, P1
Heidland, UE; Heintzen, MP; Klimek, WJ; Michel, CJ; Strauer, BE; Willers, R1
Helber, U; Heller, W; Hoffmeister, HM; Jur, M; Ruf-Lehmann, M; Seipel, L1
Channer, KS; English, KM; Jones, TH; Steeds, R1
de Zwaan, C; Glatz, JF; Hermens, WT; Mullers-Boumans, ML; Pelsers, MM1
Baumann, G; Dübel, P; Gliech, V; Grohmann, A; Langel, J; Laule, M; Melzer, C; Stangl, K; Stangl, V; Tenckhoff, B; Wernecke, KD; Ziemer, S1
Bots, ML; de Jong, PT; de Maat, MP; Grobbee, DE; Haverkate, F; Hofman, A; Kluft, C; van der Bom, JG1
Gnarpe, H; Gnarpe, J; Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L1
Danielsen, R; Morrissey, JH; Onundarson, PT; Thors, H; Vidarsson, B1
Kario, K; Kobayashi, H; Matsuo, M; Matsuo, T; Suzuki, S1
Craig, BM; Freeburn, JC; Gilmore, WS; Johnson, D; Sinnamon, DG; Strain, JJ; Wallace, JM1
Carlsson, J; Meierhenrich, R; Neuhaus, KL; Pfarr, E; Seifried, E; Smolarz, A; Tebbe, U1
Ankri, A; Bastard, JP; Bearez, E; Bigonzi, F; Carayon, A; Carrie, D; Chevrot, M; Dutoit, A; Flammang, D; Jardel, C; Montalescot, G; Philippe, F; Poulard, JE; Thomas, D; Vicaut, E1
Behar, S; Brunner, D; Goldbourt, U; Reicher-Reiss, H1
Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY1
Boldi, E; Bonandi, L; Curello, S; D'Aloia, A; Dei Cas, L; Giovannini, G; Metra, M; Nodari, S; Zanini, R1
Aubó, C; Bosch, M; Marrugat, J; Masiá, R; Pavesi, M; Pena, A; Sentí, M1
Egberg, N; Eriksson, M; Mittleman, MA; Orth-Gomér, K; Schenck-Gustafsson, K; Wamala, S1
Howard, DB; Schneider, DJ; Sobel, BE; Taatjes, DJ1
Frojmovic, M; Théroux, P; Xiao, Z1
Cambien, F1
Behar, S1
Hennekens, CH; Ma, J; Ridker, PM; Stampfer, MJ1
Dernellis, J; Diamantopoulos, L; Stefanadi, E; Stefanadis, C; Toutouzas, K; Toutouzas, P; Tsiamis, E; Vlachopoulos, C1
Goto, S; Hande, S; Ikeda, Y; Sakai, H1
Donati, MB; Iacoviello, L1
Arora, R; Bodenheimer, MM; Brown, MW; Case, RB; Dwyer, EM; Gillespie, JA; Goldstein, RE; Greenberg, H; Hochman, J; Krone, RJ; Liang, CS; Lichstein, E; Little, WC; Marcus, FI; Marder, VJ; Moss, AJ; Oakes, D; Sparks, CE; Van Voorhees, L; Watelet, LF; Weiss, HJ; Zareba, W1
Michels, HR1
Titus, K1
Di Blasio, A; Di Minno, G; Marchioli, R; Maresca, G1
Maksimenko, AV; Tischenko, EG1
Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM1
Ridker, PM1
Dickinson, RJ; Howard, AN; Palmer, CR; Rajput-Williams, J; Williams, NR1
de Faire, U; Hallqvist, J; Reuterwall, C; Theorell, T; Tsutsumi, A1
D'Orazio, A; De Lucia, D; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Negrini, R; Zito, F1
Bardorfer, I; Gadzijev, A; Keber, D; Keber, I; Vrtovec, B1
Bode, C; Kohler, B; Kübler, W; Peter, K; Schwarz, M; Straub, A; Volkmann, M1
Assmann, G; Heinrich, J; Junker, R; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A1
Boon, NA; Newby, DE1
Bode, C; Kohler, B; Kübler, W; Moser, M; Nordt, T; Peter, K; Ruef, J; Schmittner, M; Smalling, R1
Aznar, J; Fayos, L; Ferrando, F; Martínez-Sales, V; Reganon, E; Ruano, M; Vila, V1
Asano, H; Suzuki, M; Tanaka, H; Usuda, S1
Cappucci, G; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Vecchione, G1
Goldkhammer, EI; Kharash, LM1
Abrignani, MG; Braschi, A; Braschi, GB; Caruso, R; Di Girolamo, A; Novo, G; Novo, S; Strano, A; Tantillo, R1
Ford, ES; Giles, WH1
Ek, P; Frithz, G; Haglund, AC; Ronquist, G1
Applegate, D; Grieninger, G; Hertzberg, KM; Steben, LS1
Agneskirchner, J; Bode, PA; Reininger, AJ; Spannagl, M; Wurzinger, LJ1
Botticella, F; Buono, C; Chiariello, M; Cirillo, P; Condorelli, M; Ezban, M; Golino, P; Guarino, A; Lambiase, C; Piro, O; Ragni, M; Ravera, A; Scognamiglio, A1
Maurer, MC; Trumbo, TA1
Andreotti, F; Di Sciascio, G; Leone, AM; Manzoli, A; Sperti, G; Zecchi, P1
Elikowski, W; Grzywacz, A; Psuja, P; Zawilska, K; Zozulińska, M1
Dagianti, A; Penco, M; Romano, S; Tozzi-Ciancarelli, MG1
Johnson, TJ1
Armiger, LC; Norris, RM; White, HD; Woo, KS1
Iida, M; Imano, H; Iso, H; Kitamura, A; Kiyama, M; Komachi, Y; Naito, Y; Nakagawa, Y; Nakamura, M; Okamura, T; Sato, S; Shimamoto, T1
Fisher, SD; Hochman, J; Krone, RJ; Liang, C; Marder, VJ; Moss, AJ; Sparks, CE; Zareba, W1
Lindahl, B; Siegbahn, A; Toss, H; Venge, P; Wallentin, L1
Caslake, MJ; Cooney, J; Ford, I; Krishna, M; Lowe, GD; Macphee, CH; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A; Suckling, KE; Wilkinson, FE1
Bertina, RM; Cats, VM; Doggen, CJ; Rosendaal, FR1
Adamus, J; Gil, M; Olszewski, R; Zarebiński, M1
Blann, AD; Landray, MJ; Lip, GY; Lydakis, C; Nuttall, SL; Watson, RD1
Boyle, EM; Erlich, JH; Fearns, C; Kojikawa, O; Kovacich, JC; Labriola, J; Luther, T; Mackman, N; Martin, TR; Morgan, EN; Pohlman, TH; Santucci, RA; Verrier, ED; Yun, W1
Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G1
Aliberti, G; Corvisieri, P; De Michele, LV; Minisola, S; Proietta, M; Pulignano, I1
Eriksson, KF; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L1
Ami, RB; Barshtein, G; Berliner, S; Eldor, A; Goldberg, Y; Keren, G; Miller, H; Prochorov, V; Roth, A; Shapira, I; Yedgar, S; Zeltser, D1
Halinen, M; Kemppainen, A; Koukkunen, H; Penttila, I; Penttilä, K; Pyörälä, K; Rantanen, T1
Eto, K; Goto, S; Handa, S; Ikeda, Y; Isshiki, T; Ochiai, M; Sato, T; Takeshita, S; Terakura, M1
Alpsoy, S; Ata, N; Cavusoglu, Y; Gorenek, B; Timuralp, B; Unalir, A1
Hirano, T; Kazumi, T; Yoshino, G1
Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A1
Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Lacroix, B; Luc, G; Mennen, L; Scarabin, PY1
Bakken, A; Berg, K; Bohn, M; Erikssen, J; Kierulf, P; Pedersen, JC; Retterstol, L1
Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S1
De Backer, G; De Buyzere, M; De Pauw, M; De Sutter, J; Dierckx, R; Gheeraert, P; Taeymans, Y; Van de Wiele, C; Voet, J1
Curran, JM; Fatah-Ardalani, K; Green, FR; Humphries, SE; Tornvall, P1
Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Funke-Kaiser, H; Gautier-Bertrand, M; Herrmann, SM; Kee, F; Morrison, C; Nicaud, V; Orzechowski, HD; Paul, M; Schmidt-Petersen, K1
Benedetta, M; Castelnuovo, AD; Colombo, M; Gattone, M; Giannuzzi, P; Gramoni, A; Iacoviello, L; Picco, D; Soffiantino, F1
Behar, S; Benderly, M; Boyko, V; Brunner, D; Goldbourt, U; Graff, E; Mandelzweig, L; Reicher-Reiss, H; Shotan, A; Tanne, D1
Blake, GJ; Lindpaintner, K; Ridker, PM; Schmitz, C1
Bijsterveld, NR; Boekholdt, SM; Büller, HR; Levi, M; Moons, AH; Peters, RJ1
Aznar, J; Martinez, M; Martínez-Sales, V; Palencia, MA; Réganon, E; Vayá, A; Vila, V1
Barmeyer, J; Bojara, W; Germing, A; Grewe, P; Lawo, T; Lemke, B; Machraoui, A; von Dryander, S1
Acevedo, M; Foody, JM; Pearce, GL; Sprecher, DL1
Bakken, A; Berg, K; Bohn, M; Eikvar, L; Erikssen, J; Retterstol, L1
Donati, MB; Iacoviello, L; Vischetti, M; Zito, F1
Baker, IA; Bayer, A; Ebrahim, S; Elwood, PC; Pickering, J1
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O1
Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Miccio, M1
Giannitsis, E; Katus, HA; Steen, H1
Adamus, J; Gil, M; Zarebiński, M1
do Rosário, HS; e Silva, JM; Monteiro, J; Perdigão, C; Saldanha, C; Sargento, L1
Egberg, N; Eksborg, S; Eriksson-Berg, M; Schenck-Gustafsson, K1
Barshtein, G; Ben-Ami, R; Berliner, AS; Eldor, A; Roth, A; Sheinman, G; Yedgar, S1
Aznar, J; Martínez-Sales, V; Réganon, E; Vaya, A; Vila, V1
Bigger, JT; Chien, S; Jan, KM1
Abildgaard, U; Lie, M; Odegard, OR1
Loo, J1
Andreenko, GV2
Alkjaersig, NJ; Etherington, MD; Jamieson, S; Lawford, P; Lincoln, SV; O'Brien, JR1
Crawford, GP; Ogston, D; Rennie, JA1
Duckett, K; Fulton, RM1
Sharp, AA1
Kher, A1
Movshovich, BL; Naddachina, TA1
Fulton, WF; Summer, DJ1
Gorelova, AM; Guseĭnov, ChS; Likhacheva, ZM1
Ito, T; Matsui, E; Niwa, T; Sassa, H1
Gidron, E; Margalit, R; Oliven, A; Shalitin, Y1
Andreenko, GV; Bessolitsyna, LA; Sargin, KE1
Blomhoff, JP; Enger, SC; Gjone, E; Ritland, S; Skrede, S1
Vedin, A; Wilhelmsson, C1
Lundsgaard-Hansen, P1
Kakkar, VV3
Alkjaersig, NK; Fletcher, AP; Ghani, FM; Owens, O; Tulevski, V1
Belousov, IuB; Liusov, VA; Panchenko, EP; Savenkov, MP; Sidorskiĭ, AL1
Di Perri, T1
Davies, MJ; Fulton, WF; Robertson, WB1
Arnesen, H; Bjerkedal, I; Godal, HC; Skjaeggestad, O1
Belousov, IuB; Nemiro, VK; Panchenko, EP; Pivovarov, VA1
Fedorishko, SS; Palamarchuk, VI; Revutskiĭ, EL; Vendt, VP1
Gupta, B; Kulshrestha, VK; Prasad, DN; Saxena, KK; Srivastava, VK1
Johnsson, H; Orinius, E; Paul, C1
Prasad, DN; Saxena, KK; Srivastava, RK1
Kumar, M; Mehrotra, MP; Misra, SD; Mital, HS; Sondhi, SP1
Bellotti, G; Décourt, LV; Diamet, J; Lage, SH; Pillegi, F; Ping, WC; Ramires, JA1
Głuszek, J; Jasiński, K; Krug, H; Smarsz, C1
Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C1
Seth, HN; Sharma, SC1
Chernysheva, LN; Urbaniuk, KG1
Bohenszky, G; Fendler, K; Mátrai, A1
Cherry, GW; Opie, LH1
Boisseau, M; Bouloumie, J; Bricaud, H; Broustet, JP; Emeriau, JP1
Heene, DL; Matthias, FR; Reinicke, R1
Babeau, P; Pras, P1
Straub, PW1
Kohlmann, U; Müller, G; Schäbitz, J1
Caimi, G; La Bruzzo, S; Sarno, A1
Lasch, HG; Matthias, FR; Reinicke, R1
Matsuda, T; Murakami, M1
Amsterdam, EA; Carretta, RF; DeNardo, GL; Kraus, JF; Lies, JE; Mason, DT; Miller, RR; Wampold, DB1
Erhardt, LR; Sjögren, A1
Fulton, WF; Sumner, DG1
Ogston, D; Rennie, JA1
Braun, P; Gedeon, A; Meskó, E1
Neugebauer, G1
Bol'shakova, RM; Dukhina, MA; Furkalo, NK; SolovtsovA, KM1
Asoskov, VA1
Arutiunov, GP; Razumov, VB1
Bartov, E; Cristal, N; Ho, W; Ronen, M; Silverman, C; Stern, J1
Eger, H; Fiehring, H; Reichelt, D; Reimann, G; Schilling, B; Sedlarik, K; Vollmar, F; Wilde, J1
Asano, E; Hata, Y; Tsushima, M1
Chernack, W; Koss, M; McIntosh, R; Nozawa, M; Reemtsma, K; Weber, C; Weil, R1
Conkie, JA; Davidson, JF; Walker, ID; Young, P1
Dintenfass, L; Forbes, CD3
Emerson, PA1
Bulin, VA; Iliushina, IP; Mazur, NA; Metalitsa, VI; Zhukov, VN1
Bleifeld, W; Holzhüter, H; Meyer, J; Stühlen, HW; Wende, W; Wenzel, E1
Niederle, P; Prerovský, I1
Boman, G; Erhardt, LR; Unge, G1
Hermes, R; Koehler, M; Miyashita, C; Pindur, G; Schieffer, H; Sen, S; Wenzel, E1
Mamont, B; Sawicka, B1
Araújo, A; Ferreira, D; Geraldes, MJ; Monteiro, J; Nunes, V; Pais, F; Perdigão, C; Ribeiro, C; Varela, MG1
Burr, ML; Fehily, AM; Holliday, RM; Whitehead, PJ1
Gutteridge, CN; Ranjadayalan, K; Timmis, AD; Umachandran, V1
Pekkanen, J; Rasi, V; Salomaa, V1
Gläsle-Schwarz, L; Neuhaus, KL; Seifried, E; Tanswell, P; Tebbe, U; Wojcik, J1
Blombäck, B; Blombäck, M; Fatah, K; Hamsten, A1
Bär, F; Meyer, J; Ostermann, H; Schmitz-Huebner, U; van de Loo, J; Windeler, J1
Badimon, JJ; Badimon, L; Chesebro, JH1
Cazenave, JP; Grunebaum, L; Mossard, JM; Sacrez, A; Wiesel, ML1
Hughes, LO; Imeson, J; Kelleher, CC; Martin, JC; Meade, TW; Mitropoulos, KA; Reeves, BE1
Crook, M; Haq, M; Tutt, P1
Cerbone, A; Di Minno, G; Grandone, E; Mancini, M; Margaglione, M; Vecchione, G1
Arnout, J; Collen, D; de Bono, D; Rapold, HJ; Simoons, M; Verstraete, M1
Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C2
Califf, RM; Ellis, SG; George, BS; Kereiakes, DJ; Samaha, JK; Sigmon, K; Topol, EJ; Wall, TC; Worley, SJ1
de Faire, U; Hamsten, A; Landou, C; Olsson, G; Perski, A; Theorell, T1
Arntz, HR; Heitz, J; Perchalla, G; Roll, D; Schäfer, JH; Schröder, R1
Ernst, E2
Andreotti, F; Brunelli, C; Buller, N; Caponnetto, S; Foale, R; Fussell, A; Hackett, D; Haider, AW; Lipkin, D; Shahi, M1
Egashira, K; Kawai, K; Nagano, M; Nakamura, M; Sakuma, A; Tomoike, H1
Hoegee-de Nobel, H; Nieuwenhuizen, W; Oethinger, M; Seifried, E; Tanswell, P1
Bath, PM; Burr, ML; Martin, JF1
Cohen, AF; Kluft, C; Knot, EA; Leebeek, FW; Los, P; Six, AJ1
Ho, CH; Wang, SP1
Guriev, SB; Irgashev, SB; Koteliansky, VE; Shekhonin, BV1
Schelm, JA; Simpson, PJ; Smith, GF1
Bahr, RD; Braunwald, E; Flaherty, JT; Gurewich, V; Kirshenbaum, JM; Levine, HJ; Loscalzo, J; Schumacher, RR; Topol, EJ; Wahr, DW1
Chen, J; Gao, R; Kou, W; Lu, Z; Ma, J; Tao, P; Xu, Y; Yao, K; Yu, Q; Zhu, J1
Enenkel, W; Fischer, M; Fritsch, S; Pollak, H1
Barbosa, V; Caramelli, B; de Albuquerque, CP; Gebara, O; Maranhão, R; Pileggi, F; Santos Filho, RD; Tranchesi Júnior, B; Vinagre, C1
Bode, C; Hautmann, M; Kreuzer, J; Kübler, W; Nordt, T; von Hodenberg, E1
Chamone, DF; Cobbaert, C; Tranchesi, B; Van de Werf, F; Vanhove, P; Verstraete, M1
Holmbom, B; Lindström, M; Näslund, U; Thornell, LE1
Jancsó, T; Mihai, K1
Bonnier, JJ; Hoffmann, JJ1
Bates, ER; Clair, WK; George, BS; Kereiakes, DJ; Sane, DC; Sigmon, KN; Stack, RS; Stoddard, MF; Stump, DC; Topol, EJ1
Berke, AD; Bovill, EG; Collen, D; Feit, F; Frederick, M; Gore, JM; Hillis, LD; Lambrew, CT; Stump, DC; Terrin, ML1
Alexander, HM; Dobson, AJ; Heller, RF; Lloyd, DM1
Attubato, MJ; Drew, TM; Feit, F; McDonald, MJ; McKendall, GR; Sharaf, BL; Teichman, S; Thomas, ES; Williams, DO1
Rapold, HJ1
Hultin, MB1
Gregor, J; Hamet, A; Malý, J; Pecka, M; Pidrman, V; Siroký, O; Tichý, M; Vodicka, L1
Eichner, ER1
Bellotti, G; Caramelli, B; Chamone, D; de Albuquerque, CP; Gebara, OC; Matsumoto, C; Pileggi, F; Santos Filho, RD; Tranchesi Júnior, B1
Dykun, IaV; Malaia, LT; Shuliak, LN; Topchiĭ, II; Volkov, VI1
Broadhurst, P; Hughes, L; Imeson, JD; Kelleher, C; Raftery, EB1
Bogár, L; Jávor, T; Juricskay, I; Simor, T; Tóth, K1
Goldhaber, SZ; Hirsch, DR1
Abbate, R; Bonechi, F; Gensini, GF; Prisco, D; Scarti, L; Tramontana, M1
Follenfant, MJ; Ford, AJ; Hughes, B; Longridge, DJ; Maxwell, MP1
Hamsten, A; Wiman, B1
Bette, L; Jung, F; Miyashita, C; Ozbek, C; Pindur, G; Schieffer, H; Schwerdt, H; Sen, C; Wenzel, E1
Grossman, B; Kudryk, B; Owen, J; Sobel, J1
Kannel, WB1
Jávor, T; Juricskay, I; Mezey, B; Simor, T; Tóth, K1
Brügemann, J; Hillege, H; Lie, KI; Takens, BH; van der Meer, J1
Agmon, J; Davidson, E; Fuchs, J; Pinhas, A; Rotenberg, Z; Weinberger, I1
Esparaz, B; Green, D; Kies, M; Kuzel, T1
Aznar, J; Lacueva, V; Laiz, B; Regañón, E; Ruano, M; Vila, V1
Jespersen, J; Munkvad, S; Nieuwenhuizen, W1
Baur, HR; Gallino, A; Haeberli, A; Straub, PW1
Cassetti, M; Massoli, PD; Materazzi, M; Palazzesi, G1
Bounameaux, H; Collen, D; De Cock, F; Lijnen, HR; Verstraete, M1
Hagert, M; Metzner, H; Rode, B1
Gallino, A; Haeberli, A; Hess, T; Mombelli, G; Straub, PW1
Tilsner, V1
Collen, D; de Geest, H; Van de Werf, F; Vanhaecke, J; Verstraete, M1
Hanssen, M; Monassier, JP1
Gram, J; Jespersen, J; Kluft, C1
Bleifeld, W; Diefenbach, C; Erbel, R; Hamm, C; Mathey, D; Meyer, J; Ostermann, H; Pop, T; Schmitz-Hübner, U; Schofer, J1
Bode, C; Kuebler, W; Schoenermark, S; Schuler, G; Schwarz, F; Zimmermann, R1
Chen, AB; Collen, D; Hopkins, A; Stump, DC; Topol, EJ1
Büdinger, M; Heinrich, D; Oehler, G; Schöndorf, T1
Barthels, M; Daniel, WG; Fischer, K; Gulba, DC; Lichtlen, PR; Polensky, U; Reil, GH; Welzel, D1
Baur, H; Haeberli, A; Kuemmerli, H; Rapold, HJ; Weiss, M1
Bennett, KA; Booth, DC; Branco, MC; DeMaria, AN; Grines, CL; Gurley, JC; Nissen, SE1
Anderson, L; Califf, RM; Collen, D; Masek, R; Sigmon, K; Stump, DC; Thornton, D; Topol, EJ1
Feuerer, W; Jeep-Tebbe, S; Neuhaus, KL; Niederer, W; Tebbe, U; Vogt, A1
Barbash, GI; Hod, H; Laniado, S; Miller, HI; Modan, M; Rath, S; Roth, A; Seligsohn, U; Zahav, YH; Zivelin, A1
Bareiss, P; Cazenave, JP; Drawin, T; Grunebaum, L; Kieny, JR; Mossard, JM; Roul, G; Sacrez, A; Wiesel, ML1
Chen, ZJ; Tao, SQ; Yao, SK2
Sha, LR; Song, XH; Xu, NT; Zhang, LP; Zhang, Y1
Aznar, J; Laiz, B; Regañón, E; Vila, V1
Cucchi, G; Ferrara, E; Sardeo, C1
Chamberlain, DA1
Guriev, SB; Irgashev, ShB; Kotelianskiĭ, VE; Shekhonin, BV1
Bleifeld, W; Burmester, L; Erlemeier, HH; Mathey, DG; Schofer, J; Zangemeister, W1
Swahn, E; von Schenck, H; Wallentin, L1
Blanke, H; Egbring, R; Höffken, H; Joseph, K; Leschke, M; Schmidtsdorff, A; Strauer, BE1
Fratino, P; Grignani, G; Pacchiarini, L; Salerno, JA; Storti, C; Zucchella, M1
Kobayashi, N1
Tulchinsky, M; Wilensky, RL; Wish, M; Zeller, JA1
Bernard, R; Bory, M; Brower, RW; Collen, D; de Bono, DP; Erbel, R; Huhmann, W; Lennane, RJ; Lubsen, J; Verstraete, M1
Bleifeld, W; Brower, RW; Charbonnier, B; Collen, D; de Bono, DP; Dunning, AJ; Lennane, RJ; Lubsen, J; Mathey, DG; Verstraete, M1
Blombäck, M; Dahlén, G; de Faire, U; Hamsten, A; Landou, C; Szamosi, A; Walldius, G; Wiman, B1
Berglund, U; von Schenck, H; Wallentin, L1
Alkjaersig, NK; Fletcher, AP1
Aĭngorn, ED; Andreenko, GV; Belokon', NA; Karabasova, MA; Zabotina, ON1
Just, H; Kasper, W; Meinertz, T; Schumacher, M1
Bergentz, SE1
Collen, D; Nobuhara, M; Van de Werf, F1
Graor, RA; Hotchkiss, A; Lucas, FV; Robison, AK; Sobel, BE; Tiefenbrunn, AJ1
Conard, J; Horellou, MH; Nguyen, G; Samama, M1
Bell, WR; Noe, DA1
Forman, SA; Mueller, HS; Rao, AK1
Boissel, JP; Leizorovicz, A; Peyrieux, JC1
Bell, WR; Berke, A; Jaffe, A; Knatterud, G; Ockene, I; Pratt, C; Rao, AK; Robertson, TL; Schreiber, TL; Terrin, ML1
Brochier, M; Charbonnier, B; Lang, M1
Abbottsmith, C; Boswick, JM; Califf, RM; Candela, R; George, BS; Kereiakes, D; Masek, R; O'Neill, WW; Sigmon, KN; Topol, EJ1
Bonnet, JL; Bory, M; Bouvier, JL; Camilleri, JF; Djiane, P; Levy, G; Serradimigni, A1
Cooper, B; Gottlich, CM; Hillis, LD; Schumacher, JR1
Denchev, S; Ivanova, R; Kamenov, V; Tomov, I1
Amoriello, A; Eliseo, V; Piantadosi, FR; Piccenna, L; Vacca, C1
Akioka, K; Hirota, K; Itagane, H; Ochi, H; Oku, H; Takeda, T; Takeuchi, K; Teragaki, M; Yasuda, M1
Bonzel, T; Chen, C; Drexler, H; Hofmann, T; Just, H; Kasper, W; Meinertz, T; Wollschläger, H; Zeiher, A1
Brochier, ML; Cribier, A; Favier, JP; Kulbertus, H; Letac, B; Materne, P; Monassier, JP; Quilliet, L; Sacrez, A1
Aleixo, A; Aniceto Silva, J; Crespo, F; Freire, I; Freitas, R; Real, T; Seabra-Gomes, R; Torres, I1
Brown, MJ; Kinsella, PA; Marder, VJ1
Blanke, H; Leschke, M; Motz, W; Stellwaag, M; Strauer, BE1
Balnave, K; Hughes, R; Moriarty, AJ; Nelson, SD1
Bodzenta, A; Buluk, K; Lussa, A1
Fitzpatrick, PG; Francis, CW; Marder, VJ; Rothbard, RL1
Been, M; Boulton, FE; de Bono, DP; Fears, R; Ferres, H; Muir, AL; Standring, R1
Edwalds, G; Fishbein, MC; Kulber, D; Stancl, M1
Connaghan, DG; Francis, CW; Marder, VJ1
Ambrose, JA; Borrico, S; Cohen, M; Fuster, V; Gorlin, R; Hjemdahl-Monsen, C; Sherman, W1
Connaghan, DG; Francis, CW; Marder, VJ; Scott, WL1
Dobrovol'skiĭ, AB; Dorogun, BN; Pomerantsev, EV; Smirnov, AA; Staroverov, II1
Haeberli, A; Mombelli, G; Monotti, R; Straub, PW1
Bitto, S; Brieda, M; Cassin, M; Charmet, PA; Molaro, G; Rellini, G; Zanuttini, D1
Cristal, N; Shainkin-Kestenbaum, R; Winikoff, Y1
Cercek, B; Ganz, W; Hod, H; Lew, AS; Shah, PK1
Bonnet, JL; Sainsous, J; Serradimigni, A2
Gopal, R; Gupta, B; Kulshrestha, VK; Prasad, DN; Saxena, KK; Singh, RC; Srivastava, SS1
Borodkin, VV; Diukov, IV; Dudaev, VA1
Bhattacharya, SK; Dube, B; Dube, RK; Somani, PN; Tripathi, GK1
Krebber, HJ; Mathey, D; Rodewald, G1
Ernst, E; Matrai, A1
Ovsianko, IuI; Pavlovskiĭ, DP; Shuliarenko, VA1
Bonnier, JJ; Hoffmann, JJ; Van Rey, FJ1
Bell, WR; Topol, EJ; Weisfeldt, ML1
Gangadharan, V; Gordon, S; Hauser, AM; Mammen, EF; Ramos, RG; Stewart, JR; Timmis, GC; Westveer, DC1
Eisenberg, PR; Jaffe, AS; Perez, J; Schectman, K; Sherman, LA; Sobel, BE1
Arutiunova, MS; Gogishvili, AV; Kavtaradze, VG; Mamaladze, GT; Takadze, GSh1
Bachmann, F; Grbic, M; Sigwart, U1
Al-Yusuf, AR; Bhatnagar, SK; Hudak, A1
Gallino, A; Haeberli, A; Straub, PW1
Pope, WT; Walker, AN1
Gross, LF; Lurie, AA; Rogers, WJ1
Kurnik, PB; Ludbrook, PA; Robinson, AK; Sobel, BE; Tiefenbrunn, AJ1
Borer, J; Braunwald, E; Chesebro, JH; Cohen, LS; Dalen, J; Dodge, HT; Francis, CK; Hillis, LD; Knatterud, G; Ludbrook, P1
Filippova, SB; Ikonnikova, EI; Khalfen, ESh; Voronkova, LI1
Maurer, BJ; Shillingford, JP; Wray, R1
Sevitt, S1
Almer, LO; Hedner, U; Nilsson, IM1
Chakrabarti, R; Fearnley, GR1
Erhardt, LR; Lundman, T; Mellstedt, H1
Baele, G; Mussche, M; Vermeire, P1
Beattie, AG; Douglas, AS; Kenmure, AC; Ogston, D; Terry, G; Warlow, C1
Chakrabarti, R1
Kaiser, R; Mosuni, MS; Spöttl, F1
Dement'eva, MP1
Chakrabarti, R; Fearnley, GR; Hocking, ED2
Bell, WR; Goodwin, JF; Pitney, WR1
Attwell, TN; Chakrabarti, R; Fearnley, GR; Hocking, ED; Jackson, D; Mann, RD1
Rex, J1
Johansson, SA1
Cox, FC; Lawrie, TD; Lorimer, AR; Murray, TS1
Baele, G; Mussche, M; Pannier, R; Vermeire, P1
Hauss, WH; Papavassiliou, K; Schmitt, G; Winter, R1
Liusov, VA1
Rachmilewitz, EA; Shahin, W; Zlotnick, A1
Ol'shevski, V1
Bloch, KJ; Colman, RW; Myers, AR; Niewiarowski, S; Thomas, DP1
Hiramaru, M; Manmi, S; Matsuda, T; Murakami, M; Nishio, T1
Lipinski, B1
Andreenko, GV; Chazov, EI; Liutova, LV; Mazaev, AV; Sargin, KE1
Liapina, LA; Panchenko, VM1
Gritsiuk, AI; Petrus', VG1
Akhmetov, KZh; Perepelkin, EG; Zaslavskaia, RM1
Krug, H; Raszeja-Wanic, B; Wochowiak, A1
Chepelak, V1
Pavlishchuk, SA; Petrova, TR1
Woszczyk, J1
Hampton, JR; Hayes, MJ; Morris, GK1
Deutsch, E; Deutsch, M; Enenkel, W; Fasching, W; Gellert, J; Lechner, K; Leodolter, S; Navratil, J; Wolner, E1
Kuller, L1
Emerson, PA; Fleming, PR; Handley, AJ1
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP1
Carroll, JJ; Gallus, AS; Hirsh, J; Hudecki, SM; Minden, JH; O'Brien, SE; Trebilcock, R; Tutle, RJ1
Maurer, B; Shillingford, J; Wray, R1
Breddin, K; Ehrly, AM; Fechler, L; Frick, D; König, H; Kraft, H; Krause, H; Krzywanek, HJ; Kutschera, J; Lösch, HW; Ludwig, O; Mikat, B; Rausch, F; Rosenthal, P; Sartory, S; Voigt, G; Wylicil, P1
Feddersen, C; Gormsen, J; Ploug, J; Tidstrom, B1
Sova, J1
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH1
Austen, WG; Buckley, MJ; Caulfield, JB; Leinbach, RC; Nyilas, E1
Chandler, AB; Chapman, I; Erhardt, LR; Ness, PM; Roberts, WC; Schwartz, CJ; Sherry, S; Simon, TL; Sinapius, D; Spain, DM1
Didisheim, P; Fuster, V; Kazmier, FJ1
Pitney, WR; Pussell, BA1
Hampton, JR; Nicholls, DG1
Baele, G; Barbier, F; Mussche, M; Pannier, R; Vermeire, P1
Cajzl, L; Holubec, J; Kott, J; Krbec, J; Sova, J; Stanĕk, B1
Matsuda, T1
Bolocan, T; Grecu, O; Păunescu-Podeanu, A1
Krylov, AA1
Jeyasingh, K; Maurer, B; Wray, R1
Anderson, ST; Habersberger, PG; Pitt, A1
Javid, JP; Lackner, H1
Roberts, BE; Sheppard, MA; Sibbald, R; Simmons, AV; Tate, G1
Brüschke, G; Schulz, FH; Schulz, J1
Uspenskaia, VG1
Ikkala, E; Kotilainen, M; Pyörälä, K; Ristola, P1
Arnesen, H1
Arnesen, H; Godal, HC; Kierulf, P1
Bonardi, G; Coppi, G1
Benda, L; Klösel, W; Spiess, A; Zenz, W1
Verstraete, M1
Andersen, M; Eliasen, B; Eliasen, P; Kirkegard, C1
Gordon, RJ; Snyder, GK; Taylor, WJ; Tritel, H1
Nelson, C; Okuno, T1
Chapman, I1
Ferguson, EW1
Erhardt, IR1
Handley, AJ; Teather, D1
Emerson, PA; Marks, P1
Terry, G; Warlow, CP1
Amery, A; Roeber, G; Vermeulen, HJ; Verstraete, M1
Biggs, JC; Chesterman, CN1
Benda, L; Redtenbacher, L; Spiess, A; Steinbach, T1
Kakkar, V1
Schulz, FH; Schulz, J1
Gorokhovskiĭ, BI; Novosel'skaya, VV; Tarasova, VA1
Drzewiecki, J; Lipiński, B; Nowak, A1
Johansson, BG; Kindmark, CO; Trell, EY; Wollheim, FA1
Cox, AF; Sheppard, MA; Simmons, AV1
Korsan-Bengtsen, K; Tibblin, G; Wilhelmsen, L1
Shevelev, AT1
Alkjaersig, N; Fletcher, A; Owens, O; Smith, JR; Wolff, G1
Alkjaersig, N; Fletcher, A; Jacob, A; Roy, L1
Trushinskiĭ, ZK2
Basu, HN; Hussain, Q; Mittal, MM; Sharma, ML1
Baklaja-Jevremović, R; Bosnjaković, V; Dordević, BS; Nastić, D1
Kent, SP1
Mrazek, SA1
Belousov, IuB; Liusov, VA1
Parkhotik, II; Sakharchuk, II1
Gupta, NN; Mehrotra, RM; Mittal, MM1
Goldstone, J; Schmid-Schönbein, H; Wells, R1
Hashimoto, Y1
Chernysheva, GV1
Buraschi, J; Sack, ES1
Marcinkowski, A; Olszewski, W1
Nikitin, GA1
Bosisio, P; Lolli, G1
Medvedeva, ZF; Shishkova, TV; Vorob'ev, AI1
Inmon, TW; Langsjoen, PH1
Burckhardt, D; LaDue, JS; Vera, CA1
Borisenko, AP; Moiseev, SG1
Deriagina, GP; Komarova, IN1
Sitar, J1
Jeziorny, J; Kogucki, S; Laskowski, S; Olszewski, W1
Matsuoka, M1
Caroli, RK; Lal, HB1
Pavlishchuk, SA; Petrova, TP1
Allan, AG; Cash, JD; Das, PC; Woodfield, DG1
Gayer, J; Schürholz, J; Voss, D1
Ogston, CM; Ogston, D1
Vykouril, J1
Mikhalev, ID1

Reviews

63 review(s) available for fibrinogen and Cardiovascular Stroke

ArticleYear
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
    The Cochrane database of systematic reviews, 2023, 06-05, Volume: 6

    Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis

2023
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
    Circulation, 2013, Sep-17, Volume: 128, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult

2013
Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease.
    Thrombosis research, 2014, Volume: 133, Issue:6

    Topics: Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment; Stroke

2014
Fibrinogen and cardiovascular disease: genetics and biomarkers.
    Blood reviews, 2011, Volume: 25, Issue:6

    Topics: Animals; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Polymorphism, Genetic

2011
Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Reviews in cardiovascular medicine, 2002, Volume: 3 Suppl 2

    Topics: Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen; Thrombolytic Therapy

2002
The genetics of atherothrombotic disorders: a clinician's view.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:7

    Topics: Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Factor VII; Factor XII; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Inflammation; Insulin Resistance; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides

2003
The HELP system for the treatment of atherothrombotic disorders: a review.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2003, Volume: 7, Issue:4

    Topics: Chemical Precipitation; Coronary Artery Disease; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Lipoproteins, LDL; Male; Myocardial Infarction; Plasmapheresis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome

2003
PATHOPHYSIOLOGY AND MANAGEMENT OF PERICARDITIS.
    Biochemical clinics, 1963, Volume: 2

    Topics: Antistreptolysin; Blood Sedimentation; Diagnosis, Differential; Electrocardiography; Fibrinogen; Humans; Myocardial Infarction; Pericarditis; Pericarditis, Constrictive; Phonocardiography; Physiology

1963
[Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Herz, 2003, Volume: 28, Issue:6

    Topics: Acute Disease; Angioplasty, Balloon, Coronary; Arteriosclerosis; Blood Component Removal; Coronary Restenosis; Female; Fibrinogen; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Myocardial Infarction; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Stents; Stroke; Syndrome; Thrombosis

2003
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
    Current hematology reports, 2004, Volume: 3, Issue:2

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Clinical Trials as Topic; Epitopes; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Mice; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombocytopenia; Tirofiban; Tyrosine

2004
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
    Thrombosis research, 2003, Volume: 112, Issue:4

    Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking

2003
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    JAMA, 2005, Oct-12, Volume: 294, Issue:14

    Topics: Adult; Aged; Cause of Death; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Stroke; Vascular Diseases

2005
Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction.
    Journal of molecular medicine (Berlin, Germany), 2006, Volume: 84, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium

2006
The fibrinolytic system in man.
    Critical reviews in oncology/hematology, 1984, Volume: 2, Issue:1

    Topics: alpha 1-Antitrypsin; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Arteriosclerosis; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney Diseases; Liver Diseases; Myocardial Infarction; Neoplasms; Plasminogen; Pulmonary Embolism; Thrombophlebitis

1984
Hemorrheologic changes following acute myocardial infarction.
    American heart journal, 1982, Volume: 104, Issue:6

    Topics: Alpha-Globulins; Blood Viscosity; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Rheology

1982
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
    Medicine, 1983, Volume: 62, Issue:4

    Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Factor V Deficiency; Factor X Deficiency; Factor XI Deficiency; Factor XII Deficiency; Female; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Kininogens; Male; Middle Aged; Myocardial Infarction; Ohio; Prekallikrein; Thrombocytopenia; Thrombosis; von Willebrand Diseases

1983
[The influence of hemorrheology on the practice of clinical medicine].
    La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

    Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Blood Physiological Phenomena; Blood Viscosity; Diabetic Angiopathies; Erythrocytes; Female; Fibrinogen; Hematocrit; Hemodilution; Hemodynamics; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Models, Biological; Myocardial Infarction; Oxygen Consumption; Phlebitis; Plasmapheresis; Preoperative Care; Raynaud Disease; Rheology

1983
Diagnostic methods of deep vein thrombosis.
    Acta Universitatis Carolinae. Medica, 1983, Volume: 29, Issue:7-8

    Topics: Blood Volume Determination; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Phlebography; Plethysmography; Posture; Pulmonary Embolism; Thermography; Thrombophlebitis; Ultrasonography

1983
Haemorheological aspects of thrombosis.
    British journal of haematology, 1980, Volume: 45, Issue:4

    Topics: Adenosine Diphosphate; Arteries; Blood Flow Velocity; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis

1980
[Hyperfibrinogenemia and cardiovascular risk--epiphenomenon or causal relationship?].
    Versicherungsmedizin, 1995, Apr-01, Volume: 47, Issue:2

    Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Risk Factors; Survival Rate

1995
[Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention].
    Versicherungsmedizin, 1995, Apr-01, Volume: 47, Issue:2

    Topics: Adult; Aged; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors

1995
Fibrinogen in ischaemic heart disease.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Blood Viscosity; Cholesterol; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Prospective Studies; Recurrence; Risk Factors

1995
Fibrinogen and cardiovascular disease in clinical practice.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors

1995
Beyond thrombolysis: other effects of thrombolytic drugs.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:6

    Topics: Animals; Anistreplase; Blood Coagulation; Blood Platelets; Blood Viscosity; Complement System Proteins; Fibrinogen; Humans; Myocardial Infarction; Neutrophils; Reperfusion Injury; Streptokinase; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator

1994
The contribution of thrombosis to the clinical expression of coronary atherosclerosis.
    Thrombosis research, 1996, Apr-01, Volume: 82, Issue:1

    Topics: Animals; Blood Coagulation Factors; Circadian Rhythm; Coronary Artery Disease; Disease Models, Animal; Endopeptidases; Endothelium, Vascular; Fibrinogen; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia; Thrombosis

1996
[Lipid, apoprotein and fibrinogen levels in the blood of male patients following myocardial infarct and the effect of diet on these parameters in ischemic heart disease].
    Orvosi hetilap, 1996, Nov-03, Volume: 137, Issue:44

    Topics: Apolipoproteins; Body Mass Index; Cholesterol; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sex Factors

1996
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Drugs, 1996, Volume: 52, Issue:5

    Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction

1996
Testosterone and coronary heart disease: is there a link?
    QJM : monthly journal of the Association of Physicians, 1997, Volume: 90, Issue:12

    Topics: Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Hyperinsulinism; Male; Myocardial Infarction; Obesity; Risk Factors; Smoking; Testosterone

1997
Genetic prediction of myocardial infarction.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10 Suppl 1

    Topics: Alleles; Angiotensinogen; Apolipoproteins; Aryldialkylphosphatase; Carrier Proteins; Cholesterol Ester Transfer Proteins; Esterases; Fibrinogen; Glycoproteins; Humans; Lipoprotein Lipase; Myocardial Infarction; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Selectins

1999
Gene-environment interactions: implications for cardiovascular disease.
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:3

    Topics: Cardiovascular Diseases; Environment; Factor VII; Female; Fibrinogen; Genetic Variation; Genotype; Hemostasis; Humans; Male; Myocardial Infarction; Polymorphism, Genetic; Risk Factors

1999
A panorama of cardiac risk.
    CAP today, 1999, Volume: 13, Issue:2

    Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E

1999
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:6

    Topics: Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Risk Factors

1999
New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Animals; Dogs; Drug Combinations; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1999
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine

1999
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
    Annals of internal medicine, 1999, Jun-01, Volume: 130, Issue:11

    Topics: Biomarkers; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Reproducibility of Results; Risk Factors; Tissue Plasminogen Activator

1999
Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:3

    Topics: Angiotensinogen; Blood Coagulation Factors; Blood Platelets; Factor VII; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Receptors, Angiotensin

2000
TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    South Dakota journal of medicine, 2000, Volume: 53, Issue:5

    Topics: Drug Evaluation; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Myocardial Infarction; Plasminogen; Randomized Controlled Trials as Topic; Safety; Tenecteplase; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2000
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
    Journal des maladies vasculaires, 2000, Volume: 25, Issue:5

    Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine

2000
[BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Bezafibrate; Cholesterol, HDL; Coronary Artery Disease; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Triglycerides

2001
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.
    Circulation, 2001, Dec-18, Volume: 104, Issue:25

    Topics: Blood Coagulation Factors; Factor V; Fibrinogen; Genetic Variation; Humans; Mutation; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Protein Subunits; Prothrombin

2001
Analysis of gene-environment interaction in coronary heart disease: fibrinogen polymorphisms as an example.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2002, Volume: 3, Issue:1

    Topics: Coronary Artery Disease; Environmental Exposure; Exercise; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Molecular Biology; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Sex Factors

2002
[Clinical implications of rheology in cardiovascular diseases].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:3

    Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis

2002
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)].
    Pathologie-biologie, 1976, Volume: 24 Suppl

    Topics: alpha-Macroglobulins; Animals; Arteriovenous Shunt, Surgical; Chemical Phenomena; Chemistry; Coagulants; Endopeptidases; Enzyme Activation; Fibrinogen; Fibrinolysis; Humans; Hyphema; Intracranial Embolism and Thrombosis; Myocardial Infarction; Plasminogen Activators; Pulmonary Embolism; Retinal Vein; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator

1976
[Age, constitutional and genetic characteristics of the fibrinolysis system].
    Sovetskaia meditsina, 1979, Issue:8

    Topics: Adolescent; Adult; Aged; Aging; alpha-Macroglobulins; Animals; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Body Constitution; Child; Cholesterol; Ethnicity; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Molecular Biology; Myocardial Infarction; Peptide Hydrolases; Physical Exertion; Racial Groups

1979
Fibrinogen uptake test for detection of deep vein thrombosis--a review of current practice.
    Seminars in nuclear medicine, 1977, Volume: 7, Issue:3

    Topics: Cerebrovascular Disorders; Female; Femoral Neck Fractures; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Radioisotopes; Isotope Labeling; Leg; Maternal-Fetal Exchange; Milk, Human; Myocardial Infarction; Postoperative Complications; Postpartum Period; Pregnancy; Pulmonary Embolism; Radiation Dosage; Thrombophlebitis

1977
[Coagulation factors, platelets and coronary heart disease].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:15

    Topics: Blood Coagulation Factors; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator

1991
Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi.
    Circulation, 1992, Volume: 86, Issue:6 Suppl

    Topics: Angina, Unstable; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Nitric Oxide; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Rupture, Spontaneous; Stress, Mechanical; Vasoconstriction; von Willebrand Factor

1992
Fibrinogen and mechanisms of thrombosis. A difficult link.
    European journal of epidemiology, 1992, Volume: 8 Suppl 1

    Topics: Blood Viscosity; Coronary Artery Disease; Coronary Thrombosis; Fibrinogen; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Myocardial Infarction; Platelet Aggregation; Prognosis; Risk Factors

1992
[Correlation between juvenile myocardial infarct in parents and plasma fibrinogen levels in their offspring].
    Orvosi hetilap, 1991, Aug-25, Volume: 132, Issue:34

    Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Coronary Disease; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Risk Factors

1991
Fibrinogen and factor VII as risk factors in vascular disease.
    Progress in hemostasis and thrombosis, 1991, Volume: 10

    Topics: Adult; Aged; Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Cross-Sectional Studies; Epidemiologic Methods; Europe; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Thromboplastin; Triglycerides; United States

1991
Exercise and arthritis. The hematology of inactivity.
    Rheumatic diseases clinics of North America, 1990, Volume: 16, Issue:4

    Topics: Arthritis; Arthritis, Rheumatoid; Blood Platelets; Exercise; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Longevity; Myocardial Infarction; Physical Fitness

1990
[Hemorrheologic parameters in myocardial infarct during the hospitalization phase].
    Orvosi hetilap, 1990, Jan-07, Volume: 131, Issue:1

    Topics: Blood Viscosity; Diuretics; Dose-Response Relationship, Drug; Erythrocyte Count; Female; Fibrinogen; Hematocrit; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Rheology

1990
[Hemorheologic parameters during the 6 months following myocardial infarct].
    Orvosi hetilap, 1990, Apr-08, Volume: 131, Issue:14

    Topics: Blood Flow Velocity; Blood Viscosity; Blood Volume; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction

1990
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
    The American journal of cardiology, 1988, May-01, Volume: 61, Issue:13

    Topics: Adult; Aged; alpha-2-Antiplasmin; Clinical Trials as Topic; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency

1988
Unanswered questions in thrombolysis.
    The American journal of cardiology, 1989, Jul-05, Volume: 64, Issue:2

    Topics: Animals; Blood Coagulation; Blood Platelets; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Vascular Patency

1989
The hematologic consequences of thrombolytic therapy.
    Progress in hematology, 1986, Volume: 14

    Topics: Animals; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Drug Evaluation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombin; Thromboembolism

1986
Incidence of thromboembolism in association with surgical and medical diseases.
    Acta chirurgica Scandinavica. Supplementum, 1988, Volume: 543

    Topics: Cerebrovascular Disorders; Cohort Studies; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Phlebography; Postoperative Complications; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophlebitis

1988
[New thrombolytic agents in myocardial infarction].
    Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80, Issue:12

    Topics: Anistreplase; Coronary Thrombosis; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1987
[Blood rheology as a risk indicator in cardiovascular diseases?].
    Deutsche medizinische Wochenschrift (1946), 1985, Jun-14, Volume: 110, Issue:24

    Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Rheology; Risk

1985
The relation of thromboembolic disease to cardiovascular disease.
    The Milbank Memorial Fund quarterly, 1972, Volume: 50, Issue:1

    Topics: Autopsy; Blood Group Antigens; Cardiovascular Diseases; Environment; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Obesity; Posture; Pulmonary Embolism; Stress, Physiological; Thromboembolism; Thrombophlebitis

1972
[Role of changes in the state of the blood coagulation and fibrinolysis system in the pathogenesis of myocardial infarct and atherosclerosis].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Animals; Antifibrinolytic Agents; Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Chromatography; Electrophoresis; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Myocardial Infarction; Platelet Aggregation; Rats

1974
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction.
    The American journal of cardiology, 1974, Volume: 34, Issue:7

    Topics: Adult; Aged; Arteries; Arteriosclerosis; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis; Thrombosis; Time Factors

1974
Platelet inhibition in the management of thrombosis.
    Thrombosis et diathesis haemorrhagica, 1974, Sep-30, Volume: 32, Issue:1

    Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis

1974

Trials

111 trial(s) available for fibrinogen and Cardiovascular Stroke

ArticleYear
Impact of preoperative fibrinogen concentration on postoperative outcome in patients who received dual antiplatelet therapy in proximity to off-pump coronary bypass surgery.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:7

    Topics: Aged; Blood Loss, Surgical; Clopidogrel; Coronary Artery Bypass, Off-Pump; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Preoperative Care; Preoperative Period; Retrospective Studies; Risk Factors; Ticlopidine

2014
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
    JAMA, 2017, 02-21, Volume: 317, Issue:7

    Topics: Aged; Aorta; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coagulants; Double-Blind Method; Elective Surgical Procedures; Female; Fibrinogen; Heart Valve Prosthesis Implantation; Humans; Intraoperative Complications; Ischemic Attack, Transient; Male; Myocardial Infarction; Netherlands; Operative Time; Prospective Studies; Renal Insufficiency; Risk; Sample Size; Stroke

2017
Thoracic epidural anesthesia decreases C-reactive protein levels in patients undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass.
    Minerva anestesiologica, 2008, Volume: 74, Issue:11

    Topics: Aged; Analgesia, Epidural; Anesthesia Recovery Period; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Local; Bupivacaine; C-Reactive Protein; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Fentanyl; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Pain, Postoperative; Postoperative Complications; Prospective Studies; Systemic Inflammatory Response Syndrome; Troponin I

2008
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
    PLoS medicine, 2009, Jun-23, Volume: 6, Issue:6

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Kaplan-Meier Estimate; Male; Myocardial Infarction; Pravastatin; Risk Factors; Stroke

2009
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:6

    Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol; Cholesterol, HDL; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation Mediators; Italy; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome; Triglycerides; Ultrasonography

2010
[Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction].
    Revista espanola de cardiologia, 2002, Volume: 55, Issue:6

    Topics: Aged; Angina, Unstable; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis

2002
Correlation between ST-T-segment changes with markers of hemostasis in patients with acute coronary syndromes.
    Cardiology, 2002, Volume: 98, Issue:1-2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Coronary Vessels; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Germany; Hemostasis; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Myocardial Infarction; Patient Admission; Predictive Value of Tests; Risk Factors; Serum Amyloid A Protein; Statistics as Topic; Survival Analysis; Syndrome; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1

2002
[Pharmacodynamics, safety, and clinical effects of a novel glycoprotein IIb/IIIa antagonist framon during high risk coronary angioplasty].
    Kardiologiia, 2002, Volume: 42, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Receptors, Immunologic; Risk Factors

2002
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
    American heart journal, 2003, Volume: 145, Issue:1

    Topics: Adult; Coronary Stenosis; Factor V; Female; Fibrinogen; Gene Frequency; Humans; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Thrombophilia

2003
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
    European heart journal, 2003, Volume: 24, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antithrombins; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Piperidines; Survival Analysis; Troponin T

2003
Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
    Kardiologia polska, 2003, Volume: 59, Issue:9

    Topics: Adult; Case-Control Studies; Fibrinogen; Genes, bcl-1; Humans; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic

2003
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel
    Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2

    Topics: Aged; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome

2004
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:8

    Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides

2004
Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2003, Volume: 41, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Spiramycin; Treatment Outcome

2003
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Circulation, 2006, Jul-18, Volume: 114, Issue:3

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Ramipril; Risk Factors; Vitamin E

2006
Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation.
    Clinical rehabilitation, 2008, Volume: 22, Issue:4

    Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Coronary Artery Bypass; Diet; Exercise Test; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Smoking; Stress, Psychological

2008
[Coagulation studies and rheological measurements during streptokinase therapy of myocardial infarction (author's transl)].
    Klinische Wochenschrift, 1980, Jun-16, Volume: 58, Issue:12

    Topics: Acute Disease; alpha-Macroglobulins; Blood Coagulation; Blood Viscosity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Serum Globulins; Streptokinase

1980
Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.
    Circulation, 1984, Volume: 69, Issue:4

    Topics: Adult; Aged; Coronary Artery Bypass; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Streptokinase; Urokinase-Type Plasminogen Activator

1984
Fibrinogen as a risk factor for stroke and myocardial infarction.
    The New England journal of medicine, 1984, Aug-23, Volume: 311, Issue:8

    Topics: Blood Coagulation Factors; Blood Pressure; Cerebrovascular Disorders; Cholesterol; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk; Sweden

1984
The incidence of deep venous thrombosis in patients with an acute myocardial infarction treated with acenocoumarol or indobufen.
    Thrombosis and haemostasis, 1982, Oct-29, Volume: 48, Issue:2

    Topics: Acenocoumarol; Aged; Antithrombin III; Female; Fibrinogen; Humans; Isoindoles; Leg; Male; Middle Aged; Myocardial Infarction; Phenylbutyrates; Platelet Count; Plethysmography, Impedance; Radionuclide Imaging; Thrombophlebitis

1982
Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:5

    Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Glycosylation; Hemostasis; Humans; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Recombinant Proteins; Urokinase-Type Plasminogen Activator

1994
A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Circulation, 1995, Oct-15, Volume: 92, Issue:8

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Metalloendopeptidases; Middle Aged; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vascular Patency

1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
    Journal of clinical epidemiology, 1995, Volume: 48, Issue:6

    Topics: Age Factors; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Israel; Male; Middle Aged; Motor Activity; Multivariate Analysis; Myocardial Infarction; Risk Factors; Sex Factors; Smoking; Triglycerides

1995
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    The New England journal of medicine, 1995, Mar-09, Volume: 332, Issue:10

    Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Factors; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; von Willebrand Factor

1995
Artificial ultraviolet whole-body radiation does not modify serum lipoprotein, plasma fibrinogen, plasminogen or antithrombin III concentrations in post-myocardial infarction patients.
    Atherosclerosis, 1994, Volume: 107, Issue:1

    Topics: Antithrombin III; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prothrombin Time; Thrombin Time; Ultraviolet Rays; Ultraviolet Therapy; Whole-Body Irradiation

1994
[Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Wiener medizinische Wochenschrift (1946), 1993, Volume: 143, Issue:22

    Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cerebrovascular Disorders; Chemical Precipitation; Cholesterol; Coronary Disease; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Rheology; Triglycerides

1993
Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction.
    American heart journal, 1994, Volume: 127, Issue:4 Pt 1

    Topics: Alprostadil; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

1994
Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
    Thrombosis and haemostasis, 1993, Dec-20, Volume: 70, Issue:6

    Topics: Adult; Female; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Phosphorylation; Streptokinase

1993
Effects of lipoprotein(a) on thrombolysis.
    Chemistry and physics of lipids, 1994, Volume: 67-68

    Topics: alpha-2-Antiplasmin; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolysis; Humans; Lipoprotein(a); Male; Myocardial Infarction; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1994
Streptokinase, but not tissue plasminogen activator, attenuates platelet aggregation in patients with acute myocardial infarction.
    Journal of internal medicine, 1993, Volume: 234, Issue:5

    Topics: Aged; Chi-Square Distribution; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Platelet Aggregation; Streptokinase; Tissue Plasminogen Activator; Treatment Outcome

1993
Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators.
    The American journal of cardiology, 1994, Jan-01, Volume: 73, Issue:1

    Topics: Anistreplase; Body Weight; Coronary Angiography; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome

1994
The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
    European heart journal, 1993, Volume: 14, Issue:6

    Topics: Anistreplase; Blood Pressure; Blood Viscosity; Double-Blind Method; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy

1993
Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
    The American journal of cardiology, 1993, Aug-15, Volume: 72, Issue:5

    Topics: Anistreplase; Coronary Angiography; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Fibrinogen; Hematocrit; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Regression Analysis; Smoking; Streptokinase; Thrombolytic Therapy; Treatment Outcome; Vascular Patency

1993
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
    American heart journal, 1996, Volume: 131, Issue:1

    Topics: Antithrombins; Collagen; Coronary Thrombosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heart Rupture, Post-Infarction; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Plasminogen Activators; Procollagen; Recurrence; Streptokinase; Tissue Plasminogen Activator

1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
    Lancet (London, England), 1996, Mar-30, Volume: 347, Issue:9005

    Topics: Adult; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Feasibility Studies; Fibrinogen; Humans; Hypolipidemic Agents; Male; Myocardial Infarction; Risk Factors; Time Factors; Triglycerides

1996
[Evaluation of lipoprotein (a) and fibrinogen levels in men after premature myocardial infarction and in their sons].
    Polskie Archiwum Medycyny Wewnetrznej, 1996, Volume: 95, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors

1996
Platelet and leukocyte activation after myocardial infarction. Influence of enalapril.
    European heart journal, 1995, Volume: 16, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Double-Blind Method; Enalapril; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Pancreatic Elastase; Peptide Fragments; Platelet Activation; Platelet Aggregation; Risk Factors; Survival Rate

1995
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
    The American journal of cardiology, 1996, Jul-15, Volume: 78, Issue:2

    Topics: Angina, Unstable; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Prospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator

1996
Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    European heart journal, 1996, Volume: 17, Issue:2

    Topics: Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy; Time Factors; Urokinase-Type Plasminogen Activator

1996
Relationship between intracoronary thrombolysis and fibrino-coagulation--special reference to TAT/PIC and FPA/PIC.
    Japanese circulation journal, 1996, Volume: 60, Issue:3

    Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Thrombolytic Therapy

1996
[Lactovegetarian diet: effect on changes in body weight, lipid status, fibrinogen and lipoprotein (a) in cardiovascular patients during inpatient rehabilitation treatment].
    Zeitschrift fur Kardiologie, 1996, Volume: 85, Issue:6

    Topics: Adult; Aged; Body Weight; Cardiac Rehabilitation; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Diet, Vegetarian; Female; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Patient Admission; Rehabilitation Centers; Treatment Outcome; Uric Acid

1996
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Adult; Angina Pectoris; Biomarkers; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Tissue Polypeptide Antigen; von Willebrand Factor

1996
Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
    Thrombosis and haemostasis, 1996, Volume: 76, Issue:4

    Topics: Adult; Fibrin; Fibrinogen; Fibrinolysis; Gels; Humans; Lipoproteins; Logistic Models; Male; Multivariate Analysis; Myocardial Infarction; Plasminogen Activator Inhibitor 1

1996
[Lipid, apoprotein and fibrinogen levels in the blood of male patients following myocardial infarct and the effect of diet on these parameters in ischemic heart disease].
    Orvosi hetilap, 1996, Nov-03, Volume: 137, Issue:44

    Topics: Apolipoproteins; Body Mass Index; Cholesterol; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sex Factors

1996
Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction.
    American heart journal, 1997, Volume: 134, Issue:2 Pt 1

    Topics: Female; Fibrinogen; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Metalloendopeptidases; Middle Aged; Myocardial Infarction; Plasminogen Activators; Prospective Studies; Recombinant Proteins; Tissue Plasminogen Activator; Vascular Patency

1997
Heparin-induced extracorporeal fibrinogen/LDL precipitation (HELP): a promising regimen for the treatment of vascular diseases.
    Angiology, 1997, Volume: 48, Issue:12

    Topics: Acute Disease; Cerebrovascular Disorders; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolytic Agents; Fractional Precipitation; Hemodilution; Hemorheology; Heparin; Humans; Lipoproteins, LDL; Male; Myocardial Infarction; Optic Neuropathy, Ischemic; Prospective Studies; Thromboembolism; Visual Acuity; Visual Fields

1997
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
    Circulation, 1997, Dec-16, Volume: 96, Issue:12

    Topics: Aged; Angina, Unstable; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Risk Factors; Survival Analysis; Troponin; Troponin T

1997
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.
    American heart journal, 1998, Volume: 135, Issue:1

    Topics: Fibrinogen; Humans; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency

1998
Relation of von Willebrand factor to occurrence of Q waves and thrombolytic treatment in acute myocardial infarction.
    The American journal of cardiology, 1998, Feb-15, Volume: 81, Issue:4

    Topics: Adult; Aged; Electrocardiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Tissue Plasminogen Activator; von Willebrand Factor

1998
Combined use of markers of muscle necrosis and fibrinogen conversion in the early differentiation of myocardial infarction and unstable angina.
    Clinical chemistry, 1998, Volume: 44, Issue:4

    Topics: Adult; Aged; Angina, Unstable; Biomarkers; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis

1998
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
    Scandinavian cardiovascular journal : SCJ, 1998, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Disease Progression; Factor VII; Factor VIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Assessment; Sex Characteristics; Triglycerides

1998
Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
    International journal of cardiology, 1998, Jun-01, Volume: 65, Issue:1

    Topics: alpha-2-Antiplasmin; Clinical Trials, Phase II as Topic; Coronary Vessels; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Humans; Multicenter Studies as Topic; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Tissue Plasminogen Activator; Vascular Patency

1998
Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.
    Circulation, 1998, Jul-28, Volume: 98, Issue:4

    Topics: Aged; Angina, Unstable; Anticoagulants; C-Reactive Protein; Enoxaparin; Female; Fibrinogen; Heparin; Humans; International Cooperation; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Treatment Outcome; von Willebrand Factor

1998
Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study.
    European heart journal, 1998, Volume: 19 Suppl H

    Topics: Adult; Aged; Bezafibrate; Cholesterol; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Triglycerides

1998
Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:2

    Topics: Aged; Amino Acid Sequence; Angina, Unstable; Blood Platelets; Cell Aggregation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Heparin; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Neutrophils; P-Selectin; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Thrombin; Tirofiban; Tyrosine

1999
Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10 Suppl 1

    Topics: Aged; Bezafibrate; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome

1999
A double-blind randomised dose-effect trial of anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction. The APSAC Research Group.
    Clinical trials and meta-analysis, 1993, Volume: 28, Issue:6

    Topics: Anistreplase; Blood Pressure; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Safety; Thrombolytic Therapy; Treatment Outcome; Vascular Patency

1993
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Cholesterol, HDL; Double-Blind Method; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Reference Values; Risk Factors

1999
Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
    Circulation, 1999, Nov-02, Volume: 100, Issue:18

    Topics: Double-Blind Method; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

1999
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Age Factors; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Multivariate Analysis; Myocardial Infarction; Risk Factors; Troponin T

2000
[Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2000, Volume: 9, Issue:50

    Topics: Aged; Angina, Unstable; Chi-Square Distribution; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence

2000
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
    The American journal of medicine, 2001, Oct-15, Volume: 111, Issue:6

    Topics: Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk; Severity of Illness Index; Stroke; Triglycerides

2001
Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability.
    Thrombosis research, 2002, Mar-15, Volume: 105, Issue:6

    Topics: Aged; Aspirin; Dextrans; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

2002
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
    Folia haematologica (Leipzig, Germany : 1928), 1975, Volume: 102, Issue:2

    Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis

1975
Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
    Acta medica Scandinavica. Supplementum, 1975, Volume: 575

    Topics: Aged; Alanine Transaminase; Alprenolol; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Cholesterol; Clinical Trials as Topic; Creatinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Myocardial Infarction; Phosphoric Monoester Hydrolases; Placebos; Potassium; Thymol; Triglycerides

1975
Plasma free-fatty-acids and small doses of subcutaneous heparin in acute myocardial infarction.
    Thrombosis research, 1979, Volume: 14, Issue:4-5

    Topics: Aged; Blood Coagulation Tests; Fatty Acids, Nonesterified; Female; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Triglycerides; Warfarin

1979
Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography.
    Annals of internal medicine, 1976, Volume: 84, Issue:6

    Topics: Acute Disease; Adult; Aged; Early Ambulation; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Phlebography; Thrombophlebitis; Time Factors

1976
Primary prevention of atherosclerotic vascular disease with ethylnandrol. An interim report of four-year observations.
    Japanese circulation journal, 1975, Volume: 39, Issue:3

    Topics: Adult; Aged; Arteriosclerosis; Aspartate Aminotransferases; Blood Pressure; Cholesterol; Clinical Trials as Topic; Ethylestrenol; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Japan; Male; Middle Aged; Myocardial Infarction; Placebos; Serum Globulins; Solubility; Triglycerides

1975
Plasma fibrinolytic activity following oral anabolic steroid therapy.
    Thrombosis et diathesis haemorrhagica, 1975, Sep-30, Volume: 34, Issue:1

    Topics: Adult; Aged; Anabolic Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Clot Retraction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators

1975
Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART).
    European heart journal, 1992, Volume: 13, Issue:2

    Topics: Blood Viscosity; Dietary Fats; Dietary Fiber; Fibrinogen; Fish Oils; Follow-Up Studies; Hemoglobinometry; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Recurrence; Smoking; Smoking Cessation; Survival Rate

1992
Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
    European heart journal, 1992, Volume: 13, Issue:9

    Topics: Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Recombinant Proteins; Recurrence; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vascular Patency

1992
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Journal of the American College of Cardiology, 1992, Volume: 20, Issue:3

    Topics: Adult; Aged; Blood Coagulation; Coronary Vessels; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency

1992
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:9

    Topics: Aged; Angina Pectoris; Arteriosclerosis; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Thrombosis; Vascular Diseases

1992
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
    Journal of the American College of Cardiology, 1992, Mar-01, Volume: 19, Issue:3

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency; Ventricular Function, Left

1992
Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo.
    European heart journal, 1992, Volume: 13, Issue:2

    Topics: Adult; Aged; Blood Flow Velocity; Blood Viscosity; Dose-Response Relationship, Drug; Electrocardiography; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase

1992
Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs.
    Journal of the American College of Cardiology, 1992, Volume: 20, Issue:1

    Topics: alpha-2-Antiplasmin; Anesthesia; Animals; Dogs; Female; Fibrinogen; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Ventricular Function, Left

1992
Influence of platelet size on outcome after myocardial infarction.
    Lancet (London, England), 1991, Dec-07, Volume: 338, Issue:8780

    Topics: Aged; Blood Viscosity; Blood Volume; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Megakaryocytes; Myocardial Infarction; Platelet Count; Prognosis; Recurrence; Risk Factors; Time Factors

1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
    The American journal of cardiology, 1991, Dec-15, Volume: 68, Issue:17

    Topics: Adult; Aged; Coronary Angiography; Coronary Thrombosis; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vascular Patency

1991
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
    Atherosclerosis, 1991, Volume: 90, Issue:2-3

    Topics: Aged; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Electrocardiography; Female; Fibrinogen; Hemostasis; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Protein C; Risk Factors; Smoking

1991
Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
    The American journal of cardiology, 1991, Jul-15, Volume: 68, Issue:2

    Topics: Adult; Aged; Coronary Angiography; Female; Fibrinogen; Humans; Injections, Intravenous; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator

1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Circulation, 1991, Volume: 83, Issue:1

    Topics: Black People; Blood Transfusion; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; White People

1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Annals of internal medicine, 1991, Aug-15, Volume: 115, Issue:4

    Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Metoprolol; Myocardial Infarction; Plasminogen; Recombinant Proteins; Statistics as Topic; Thrombolytic Therapy; Tissue Plasminogen Activator

1991
Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration.
    Journal of the American College of Cardiology, 1991, Volume: 18, Issue:7

    Topics: Adult; Clinical Protocols; Coronary Angiography; Emergency Medical Services; Female; Fibrinogen; Hemorrhage; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; New York City; Recurrence; Rhode Island; Tissue Plasminogen Activator; Vascular Patency

1991
Modern strategies for treatment of acute myocardial infarction: significance of haemostaseological and rheological findings.
    Advances in experimental medicine and biology, 1990, Volume: 281

    Topics: Anistreplase; Blood Viscosity; Drug Therapy, Combination; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen Activators; Streptokinase; Urokinase-Type Plasminogen Activator

1990
Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
    Circulation, 1986, Volume: 73, Issue:3

    Topics: alpha-2-Antiplasmin; Blood Coagulation; Factor V; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Myocardial Infarction; Recombinant Proteins; Streptokinase; Tissue Plasminogen Activator

1986
Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    American heart journal, 1986, Volume: 112, Issue:2

    Topics: Aged; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation Tests; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Infusions, Parenteral; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Factor 4; Time Factors

1986
Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Drugs, 1987, Volume: 33 Suppl 3

    Topics: alpha-2-Antiplasmin; Anistreplase; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen; Prothrombin Time; Streptokinase; Thrombin Time

1987
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
    The American journal of cardiology, 1988, May-01, Volume: 61, Issue:13

    Topics: Adult; Aged; alpha-2-Antiplasmin; Clinical Trials as Topic; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency

1988
Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    The American journal of cardiology, 1988, May-01, Volume: 61, Issue:13

    Topics: alpha-2-Antiplasmin; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Glycosylation; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Plasminogen; Plasminogen Activators; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency

1988
Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.
    Lancet (London, England), 1989, Apr-22, Volume: 1, Issue:8643

    Topics: Adult; Aged; Blood Flow Velocity; Double-Blind Method; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Plasminogen Activators; Radiography; Random Allocation; Recombinant Proteins; Streptokinase; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency

1989
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator.
    Lancet (London, England), 1985, Apr-13, Volume: 1, Issue:8433

    Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Radiography; Streptokinase

1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction.
    Lancet (London, England), 1985, Nov-02, Volume: 2, Issue:8462

    Topics: Adult; Aged; Angioplasty, Balloon; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Tissue Plasminogen Activator

1985
The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
    The American journal of cardiology, 1988, Sep-01, Volume: 62, Issue:7

    Topics: Anistreplase; Arteries; Clinical Trials as Topic; Coronary Vessels; Creatine Kinase; Fibrinogen; Heart; Heart Ventricles; Heparin; Humans; Myocardial Infarction; Plasminogen; Streptokinase; Vascular Patency

1988
A kinetic analysis of fibrinogenolysis during plasminogen activator therapy.
    Clinical pharmacology and therapeutics, 1987, Volume: 41, Issue:3

    Topics: Clinical Trials as Topic; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrinogen; Humans; Infusions, Intravenous; Kinetics; Models, Biological; Myocardial Infarction; Plasminogen; Prospective Studies; Random Allocation; Tissue Plasminogen Activator

1987
Dose-effect relationship estimation for thrombolytic therapy in acute myocardial infarction.
    Seminars in thrombosis and hemostasis, 1987, Volume: 13, Issue:2

    Topics: Angiography; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Recombinant Proteins; Research Design; Streptokinase; Tissue Plasminogen Activator

1987
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
    Journal of the American College of Cardiology, 1988, Volume: 11, Issue:1

    Topics: Clinical Trials as Topic; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Myocardial Infarction; Random Allocation; Recombinant Proteins; Streptokinase; Thrombocytopenia; Tissue Plasminogen Activator

1988
Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Drugs, 1987, Volume: 33 Suppl 3

    Topics: Adult; Aged; Anistreplase; Clinical Trials as Topic; Coronary Angiography; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Vascular Patency

1987
Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Drugs, 1987, Volume: 33 Suppl 3

    Topics: Adult; Aged; Anistreplase; Fibrinogen; Fibrinolytic Agents; Heart Ventricles; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Myocardial Infarction; Plasminogen; Random Allocation; Streptokinase; Vascular Patency

1987
Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Drugs, 1987, Volume: 33 Suppl 3

    Topics: Aged; Anistreplase; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Random Allocation; Streptokinase; Vascular Patency

1987
Intravenous streptokinase versus heparin in the acute stage of myocardial infarction. A prospective randomised trial in south-east France.
    Haemostasis, 1986, Volume: 16 Suppl 3

    Topics: Adult; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation; Recurrence; Streptokinase

1986
[Intravenous streptokinase versus heparin in the acute phase of myocardial infarction. Randomized prospective study in southeast France].
    Haemostasis, 1986, Volume: 16 Suppl 4

    Topics: Aged; Angiography; Electrocardiography; Female; Fibrinogen; France; Heart Ventricles; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation; Streptokinase

1986
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
    Lancet (London, England), 1973, Oct-27, Volume: 2, Issue:7835

    Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Hypercholesterolemia; Informed Consent; Injections, Subcutaneous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Tachycardia; Thrombophlebitis; Time Factors

1973
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Lancet (London, England), 1967, Nov-11, Volume: 2, Issue:7524

    Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases

1967
Heparin in the prevention of deep vein thrombosis after myocardial infarction.
    British medical journal, 1972, May-20, Volume: 2, Issue:5811

    Topics: Aged; Clinical Trials as Topic; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis

1972
Fibrinolytic enhancement by stanozolol: a double blind trial.
    British journal of haematology, 1972, Volume: 22, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol

1972
Small subcutaneous doses of heparin in prevention of venous thrombosis.
    The New England journal of medicine, 1973, Mar-15, Volume: 288, Issue:11

    Topics: Adult; Aged; Blood Coagulation Tests; Blood Transfusion; Clinical Trials as Topic; Female; Femoral Fractures; Femoral Vein; Fibrinogen; Hematocrit; Heparin; Hip; Humans; Injections, Subcutaneous; Iodine Isotopes; Male; Middle Aged; Myocardial Infarction; Phlebography; Popliteal Vein; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Thrombophlebitis; Thromboplastin; Thrombosis

1973
Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
    The New England journal of medicine, 1973, Apr-19, Volume: 288, Issue:16

    Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Clinical Trials as Topic; Exercise Therapy; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Iodine Isotopes; Leg; Movement; Myocardial Infarction; Prognosis; Thrombophlebitis; Time Factors; Warfarin

1973
[Short-term fibrinolytic treatment in acute myocardial infarction].
    Deutsche medizinische Wochenschrift (1946), 1973, Apr-27, Volume: 98, Issue:17

    Topics: Acute Disease; Adult; Aged; Anticoagulants; Benzyl Compounds; Blood Viscosity; Clinical Trials as Topic; Coumarins; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Placebos; Streptokinase; Time Factors

1973
Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
    Acta medica Scandinavica, 1973, Volume: 194, Issue:3

    Topics: Acute Disease; alpha 1-Antitrypsin; Blood Coagulation; Clinical Trials as Topic; Clot Retraction; Depression, Chemical; Drug Evaluation; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Macroglobulins; Male; Myocardial Infarction; Placebos; Plasminogen; Platelet Adhesiveness; Prothrombin Time; Serum Globulins; Stimulation, Chemical; Time Factors

1973
Evaluation of hematologic effects of intra-aortic balloon assistance in man.
    Transactions - American Society for Artificial Internal Organs, 1972, Volume: 18, Issue:0

    Topics: Anticoagulants; Aorta; Assisted Circulation; Blood Cell Count; Blood Platelets; Blood Transfusion; Cardiac Surgical Procedures; Clinical Trials as Topic; Fibrinogen; Hemoglobins; Humans; Microscopy, Electron, Scanning; Myocardial Infarction; Preoperative Care; Shock, Cardiogenic

1972
Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
    Acta medica Scandinavica. Supplementum, 1969, Volume: 505

    Topics: Acute Disease; Aspartate Aminotransferases; Blood Coagulation Tests; Blood Sedimentation; Clinical Trials as Topic; Coumarins; Creatine Kinase; Electrocardiography; Erythrocytes; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Heparin; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prednisolone; Streptokinase

1969

Other Studies

698 other study(ies) available for fibrinogen and Cardiovascular Stroke

ArticleYear
Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome.
    BMC cardiovascular disorders, 2021, 12-07, Volume: 21, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Patient Acuity; Predictive Value of Tests; Risk Assessment; Risk Factors; Serum Albumin, Human

2021
The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction.
    Disease markers, 2022, Volume: 2022

    Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Female; Fibrinogen; Glucose; Hemostatics; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Thrombophilia; Triglycerides

2022
Synergistic role of circulating CD14++CD16+ monocytes and fibrinogen in predicting the cardiovascular events after myocardial infarction.
    Clinical cardiology, 2023, Volume: 46, Issue:5

    Topics: Fibrinogen; Flow Cytometry; Humans; Monocytes; Myocardial Infarction

2023
The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort.
    Journal of cardiovascular translational research, 2023, Volume: 16, Issue:5

    Topics: Albumins; Coronary Artery Disease; Fibrinogen; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Risk Factors

2023
Predictive Biochemical Model of Frailty and Mortality After Acute Myocardial Infarction.
    The American journal of cardiology, 2023, 10-15, Volume: 205

    Topics: Acute Coronary Syndrome; Aged; Fibrinogen; Frailty; Growth Differentiation Factor 15; Humans; Myocardial Infarction

2023
Serum fibrinogen-to-albumin ratio predicts new-onset atrial fibrillation risk during hospitalization in patients with acute myocardial infarction after percutaneous coronary intervention: a retrospective study.
    BMC cardiovascular disorders, 2023, 09-01, Volume: 23, Issue:1

    Topics: Albumins; Atrial Fibrillation; Fibrinogen; Hospitalization; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Retrospective Studies

2023
Human endurance and AI: Audentes Fortna Iuvat - fortune favours the bold.
    Perfusion, 2019, Volume: 34, Issue:8

    Topics: Achievement; Artificial Intelligence; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Fibrinogen; Humans; Interleukins; Lactic Acid; Myocardial Infarction; Physical Endurance; Postoperative Hemorrhage; Running

2019
Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121

    Topics: Animals; Apolipoprotein A-I; Blood Coagulation; Collagen; Complement C3; Coronary Disease; Down-Regulation; Drugs, Chinese Herbal; Fibrinogen; Inflammation; Interleukin-16; Male; Myocardial Infarction; Myocardium; Protective Agents; Rats; Rats, Sprague-Dawley

2020
Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Coronary artery disease, 2020, Volume: 31, Issue:2

    Topics: Acute Coronary Syndrome; Age Factors; Aged; Angina, Unstable; Blood Pressure; Cohort Studies; Creatinine; Electrocardiography; Female; Fibrinogen; Heart Arrest; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve

2020
Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart.
    Scientific reports, 2020, 03-16, Volume: 10, Issue:1

    Topics: Amidinotransferases; Animals; Arginine; Connective Tissue Growth Factor; Creatine; Desmocollins; Disease Models, Animal; Energy Metabolism; Fibrinogen; Gene Expression Regulation; Genetic Association Studies; Homoarginine; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Mice, Transgenic; Myocardial Infarction; Myocardium; Potassium Channels; Transcriptome

2020
Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease.
    The Journal of pediatrics, 2020, Volume: 221

    Topics: Anticoagulants; Antithrombin III; Antithrombins; Biomarkers; Child; Clinical Decision-Making; Clinical Protocols; Coronary Aneurysm; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Tissue Plasminogen Activator

2020
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
    Stroke, 2021, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis

2021
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
    BMJ open, 2017, 06-09, Volume: 7, Issue:6

    Topics: Aged; Beijing; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Death; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume

2017
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
    BMJ (Clinical research ed.), 2017, 09-13, Volume: 358

    Topics: Antineoplastic Agents, Hormonal; Cardiovascular Diseases; Clinical Trials as Topic; Endometrial Neoplasms; Female; Fibrinogen; Humans; Multivariate Analysis; Myocardial Infarction; Network Meta-Analysis; Progesterone; Thrombolytic Therapy; Treatment Outcome

2017
Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons.
    Acta cardiologica, 2018, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Blood Coagulation; DNA; Factor XIIIa; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genotype; Homocysteine; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Young Adult

2018
Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    Gene, 2018, Jan-30, Volume: 641

    Topics: Alleles; Case-Control Studies; Egypt; Factor XIII; Female; Fibrinogen; Genotype; Hemostasis; Heterozygote; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prothrombin; Risk

2018
Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
    Angiology, 2018, Volume: 69, Issue:6

    Topics: Aged; Ambulatory Care; Amputation, Surgical; Brain Ischemia; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Registries; Risk Factors; Spain; Stroke

2018
Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
    Thrombosis and haemostasis, 2018, Volume: 118, Issue:4

    Topics: Aged; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Neopterin; Prognosis; Proportional Hazards Models; Prospective Studies; Risk; Smoking; Troponin T

2018
Is a variability of platelet inhibitory effect of anti-platelet agents important for predicting new lesion in atherothrombotic stroke?
    International journal of stroke : official journal of the International Stroke Society, 2018, Volume: 13, Issue:6

    Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis

2018
Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study.
    Scientific reports, 2019, 02-28, Volume: 9, Issue:1

    Topics: Adult; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Vascular Diseases

2019
Digit ratio (2D:4D), myocardial infarction and fibrinogen in men.
    Early human development, 2019, Volume: 133

    Topics: Aged; Blood Viscosity; Fibrinogen; Fingers; Humans; Male; Middle Aged; Myocardial Infarction

2019
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Alleles; Coronary Disease; Fibrinogen; Genetic Pleiotropy; Genetic Variation; Genome-Wide Association Study; Humans; Incidence; Mendelian Randomization Analysis; Models, Genetic; Multivariate Analysis; Myocardial Infarction; Odds Ratio

2019
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:8

    Topics: ABO Blood-Group System; Adult; Aged; Case-Control Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Pedigree; Polymorphism, Single Nucleotide; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism

2019
Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
    Atherosclerosis, 2013, Volume: 228, Issue:1

    Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors

2013
Early pseudoaneurysm formation after the sutureless technique for left ventricular rupture due to acute myocardial infarction.
    General thoracic and cardiovascular surgery, 2014, Volume: 62, Issue:3

    Topics: Administration, Topical; Aged; Aneurysm, False; Aprotinin; Cardiac Tamponade; Drug Combinations; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Male; Myocardial Infarction; Reoperation; Suture Techniques; Thrombin; Time Factors; Ventricular Septal Rupture

2014
Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.
    Global journal of health science, 2013, Mar-20, Volume: 5, Issue:4

    Topics: Acute Disease; Age Factors; Angioplasty; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Agents; Cardiovascular Diseases; Electrocardiography; Fibrinogen; Humans; Inflammation Mediators; Myocardial Infarction; Socioeconomic Factors

2013
Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
    JPMA. The Journal of the Pakistan Medical Association, 2012, Volume: 62, Issue:7

    Topics: Aged; Angina, Unstable; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Saudi Arabia; Tissue Plasminogen Activator

2012
Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model.
    Biomaterials, 2013, Volume: 34, Issue:33

    Topics: Cell Movement; Cell Proliferation; Cells, Cultured; Echocardiography; Fibrinogen; Hemodynamics; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Myocardial Infarction; Polyethylene Glycols; Vascular Endothelial Growth Factor A

2013
Oral health status and the occurrence and clinical course of myocardial infarction in hospital phase: a case-control study.
    Cardiology journal, 2013, Volume: 20, Issue:4

    Topics: Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Dental Plaque Index; Fibrinogen; Health Status; Hospitalization; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Mouth, Edentulous; Myocardial Infarction; Oral Health; Periodontal Diseases; Periodontal Index; Plaque, Atherosclerotic; Predictive Value of Tests; Prevalence; Risk Factors; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left

2013
High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:6

    Topics: Acute Disease; Aged; Blood Coagulation; Computational Biology; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Kininogen, High-Molecular-Weight; Male; Middle Aged; Myocardial Infarction; Proteomics; Systems Biology

2013
Blunted inflammatory response in STEMI patients timely reperfused.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:1

    Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors; Tenecteplase; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome

2014
PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium.
    Cell death & disease, 2014, Feb-13, Volume: 5

    Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Fibrinogen; Genetic Engineering; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; Induced Pluripotent Stem Cells; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred NOD; Mice, SCID; Myocardial Contraction; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Placenta Growth Factor; Polyethylene Glycols; Pregnancy Proteins; Recovery of Function; Regeneration; Time Factors; Tissue Engineering; Tissue Scaffolds; Transduction, Genetic; Transfection

2014
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
    Atherosclerosis, 2014, Volume: 233, Issue:2

    Topics: Angina Pectoris; Angina, Unstable; Antigens, Surface; C-Reactive Protein; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Milk Proteins; Myocardial Infarction; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Triglycerides

2014
Hemostatic status of pre and post intracoronary injection of peripheral blood stem cells in patients with recent myocardial infarction.
    Acta medica Indonesiana, 2014, Volume: 46, Issue:1

    Topics: Adult; Aged; Blood Viscosity; C-Reactive Protein; Drug-Eluting Stents; Erythropoietin; Female; Fibrinogen; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Percutaneous Coronary Intervention; Peripheral Blood Stem Cell Transplantation; Platelet Aggregation; Prothrombin Time; Transplantation, Autologous

2014
Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7

    Topics: Aged; Blood Coagulation; Case-Control Studies; Circular Dichroism; Female; Fibrinogen; Fibrinolysis; Humans; Male; Microscopy, Electron, Transmission; Microscopy, Interference; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Protein Carbonylation; Protein Structure, Secondary; Structure-Activity Relationship; Time Factors

2014
Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
    Journal of the American Heart Association, 2014, Jun-23, Volume: 3, Issue:3

    Topics: Adipokines; Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Cholesterol, LDL; Female; Fibrinogen; Genome-Wide Association Study; Humans; Incidence; Intercellular Adhesion Molecule-1; Lectins; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prospective Studies; Stroke

2014
Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:4

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; alpha-Macroglobulins; Biomarkers; Coronary Artery Disease; Electrophoresis, Gel, Two-Dimensional; Female; Fibrinogen; Humans; Image Processing, Computer-Assisted; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Open Reading Frames; Oxidoreductases Acting on CH-CH Group Donors; Protein Interaction Mapping; Proteins; Proteome; Proteomics; Systems Biology

2014
Changes in thrombus composition and profilin-1 release in acute myocardial infarction.
    European heart journal, 2015, Apr-21, Volume: 36, Issue:16

    Topics: Analysis of Variance; Blood Platelets; Clopidogrel; Coronary Thrombosis; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Profilins; Thrombectomy; Thrombin; Ticlopidine; Time-to-Treatment

2015
Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.
    BMC cardiovascular disorders, 2014, Dec-09, Volume: 14

    Topics: Adult; Age Factors; Aged; Biomarkers; Female; Fibrinogen; Genetic Predisposition to Disease; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Sex Factors; Smoking

2014
Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
    International journal of molecular sciences, 2015, Jan-06, Volume: 16, Issue:1

    Topics: Aged; Alleles; Case-Control Studies; Coronary Artery Disease; Factor XIII; Factor XIIIa; Female; Fibrinogen; Genotype; Heterozygote; Humans; Introns; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors

2015
Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states.
    Journal of visualized experiments : JoVE, 2015, Apr-01, Issue:98

    Topics: Anemia, Sickle Cell; Blood Chemical Analysis; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Microscopy, Confocal; Myocardial Infarction; Myocardial Ischemia; Stroke; Thrombin; Thrombosis

2015
A Risk Score Derived from the Analysis of a Cluster of 27 Serum Inflammatory Cytokines to Predict Long Term Outcome in Patients with Acute Myocardial Infarction: a Pilot Study.
    Annals of clinical and laboratory science, 2015,Summer, Volume: 45, Issue:4

    Topics: Acute Disease; Aged; Aged, 80 and over; Cholesterol; Cytokines; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Risk Factors; Statistics, Nonparametric

2015
Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.
    Cardiovascular toxicology, 2016, Volume: 16, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Coagulation; Cytokines; Disease Models, Animal; Eugenol; Fibrinogen; Fibrinolytic Agents; Hemodynamics; Inflammation Mediators; Isoproterenol; Kidney; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Necrosis; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Renin-Angiotensin System; Ventricular Remodeling

2016
Variants of the Coagulation and Inflammation Genes Are Replicably Associated with Myocardial Infarction and Epistatically Interact in Russians.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Adult; Aged; Alleles; Blood Coagulation; C-Reactive Protein; Cyclooxygenase 1; Female; Fibrinogen; Genetic Association Studies; Genetic Markers; Genotype; Humans; Inflammation; Interferon-gamma; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Russia; Transforming Growth Factor beta1

2015
Influence of pre-existing inflammation on the outcome of acute coronary syndrome: a cross-sectional study.
    BMJ open, 2016, Jan-12, Volume: 6, Issue:1

    Topics: Acute Coronary Syndrome; Adult; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Risk Factors; Serum Amyloid A Protein

2016
Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.
    The American journal of cardiology, 2016, 05-15, Volume: 117, Issue:10

    Topics: Acute Coronary Syndrome; Aged; California; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Male; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Prognosis; Prosthesis Design; Retrospective Studies; Stents; Survival Rate; Thrombolytic Therapy; Time Factors

2016
Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.
    Molecular & cellular proteomics : MCP, 2016, Volume: 15, Issue:8

    Topics: Aged; Angina, Stable; Biomarkers; Chromatography, Liquid; Extracellular Vesicles; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Proteomics; Tandem Mass Spectrometry; Up-Regulation

2016
Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
    European heart journal, 2008, Volume: 29, Issue:16

    Topics: Acute Coronary Syndrome; Angina Pectoris; Biomarkers; Epidemiologic Methods; Fibrin Fibrinogen Degradation Products; Fibrinogen; France; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Northern Ireland; von Willebrand Factor

2008
Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
    American heart journal, 2008, Volume: 156, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Artery Bypass; Female; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prothrombin Time; Recurrence; Retrospective Studies; Risk Assessment; Stents

2008
Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    The American journal of cardiology, 2008, Sep-01, Volume: 102, Issue:5

    Topics: Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome

2008
Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study.
    Journal of the American College of Cardiology, 2008, Sep-09, Volume: 52, Issue:11

    Topics: Aged; C-Reactive Protein; Fibrinogen; Genotype; Haplotypes; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; White People

2008
Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.
    Clinical chemistry and laboratory medicine, 2008, Volume: 46, Issue:9

    Topics: Case-Control Studies; Death, Sudden; Factor XIII; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prevalence; Prothrombin; Toll-Like Receptor 4; Ventricular Fibrillation

2008
Epidural anesthesia and analgesia in cardiac surgery.
    Minerva anestesiologica, 2008, Volume: 74, Issue:11

    Topics: Analgesia, Epidural; Anesthesia, Epidural; C-Reactive Protein; Cardiac Surgical Procedures; Fibrinogen; Humans; Meta-Analysis as Topic; Myocardial Infarction; Postoperative Complications; Randomized Controlled Trials as Topic; Systemic Inflammatory Response Syndrome

2008
Influence of fibrinogen beta-chain gene variations on risk of myocardial infarction in a Chinese Han population.
    Chinese medical journal, 2008, Aug-20, Volume: 121, Issue:16

    Topics: Adult; Aged; China; Female; Fibrinogen; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide

2008
Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2009, Volume: 57, Issue:2

    Topics: Animals; Collagen; Dogs; Extracellular Matrix; Female; Fibrinogen; Fibronectins; Histological Techniques; Laminin; Male; Mesenchymal Stem Cell Transplantation; Myocardial Infarction; Myocardium; Transplantation, Homologous

2009
Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
    Bulletin of experimental biology and medicine, 2008, Volume: 145, Issue:4

    Topics: Adult; Aged; Blood Coagulation Disorders; Case-Control Studies; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Vascular Diseases

2008
Fibrinogen genes modify the fibrinogen response to ambient particulate matter.
    American journal of respiratory and critical care medicine, 2009, Mar-15, Volume: 179, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Environmental Exposure; Europe; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Urban Population

2009
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Stroke; Thrombosis

2009
Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Minerva cardioangiologica, 2009, Volume: 57, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Electrocardiography; Emergency Treatment; Female; Fibrinogen; Humans; Lipids; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Troponin I

2009
Breathe deeply into your genes!: genetic variants and air pollution effects.
    American journal of respiratory and critical care medicine, 2009, Mar-15, Volume: 179, Issue:6

    Topics: Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Urban Population

2009
G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
    Thrombosis research, 2010, Volume: 125, Issue:1

    Topics: Adult; Age of Onset; Alleles; Coronary Disease; Female; Fibrinogen; Genotype; Greece; Humans; Male; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors

2010
Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.
    Thrombosis research, 2009, Volume: 124, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Carotid Artery, Common; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Tunica Media; Ultrasonography; von Willebrand Factor

2009
Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction.
    Cardiology journal, 2009, Volume: 16, Issue:4

    Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Infarction; Predictive Value of Tests; Protein C; Protein S; Risk Factors; Smoking

2009
The role of platelets CD40 ligand (CD154) in acute coronary syndromes.
    Thrombosis research, 2009, Volume: 124, Issue:6

    Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angina, Unstable; Blood Platelets; Case-Control Studies; CD40 Ligand; Female; Fibrinogen; Humans; Lipoproteins, LDL; Male; Middle Aged; Models, Biological; Myocardial Infarction; Nitric Oxide; P-Selectin

2009
Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample.
    Occupational and environmental medicine, 2009, Volume: 66, Issue:11

    Topics: Aged; Air Pollutants; Air Pollution; Biomarkers; Blood Coagulation; Case-Control Studies; Environmental Exposure; Environmental Monitoring; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Sweden; Urban Health

2009
Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study.
    Vascular health and risk management, 2009, Volume: 5

    Topics: Adult; Age of Onset; Asian People; Biomarkers; Case-Control Studies; Fibrinogen; Humans; Iran; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Assessment; Risk Factors; Up-Regulation

2009
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
    Cardiovascular diabetology, 2009, Sep-07, Volume: 8

    Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia

2009
Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms.
    Environmental health perspectives, 2009, Volume: 117, Issue:9

    Topics: Aged; Air Pollution; Carbon Monoxide; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Nitrogen Dioxide; Polymorphism, Single Nucleotide

2009
[Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction].
    Kardiologiia, 2009, Volume: 49, Issue:9

    Topics: Adult; Aged; Blood Coagulation Disorders; Coronary Artery Disease; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Platelet Aggregation; Prognosis; Vasodilation

2009
Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:12

    Topics: Aged; Atherosclerosis; Biomarkers; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Inflammation; Kaplan-Meier Estimate; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Risk Factors; Serum Albumin; Smoking; United States; von Willebrand Factor

2009
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
    Free radical biology & medicine, 2010, Jan-15, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine

2010
Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes.
    Circulation. Cardiovascular genetics, 2009, Volume: 2, Issue:5

    Topics: Adult; Aged; Alcohol Dehydrogenase; Alcohol Drinking; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Denmark; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors

2009
Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction.
    Frontiers in bioscience (Elite edition), 2010, 01-01, Volume: 2, Issue:2

    Topics: Adult; Antigens, Human Platelet; Autoantigens; Factor V; Female; Fibrinogen; Humans; Integrin beta3; Iodide Peroxidase; Iron-Binding Proteins; Italy; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Thrombomodulin; von Willebrand Factor

2010
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
    Annals of human genetics, 2010, Volume: 74, Issue:1

    Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke

2010
[Relationship between activity of fibrinolysis, parameters of lipid spectrum and carbohydrate metabolism].
    Kardiologiia, 2010, Volume: 50, Issue:2

    Topics: Aged; Angina Pectoris; Atherosclerosis; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Chi-Square Distribution; Cohort Studies; Data Interpretation, Statistical; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Insulin; Lipids; Male; Myocardial Infarction; Myocardial Ischemia; Obesity, Abdominal; Prospective Studies; Sex Factors

2010
-94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:9

    Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Polymorphism, Genetic

2011
Momentary stress moderates procoagulant reactivity to a trauma-specific interview in patients with posttraumatic stress disorder caused by myocardial infarction.
    Journal of psychiatric research, 2010, Volume: 44, Issue:14

    Topics: Aged; Case-Control Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Interview, Psychological; Male; Middle Aged; Myocardial Infarction; Risk Factors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Stress, Psychological; Surveys and Questionnaires

2010
Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction.
    Wiener klinische Wochenschrift, 2010, Volume: 122 Suppl 2

    Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prospective Studies; Ramipril; Slovenia; von Willebrand Factor

2010
Clinical and laboratory characteristics in patients with acute myocardial infarction due to occlusive vasospasm.
    Journal of cardiology, 2010, Volume: 56, Issue:3

    Topics: Adult; Aged; Angina Pectoris, Variant; Biomarkers; C-Reactive Protein; Clinical Laboratory Information Systems; Coronary Stenosis; Coronary Vasospasm; Ergonovine; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

2010
The development of anemia of inflammation during acute myocardial infarction.
    International journal of cardiology, 2012, Apr-19, Volume: 156, Issue:2

    Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prospective Studies

2012
[To prevent myocardial infarction with a tooth brush?].
    Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:12

    Topics: C-Reactive Protein; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Periodontitis; Risk Factors; Scotland; Socioeconomic Factors; Toothbrushing

2010
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
    Stroke, 2011, Volume: 42, Issue:1

    Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Risk Factors; Stroke

2011
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2010, Volume: 48, Issue:2

    Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference

2010
A combined cell therapy and in-situ tissue-engineering approach for myocardial repair.
    Biomaterials, 2011, Volume: 32, Issue:30

    Topics: Animals; Cell- and Tissue-Based Therapy; Cells, Cultured; Echocardiography; Embryonic Stem Cells; Fibrinogen; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Polyethylene Glycols; Rats; Rats, Inbred F344; Tissue Engineering

2011
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
    Circulation. Cardiovascular genetics, 2011, Volume: 4, Issue:5

    Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Heterozygote; Humans; Ischemia; Lipids; Lipoproteins; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Myocardial Infarction; Pseudoxanthoma Elasticum; Risk Factors; Vascular Diseases

2011
Influence of matrix metalloproteinase-12 on fibrinogen level.
    Atherosclerosis, 2012, Volume: 220, Issue:2

    Topics: Animals; Atherosclerosis; England; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Italy; Linear Models; Linkage Disequilibrium; Logistic Models; Matrix Metalloproteinase 12; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors

2012
Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions.
    Cardiology, 2012, Volume: 121, Issue:1

    Topics: Aged; Angina Pectoris; Biomarkers; Chemokine CCL4; Coronary Stenosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Risk Factors; Survival Analysis

2012
Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center Augsburg.
    Thrombosis and haemostasis, 2012, Volume: 107, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Biomarkers; Europe; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Nephelometry and Turbidimetry; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors

2012
Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
    Thrombosis research, 2012, Volume: 130, Issue:3

    Topics: Biomarkers; Blood Coagulation Factors; Comorbidity; Coronary Thrombosis; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Reproducibility of Results; Sensitivity and Specificity; Spain; Thromboplastin

2012
The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message.
    Scandinavian journal of clinical and laboratory investigation, 2012, Volume: 72, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Risk

2012
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
    Cardiovascular journal of Africa, 2012, Apr-12, Volume: 23, Issue:3

    Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine

2012
Fever in myocardial infarction: is it still common, is it still predictive?
    Cardiology journal, 2012, Volume: 19, Issue:4

    Topics: Aged; Biomarkers; Body Temperature Regulation; C-Reactive Protein; Female; Fever; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left

2012
[Endogenous sex hormone testosterone and haemostatic factors in young men after myocardial infarction].
    Kardiologiia, 2012, Volume: 52, Issue:6

    Topics: Adult; Age Factors; Blood Coagulation Factors; Blood Coagulation Tests; Estradiol; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Risk Factors; Sex Factors; Statistics as Topic; Testosterone

2012
Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention.
    Journal of Zhejiang University. Science. B, 2012, Volume: 13, Issue:8

    Topics: Aged; Dimerization; Electrocardiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glomerular Filtration Rate; Hospitalization; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Renal Insufficiency; Retrospective Studies; Treatment Outcome

2012
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2012, Volume: 29, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; China; Factor VII; Factor XII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic

2012
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Nov-15, Volume: 186, Issue:10

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity

2012
Increased inflammatory response in patients with the first myocardial infarction and nonsignificant stenosis of infarct-related artery.
    Vojnosanitetski pregled, 2012, Volume: 69, Issue:9

    Topics: Adult; Aged; Blood Sedimentation; C-Reactive Protein; Coronary Stenosis; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy

2012
IgG, IgM and inflammatory markers serum concentration in patients with acute coronary syndrome: a pilot study.
    Kardiologia polska, 2012, Volume: 70, Issue:10

    Topics: Acute Coronary Syndrome; Angina, Unstable; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Myocardial Infarction; Pilot Projects

2012
Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients.
    Cytokine, 2013, Volume: 61, Issue:1

    Topics: Adult; Age Factors; Biomarkers; Creatine Kinase, MB Form; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prothrombin; Troponin; Tumor Necrosis Factor-alpha; Young Adult

2013
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
    Journal of the American College of Cardiology, 2013, Jan-08, Volume: 61, Issue:1

    Topics: Aged; Blood Platelets; C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Predictive Value of Tests; Premedication; Prospective Studies; ROC Curve; Sensitivity and Specificity; Ticlopidine; Troponin

2013
[Case-cohort surveys].
    Revue d'epidemiologie et de sante publique, 2013, Volume: 61, Issue:1

    Topics: Biomarkers; Case-Control Studies; Cohort Studies; Computer Simulation; Epidemiologic Methods; Fibrinogen; France; Humans; Mathematical Computing; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Risk; Sensitivity and Specificity

2013
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:2

    Topics: Adenosine Diphosphate; Coronary Artery Disease; Female; Fibrinogen; Flow Cytometry; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Microscopy, Confocal; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Renal Dialysis; Risk Factors

2002
[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:6

    Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hospitalization; Humans; Incidence; Inflammation; Leukocyte Count; Life Tables; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Risk Factors; Sensitivity and Specificity

2002
Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?
    The new microbiologica, 2002, Volume: 25, Issue:3

    Topics: Adult; Age Factors; Aged; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Blotting, Western; Case-Control Studies; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Hyperglycemia; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors; Virulence

2002
[Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants].
    Revista espanola de cardiologia, 2002, Volume: 55, Issue:8

    Topics: Acute Disease; Acute-Phase Proteins; Adult; Age Factors; Aged; Aged, 80 and over; Angina, Unstable; Biomarkers; C-Reactive Protein; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Electrocardiography; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Syndrome; Time Factors; Troponin I

2002
Smoking, low density lipoprotein cholesterol, fibrinogen and myocardial infarction before 41 years of age: a Danish case-control study.
    Journal of cardiovascular risk, 2002, Volume: 9, Issue:3

    Topics: Adult; Age Factors; Case-Control Studies; Cholesterol, LDL; Denmark; Female; Fibrinogen; Humans; Hypercholesterolemia; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors; Smoking; Statistics as Topic; Surveys and Questionnaires

2002
The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
    Journal of internal medicine, 2002, Volume: 252, Issue:4

    Topics: Age Factors; Aged; Alleles; Chi-Square Distribution; Exercise; Female; Fibrinogen; Genotype; Humans; Hypercholesterolemia; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires

2002
[Blood coagulation in normotensives and hypertensives in relation to their body mass index].
    Deutsche medizinische Wochenschrift (1946), 2002, Nov-08, Volume: 127, Issue:45

    Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Pressure; Body Mass Index; Cholesterol, HDL; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Risk Factors; Stroke; Triglycerides

2002
[The relationship of beta-fibrinogen gene polymorphisms and ischaemic cardiocerebral vascular disease].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2002, Volume: 23, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Caenorhabditis elegans Proteins; Cerebral Infarction; Female; Fibrinogen; Gene Frequency; Humans; Linkage Disequilibrium; Male; Middle Aged; Muscle Proteins; Myocardial Infarction; Polymorphism, Genetic

2002
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
    Atherosclerosis, 2003, Volume: 166, Issue:1

    Topics: Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; France; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors

2003
Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid.
    Phytotherapy research : PTR, 2003, Volume: 17, Issue:1

    Topics: Animals; Antioxidants; Ascorbic Acid; Blood Viscosity; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Aggregation; Fibrinogen; Male; Myocardial Infarction; Phytotherapy; Quercetin; Rats; Rats, Wistar

2003
[The whole blood and plasma viscosity changes in course of acute myocardial infarction].
    Polskie Archiwum Medycyny Wewnetrznej, 2002, Volume: 108, Issue:4

    Topics: Adult; Aged; Blood Coagulation; Blood Viscosity; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Risk Factors; Time Factors; Triglycerides

2002
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Jul-01, Volume: 23, Issue:7

    Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Fibrinogen; France; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors; Statistics, Nonparametric

2003
Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2002, Volume: 17, Issue:1

    Topics: Aged; Antithrombin III; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

2002
Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.
    Journal of internal medicine, 2003, Volume: 254, Issue:3

    Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Thrombolytic Therapy

2003
Observations on the plasma fibrinogen content after myocardial infarction.
    Edinburgh medical journal, 1952, Volume: 59, Issue:11

    Topics: Coronary Disease; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Plasma

1952
Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate.
    A.M.A. archives of internal medicine, 1954, Volume: 93, Issue:2

    Topics: Anterior Wall Myocardial Infarction; Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction

1954
Plasma protein changes after acute myocardial infarction: alpha 2-globulin and fibrinogen.
    Scandinavian journal of clinical and laboratory investigation, 1955, Volume: 7, Issue:2

    Topics: Blood Proteins; Blood Sedimentation; Fibrinogen; Globulins; Humans; Myocardial Infarction; Serum Globulins

1955
The clot-density method of determination of fibrinogen in acute myocardial infarction.
    Bulletin of the New York Academy of Medicine, 1956, Volume: 32, Issue:3

    Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction

1956
[Prothrombin and fibrinogen levels in myocardial infarct and stenocardia].
    Terapevticheskii arkhiv, 1956, Volume: 28, Issue:6

    Topics: Angina Pectoris; Fibrinogen; Humans; Myocardial Infarction; Prothrombin

1956
Plasma fibrinogen and erythrocyte sedimentation rate in myocardial infarction.
    Acta medica Scandinavica, 1957, Jan-15, Volume: 156, Issue:5

    Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction; Plasma

1957
The value of estimating fibrinogen and C-reactive-protein levels in myocardial ischaemia.
    Lancet (London, England), 1957, Aug-10, Volume: 273, Issue:6989

    Topics: Blood Proteins; Coronary Artery Disease; Fibrinogen; Humans; Myocardial Infarction; Myocardial Ischemia

1957
[Protein-bound carbohydrates in plasma & serum in myocardial infarct. II. Hexoses & hexosamine of the fibrinogen fraction & blood mucoprotein].
    Arztliche Wochenschrift, 1957, Oct-11, Volume: 12, Issue:41

    Topics: Blood Proteins; Fibrinogen; Glucosamine; Hexosamines; Hexoses; Humans; Mucoproteins; Myocardial Infarction

1957
[Comparative studies of the significance of serum transaminase and fibrinogen levels in differential diagnosis and prognosis of myocardial infarct].
    Medizinische Klinik, 1958, Oct-10, Volume: 53, Issue:41

    Topics: Diagnosis, Differential; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Transaminases

1958
Clinical evaluation of plasma fibrinogen determination in cases of myocardial infarction.
    The Journal of the American Osteopathic Association, 1959, Volume: 58, Issue:6

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Myocardial Infarction

1959
[Clinical significance of fibrinogen test in myocardial infarction and stenocardia].
    Terapevticheskii arkhiv, 1958, Volume: 30, Issue:12

    Topics: Angina Pectoris; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction

1958
[Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
    Srpski arhiv za celokupno lekarstvo, 1961, Volume: 89

    Topics: Coronary Artery Disease; Coronary Disease; Fibrinogen; Hematologic Diseases; Humans; Myocardial Infarction

1961
[C-Reactive protein and fibrinogen in the blood in patients with myocardial infarct].
    Sovetskaia meditsina, 1961, Volume: 25

    Topics: C-Reactive Protein; Coagulants; Fibrinogen; Hemostatics; Humans; Myocardial Infarction

1961
[Studies on fibrinolytic activity and fibrinogen in the blood in atherosclerosis of the coronary vessels, myocardial infarction and during seizures of stenocardia].
    Terapevticheskii arkhiv, 1961, Volume: 33

    Topics: Angina Pectoris; Atherosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Seizures

1961
[Simplified method for the determination of fibrinogen in the plasma in myocardial infarct and stenocardia].
    Azerbaidzhanskii meditsinskii zhurnal = Aserbaidschanische medizinische Zeitschrift, 1963, Volume: 3

    Topics: Angina Pectoris; Coagulants; Fibrinogen; Hemostatics; Humans; Myocardial Infarction

1963
[THE IMPORTANCE OF INDICES OF PROTEIN AND LIPID METABOLISM FOR THE DIFFERENTIAL DIAGNOSIS OF VARIOUS FORMS OF CORONARY INSUFFICIENCY].
    Terapevticheskii arkhiv, 1963, Volume: 35

    Topics: Angina Pectoris; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diagnosis, Differential; Fibrinogen; Glycoproteins; Humans; Lipid Metabolism; Lipids; Lipoproteins; Myocardial Infarction; Phospholipids

1963
ABNORMAL GLOBULINS IN MYOCARDIAL INFARCTION. WITH SPECIAL REFERENCE TO A MATERIAL COATING ERYTHROCYTES AND A COLD-INSOLUBLE PROTEIN.
    The American journal of medicine, 1963, Volume: 35

    Topics: Angina Pectoris; Blood Protein Disorders; Blood Protein Electrophoresis; Blood Sedimentation; Capillaries; Conjunctiva; Cryoglobulins; Dextrans; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Hemagglutination; Humans; Latex Fixation Tests; Microscopy; Myocardial Infarction; Serologic Tests

1963
STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD FOR OBTAINING A THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    Acta medica Scandinavica, 1963, Volume: 174

    Topics: Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Geriatrics; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Streptodornase and Streptokinase; Streptokinase; Thromboembolism; Thrombosis

1963
PLASMA-FIBRINOGEN LEVELS IN CORONARY-ARTERY DISEASE.
    Lancet (London, England), 1963, Dec-07, Volume: 2, Issue:7319

    Topics: Angina Pectoris; Anticoagulants; Arteries; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Edema; Pulmonary Embolism; Thrombophlebitis

1963
[COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1963, Aug-01, Volume: 18

    Topics: Angina Pectoris; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysin; Heparin; Humans; Myocardial Infarction; Niacin; Statistics as Topic

1963
[DIAGNOSTIC VALUE OF THE COMPLEX INVESTIGATION OF THE BLOOD ENZYMES AND PROTEINS IN MYOCARDIAL INFARCT].
    Klinicheskaia meditsina, 1963, Volume: 41

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Clinical Enzyme Tests; Fibrinogen; Fructose-Bisphosphate Aldolase; Humans; Myocardial Infarction

1963
[COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    Terapevticheskii arkhiv, 1964, Volume: 36

    Topics: Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Circulation; Coronary Disease; Drug Therapy; Factor VII; Fibrinogen; Fibrinolysis; Heparin; Myocardial Infarction; Niacin; Prothrombin Time; Toxicology

1964
THROMBIN GENERATION IN NORMAL SUBJECTS AND CARDIAC PATIENTS.
    Circulation research, 1964, Volume: 14

    Topics: Biomedical Research; Blood Coagulation Tests; Ebstein Anomaly; Exercise Test; Fibrinogen; Humans; Myocardial Infarction; Physiology; Rheumatic Heart Disease; Tetralogy of Fallot; Thrombin

1964
EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    Clinical science, 1964, Volume: 26

    Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Electrocardiography; Fibrinogen; Heparin; Heparin Antagonists; Humans; Myocardial Infarction; Phenindione; Prothrombin Time

1964
[DIAGNOSTIC VALUE OF THE DETERMINATION OF BLOOD FIBRINOGEN IN MYOCARDIAL INFARCTION AND ARTERIAL THROMBOSIS].
    Sovetskaia meditsina, 1964, Volume: 27

    Topics: Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Thrombosis

1964
FIBRINOLYTIC ACTIVITY AND THYROID FUNCTION.
    British medical journal, 1965, Mar-13, Volume: 1, Issue:5436

    Topics: Aging; Cholesterol; Fibrinogen; Fibrinolysis; Geriatrics; Hyperthyroidism; Hypothyroidism; Iodine Isotopes; Middle Aged; Myocardial Infarction; Sex; Thyroid Function Tests; Thyroxine

1965
PLASMA FIBRINOLYTIC ACTIVITY FOLLOWING RECENT MYOCARDIAL AND CEREBRAL INFARCTION.
    Lancet (London, England), 1965, Jul-17, Volume: 2, Issue:7403

    Topics: Cerebral Infarction; Fibrinogen; Fibrinolysis; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Stroke; Thrombolytic Therapy; Thrombosis

1965
Clot density determination of fibrinogen in experimental myocardial infarction.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1955, Volume: 89, Issue:2

    Topics: Coagulants; Fibrinogen; Hemostatics; Myocardial Infarction; Thrombosis

1955
The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
    International journal of cardiology, 2003, Volume: 91, Issue:2-3

    Topics: Acute Disease; Adult; Aged; Angina Pectoris; Apolipoprotein A-I; Biomarkers; Blood Glucose; Blood Pressure; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Angiography; Coronary Artery Disease; Diastole; Female; Fibrinogen; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies; Statistics as Topic; Systole; Triglycerides

2003
Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:11

    Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Risk Factors; Survivors

2003
Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.
    Thrombosis and haemostasis, 2003, Volume: 90, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Case-Control Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; New Zealand; Permeability; Polymorphism, Genetic; Smoking

2003
Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Volume: 23, Issue:12

    Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Fibrinogen; Haptoglobins; Humans; Incidence; Inflammation; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Risk Factors

2003
Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3

    Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Carboxyhemoglobin; Ceruloplasmin; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Orosomucoid; Prospective Studies; Risk; Smoking; Smoking Cessation; Stroke; Surveys and Questionnaires; Sweden

2004
Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Apolipoproteins; Blood Glucose; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Erythrocyte Membrane; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Survivors; Triglycerides

2004
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:3

    Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Spain; Survival Analysis

2004
Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:3

    Topics: Aged; Apolipoproteins; Arteriosclerosis; Cardiovascular System; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; Serum Amyloid A Protein; Time Factors; Treatment Outcome

2004
4 new tests for heart disease. Here's what your doctor might order in the future.
    Heart advisor, 2004, Volume: 7, Issue:4

    Topics: Albuminuria; Biomarkers; C-Reactive Protein; Fibrinogen; Humans; Myocardial Infarction; Peroxidase

2004
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.
    European heart journal, 2004, Volume: 25, Issue:9

    Topics: Aged; Apolipoproteins; C-Reactive Protein; Death, Sudden, Cardiac; Disease-Free Survival; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Peripheral Vascular Diseases; Prospective Studies; Serum Amyloid A Protein; Treatment Outcome

2004
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction.
    Acta cardiologica, 2004, Volume: 59, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Female; Fibrinogen; Humans; Isoenzymes; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Predictive Value of Tests; Retrospective Studies; Sex Factors

2004
Effects of flow on solute exchange between fluids and supported biosurfaces.
    Biotechnology and applied biochemistry, 2004, Volume: 39, Issue:Pt 3

    Topics: Adsorption; Biological Transport; Blood Platelets; Convection; Diffusion; Fibrinogen; Kinetics; Mathematics; Models, Biological; Myocardial Infarction; Rheology; Solutions; Surface Properties; Thrombin

2004
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes.
    BMC medical genetics, 2004, Jun-01, Volume: 5

    Topics: Acute Disease; Angina, Unstable; Biomarkers; C-Reactive Protein; Clinical Trials as Topic; Coronary Thrombosis; Fibrinogen; Genetic Variation; Genotype; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Leukocyte Count; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors; Sialoglycoproteins; Syndrome

2004
Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:8

    Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Body Mass Index; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypertension; Incidence; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Obesity; Orosomucoid; Predictive Value of Tests; Proportional Hazards Models; Smoking; Stroke; Sweden

2004
Sutureless patch repair for small blowout rupture of the left ventricle after myocardial infarction.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2004, Volume: 52, Issue:5

    Topics: Aged; Collagen; Fibrinogen; Heart Rupture, Post-Infarction; Hemostatics; Humans; Male; Myocardial Infarction; Prosthesis Implantation; Tissue Adhesives; Treatment Outcome

2004
[Inflammation markers in acute coronary syndrome].
    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2004, Volume: 58, Issue:2

    Topics: Angina, Unstable; Biomarkers; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Humans; Inflammation; Interleukin-6; Myocardial Infarction

2004
Erythrocyte aggregation and -455G/A polymorphism of the beta-fibrinogen gene in survivors of acute myocardial infarction.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:1

    Topics: Case-Control Studies; Erythrocyte Aggregation; Fibrinogen; Genotype; Humans; Myocardial Infarction; Polymorphism, Genetic

2004
C-reactive protein increase in acute myocardial infarction.
    Acta cardiologica, 2004, Volume: 59, Issue:3

    Topics: Acute Disease; Aged; C-Reactive Protein; Chest Pain; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Male; Middle Aged; Myocardial Infarction; Observation; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index

2004
A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:8

    Topics: Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; International System of Units; Kinetics; Laboratories; Models, Chemical; Myocardial Infarction; Plasminogen Activators; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Reference Standards; Reproducibility of Results; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

2004
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings

2004
Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
    Stroke, 2004, Volume: 35, Issue:10

    Topics: Aged; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke

2004
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
    Journal of internal medicine, 2004, Volume: 256, Issue:4

    Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides

2004
Combination of thrombophilia markers in acute myocardial infarction of the young.
    Indian journal of medical sciences, 2004, Volume: 58, Issue:9

    Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia

2004
[Increased platelet aggregation induced activity by anti-glycoprotein IIb/IIIa antibody in patients with acute coronary syndrome].
    Kardiologiia, 2004, Volume: 44, Issue:10

    Topics: Alprostadil; Angina, Unstable; Antibodies, Monoclonal; Blood Platelets; Data Interpretation, Statistical; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

2004
Proteomic analysis of plasma from patients during an acute coronary syndrome.
    Journal of the American College of Cardiology, 2004, Oct-19, Volume: 44, Issue:8

    Topics: Acute Disease; Aged; alpha 1-Antitrypsin; Angina, Unstable; Apolipoprotein A-I; Blood Proteins; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Isoforms; Proteomics; Reference Values; Risk Factors; Syndrome

2004
[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].
    Genetika, 2004, Volume: 40, Issue:10

    Topics: Alleles; Coronary Disease; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Male; Moscow; Myocardial Infarction; Polymorphism, Single Nucleotide

2004
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:6

    Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis

2004
No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:1

    Topics: Blood Platelets; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; DNA; Factor V; Factor VII; Factor XIII; Family Health; Fibrinogen; Humans; Integrin alpha2beta1; Integrin beta3; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Risk; Risk Factors; Thrombosis

2005
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
    International journal of cardiology, 2005, Feb-15, Volume: 98, Issue:2

    Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin I

2005
Fibrinogen and other coronary risk factors.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:2

    Topics: Adult; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Denmark; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Socioeconomic Factors; Triglycerides

2005
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
    Folia biologica, 2004, Volume: 50, Issue:6

    Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People

2004
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction.
    The American journal of cardiology, 2005, Mar-01, Volume: 95, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Prospective Studies; Simvastatin; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left

2005
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:3

    Topics: Case-Control Studies; Female; Fibrinogen; Gene Frequency; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Multigene Family; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk

2005
[Inflammatory, lipid, and metabolic profile in acute ischemic syndrome: correlation with hospital and posthospital events].
    Arquivos brasileiros de cardiologia, 2005, Volume: 84, Issue:2

    Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; Blood Glucose; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Lipids; Male; Middle Aged; Myocardial Infarction; Risk Factors; Syndrome

2005
Body temperature - a marker of infarct size in the era of early reperfusion.
    Cardiology, 2005, Volume: 103, Issue:4

    Topics: Biomarkers; Body Temperature; C-Reactive Protein; Cohort Studies; Creatine Kinase; Echocardiography; Female; Fever; Fibrinogen; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Leukocyte Count; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Prospective Studies; Troponin I; Ventricular Function, Left

2005
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
    American heart journal, 2005, Volume: 149, Issue:2

    Topics: Aged; Analysis of Variance; Angina, Unstable; Biomarkers; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myoglobin; Prognosis; Recurrence; Risk Assessment; Risk Factors; Troponin I

2005
Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage.
    International journal of clinical practice, 2005, Volume: 59, Issue:2

    Topics: Angina, Unstable; Coronary Artery Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen; Predictive Value of Tests; Risk Factors; Troponin I

2005
Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:4

    Topics: Adult; Age Factors; Aged; Biomarkers; Blood Chemical Analysis; Cause of Death; Coronary Angiography; Fibrinogen; Follow-Up Studies; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Probability; Recurrence; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors

2005
Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
    Journal of internal medicine, 2005, Volume: 258, Issue:1

    Topics: Analysis of Variance; Body Mass Index; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypercholesterolemia; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Proinsulin; Risk Factors; Tissue Plasminogen Activator; Triglycerides

2005
Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk.
    Cardiology, 2005, Volume: 104, Issue:2

    Topics: Adult; Aged; Blood Viscosity; Coronary Artery Disease; Female; Fibrinogen; Hemorheology; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Oxygen; Polysomnography; Risk Factors; Sleep Apnea, Obstructive; Statistics as Topic

2005
Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction.
    Atherosclerosis, 2005, Volume: 182, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Serum Amyloid A Protein; Severity of Illness Index; Troponin I

2005
Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men.
    Circulation, 2005, Sep-06, Volume: 112, Issue:10

    Topics: Aged; Alcohol Drinking; Biomarkers; Case-Control Studies; Cholesterol, HDL; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Sex Distribution

2005
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
    Scandinavian journal of clinical and laboratory investigation, 2005, Volume: 65, Issue:6

    Topics: Apolipoproteins B; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Fibrinogen; Genotype; Humans; Lipoprotein(a); Male; Matrix Metalloproteinase 9; Myocardial Infarction; Point Mutation; Polymorphism, Genetic; Risk Factors

2005
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:10

    Topics: Age of Onset; Atherosclerosis; Family Health; Female; Fibrinogen; Genetic Markers; Genotype; Homocysteine; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Pedigree; Risk Factors; Thrombosis

2005
[Predictive value of the markers of inflammation in acute coronary syndromes].
    Archives des maladies du coeur et des vaisseaux, 2005, Volume: 98, Issue:9

    Topics: Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Stenosis; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Severity of Illness Index; Troponin I

2005
Genetic risk factors for arterial thrombosis and inflammation.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis

2005
[Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age].
    Kardiologiia, 2005, Volume: 45, Issue:12

    Topics: Adult; Age Factors; Aged; Alleles; Blood Coagulation Factors; Data Interpretation, Statistical; Factor V; Factor VII; Female; Fibrinogen; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Smoking; Tissue Plasminogen Activator

2005
Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:2

    Topics: Case-Control Studies; Fibrinogen; Haplotypes; Humans; Male; Myocardial Infarction; Netherlands; Polymorphism, Single Nucleotide; Risk Factors

2006
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).
    American heart journal, 2006, Volume: 151, Issue:2

    Topics: Aged; Algorithms; C-Reactive Protein; Cardiomegaly; Cohort Studies; Coronary Disease; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Failure; Humans; Indians, North American; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke; United States

2006
[Specific features of the laboratory diagnosis of myocardial infarction in patients with anemia].
    Klinicheskaia laboratornaia diagnostika, 2005, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Creatine Kinase; Erythrocyte Count; Female; Fibrinogen; Hemoglobins; Humans; Hydroxybutyrate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myoglobin

2005
A PEGylated fibrin patch for mesenchymal stem cell delivery.
    Tissue engineering, 2006, Volume: 12, Issue:1

    Topics: Animals; Cell Differentiation; Cells, Cultured; Fibrin; Fibrinogen; Mesenchymal Stem Cells; Myocardial Infarction; Polyethylene Glycols; Stem Cell Transplantation; Swine; Time Factors; Triazoles

2006
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:3

    Topics: Environment; Epistasis, Genetic; Factor XIII; Fibrin; Fibrinogen; Gels; Genetic Markers; Genetic Predisposition to Disease; Humans; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Porosity; Risk Factors

2006
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:5

    Topics: Adult; Aged; C-Reactive Protein; Case-Control Studies; Fibrin; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction

2006
C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
    Stroke, 2006, Volume: 37, Issue:7

    Topics: Aged; Angina Pectoris; Bezafibrate; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Incidence; Israel; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment

2006
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    The American journal of cardiology, 2006, Jul-01, Volume: 98, Issue:1

    Topics: Aged; Angina Pectoris; Blood Glucose; Body Mass Index; Case-Control Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Factors; Smoking

2006
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:11

    Topics: Adult; Coronary Artery Disease; Coronary Thrombosis; Elasticity; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lipoprotein(a); Male; Microscopy, Confocal; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Viscosity; von Willebrand Factor

2006
High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Kardiologia polska, 2006, Volume: 64, Issue:9

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Risk Factors; Stents; Treatment Outcome

2006
Preoperative serum fibrinogen as a predictor of myocardial infarction in the surgical myocardial revascularization.
    Arquivos brasileiros de cardiologia, 2006, Volume: 87, Issue:3

    Topics: Biomarkers; Cohort Studies; Female; Fibrinogen; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Pulmonary Embolism; Retrospective Studies; Stroke

2006
AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults.
    Clinica chimica acta; international journal of clinical chemistry, 2007, Volume: 377, Issue:1-2

    Topics: Adult; Coronary Angiography; Female; Fibrinogen; Genotype; Humans; Male; Myocardial Infarction; Nitrates; Nitric Oxide Synthase Type III; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Regional Blood Flow; Risk Factors

2007
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    European heart journal, 2006, Volume: 27, Issue:24

    Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Stenosis; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors

2006
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
    Journal of internal medicine, 2007, Volume: 261, Issue:2

    Topics: Aged; Base Sequence; Blood Coagulation; Case-Control Studies; Chi-Square Distribution; Fibrinogen; Haplotypes; Humans; Interleukin-6; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction

2007
Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Thrombosis research, 2007, Volume: 120, Issue:4

    Topics: Arteriosclerosis; Coronary Artery Disease; Factor XIII; Fibrinogen; Hungary; Molecular Epidemiology; Mutation, Missense; Myocardial Infarction; Polymorphism, Genetic; Protein Subunits; Risk

2007
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:4

    Topics: Female; Fibrin; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Models, Genetic; Myocardial Infarction; Peptide Fragments; Polymorphism, Genetic; Protein Isoforms; Risk; Risk Factors; RNA, Messenger

2007
The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis.
    Atherosclerosis, 2008, Volume: 197, Issue:1

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Platelets; Coronary Restenosis; Female; Fibrinogen; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stents; Thrombospondins; Ultrasonography, Interventional

2008
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Neurology, 2007, May-15, Volume: 68, Issue:20

    Topics: Anticoagulants; Cerebral Hemorrhage; Factor VII; Factor VIIa; Factor VIII; Fibrinogen; Humans; Myocardial Infarction; Plasma; Recombinant Proteins; Research Design; Retrospective Studies; Risk; Selection Bias; Troponin; Warfarin

2007
The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion.
    Shock (Augusta, Ga.), 2007, Volume: 27, Issue:6

    Topics: Animals; CD18 Antigens; Cyclic N-Oxides; Disease Models, Animal; Fibrinogen; Free Radical Scavengers; Interleukin-6; Mice; Mice, Inbred BALB C; Models, Biological; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Rats; Reperfusion Injury; Spin Labels

2007
Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.
    Tissue engineering, 2007, Volume: 13, Issue:8

    Topics: Animals; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Delayed-Action Preparations; Female; Fibrinogen; Mice; Mice, Inbred BALB C; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-kit

2007
Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5

    Topics: Alleles; Amino Acid Substitution; Biomarkers; C-Reactive Protein; Coronary Disease; Factor VIIa; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Quantitative Trait Loci

2007
Procoagulant stress reactivity and recovery in apparently healthy men with systolic and diastolic hypertension.
    Journal of psychosomatic research, 2007, Volume: 63, Issue:1

    Topics: Adult; Aged; Antigens; Cerebral Infarction; Factor VII; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Stress, Psychological

2007
Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Thrombosis research, 2008, Volume: 121, Issue:4

    Topics: Coronary Artery Disease; Coronary Vessels; Factor XIII; Fibrinogen; Genotype; Homozygote; Humans; Myocardial Infarction; Protein Subunits; Sclerosis

2008
Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors.
    Environmental health perspectives, 2007, Volume: 115, Issue:7

    Topics: Air Pollution; C-Reactive Protein; Fibrinogen; Humans; Inflammation; Interleukin-6; Myocardial Infarction

2007
Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.
    Prilozi, 2007, Volume: 28, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Necrosis

2007
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    American heart journal, 2007, Volume: 154, Issue:6

    Topics: Analysis of Variance; Angina Pectoris; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator

2007
Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:1-2

    Topics: Age Factors; Aged; Blood Glucose; Cohort Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stroke

2008
Blood fibrinogen in myocardial infarction.
    Archives of internal medicine (Chicago, Ill. : 1908), 1948, Volume: 82, Issue:5

    Topics: Blood; Cardiovascular Diseases; Fibrinogen; Heart; Humans; Infarction; Myocardial Infarction

1948
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:4

    Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Age Factors; Aged; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Smoking; Triglycerides; von Willebrand Factor

2008
Fibrinogen genes and myocardial infarction: a haplotype analysis.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:4

    Topics: Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Variation; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors

2008
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
    Human heredity, 2008, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings

2008
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:2

    Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Coagulation; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombin; Time Factors; Up-Regulation

2008
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:2

    Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People

2008
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:5

    Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors

2008
Air temperature and inflammatory responses in myocardial infarction survivors.
    Epidemiology (Cambridge, Mass.), 2008, Volume: 19, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Europe; Female; Fibrinogen; Health Status Indicators; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Prospective Studies; Risk Factors; Survivors; Temperature

2008
Haemorheological parameters in young patients with acute myocardial infarction.
    Clinical hemorheology and microcirculation, 2008, Volume: 39, Issue:1-4

    Topics: Adult; Blood Viscosity; C-Reactive Protein; Case-Control Studies; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Myocardial Infarction; Risk

2008
Myocardial infarction and whole-blood viscosity.
    Scandinavian journal of clinical and laboratory investigation. Supplementum, 1967, Volume: 100

    Topics: Adult; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction; Rheology

1967
[Hypofibrinolysis and thrombophilia].
    Folia haematologica (Leipzig, Germany : 1928), 1984, Volume: 111, Issue:4

    Topics: Adult; Blood Coagulation Tests; Deamino Arginine Vasopressin; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Thrombophlebitis; Thrombosis

1984
Fibrinopeptide A in acute coronary insufficiency.
    Lancet (London, England), 1981, Jan-10, Volume: 1, Issue:8211

    Topics: Acute Disease; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction

1981
Beta-thromboglobulin levels in relation to myocardial infarction--preliminary observations.
    Acta haematologica, 1980, Volume: 64, Issue:3

    Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Tobacco Use Disorder

1980
beta-Thromboglobulin in acute myocardial infarction.
    Acta medica Scandinavica. Supplementum, 1980, Volume: 642

    Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Prekallikrein; Time Factors

1980
Rheological and clotting changes in the immediate post-myocardial infarction period.
    Folia haematologica (Leipzig, Germany : 1928), 1981, Volume: 108, Issue:1

    Topics: Adult; Aged; Antithrombin III; Blood Coagulation Tests; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen

1981
Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
    Blood, 1982, Volume: 60, Issue:3

    Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation Factors; Blood Platelets; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Factor 4

1982
Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Thrombosis and haemostasis, 1983, Aug-30, Volume: 50, Issue:2

    Topics: Adult; Aged; Angina, Unstable; Beta-Globulins; beta-Thromboglobulin; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Pain; Thorax

1983
Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    American heart journal, 1984, Volume: 107, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Myocardium; Thrombin; Thrombophlebitis

1984
Haemostatic variables and the outcome of myocardial infarction.
    Thrombosis and haemostasis, 1983, Dec-30, Volume: 50, Issue:4

    Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antigens; Creatine Kinase; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prognosis; von Willebrand Factor

1983
[Myocardial repair in infarction: parallels of clinico-laboratory indices, morphology and biochemistry of infarcted myocardium].
    Kardiologiia, 1982, Volume: 22, Issue:9

    Topics: Adult; Aged; Blood Sedimentation; Female; Fibrinogen; Glycosaminoglycans; Humans; Hydroxyproline; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardium

1982
Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction.
    Thrombosis research, 1983, Jun-01, Volume: 30, Issue:5

    Topics: Adult; Aged; Antigens; Blood Coagulation Factors; Factor VIII; Female; Fibrinogen; Humans; Immunoelectrophoresis, Two-Dimensional; Male; Middle Aged; Myocardial Infarction; von Willebrand Factor

1983
Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
    Journal of the American College of Cardiology, 1984, Volume: 4, Issue:2

    Topics: Aged; Anistreplase; Coronary Vessels; Drug Evaluation; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Thrombin Time

1984
Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
    Thrombosis research, 1984, Aug-01, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Blood Protein Electrophoresis; Child; Child, Preschool; Edetic Acid; Female; Fibrin; Fibrinogen; Hip Prosthesis; Humans; Infant; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Postoperative Period; Sex Factors

1984
Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
    Thrombosis and haemostasis, 1984, Dec-29, Volume: 52, Issue:3

    Topics: alpha-2-Antiplasmin; Antigens; Antithrombin III; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Myocardial Infarction; von Willebrand Factor

1984
Intracoronary thrombolysis in evolving myocardial infarction.
    American heart journal, 1981, Volume: 101, Issue:1

    Topics: Adult; Animals; Arterial Occlusive Diseases; Coronary Vessels; Creatine Kinase; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Nitroglycerin; Plasminogen; Serum Globulins; Streptokinase; Time Factors

1981
[Effect of streptodecase and heparin on the state of hemostasis in patients with acute myocardial infarction].
    Kardiologiia, 1984, Volume: 24, Issue:7

    Topics: Adult; Aged; Blood Coagulation; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Streptokinase

1984
Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarction. Does nonreperfusion indicate failure to achieve a systemic lytic state?
    The American journal of cardiology, 1984, Oct-01, Volume: 54, Issue:7

    Topics: Coronary Angiography; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase

1984
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1984, Sep-15, Volume: 39, Issue:18

    Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis

1984
[Prognostic significance of the state of the blood coagulation system for the development of myocardial infarction and sudden death in patients with ischemic heart disease].
    Kardiologiia, 1984, Volume: 24, Issue:10

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Disorders; Coronary Disease; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis

1984
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    The New England journal of medicine, 1984, Mar-08, Volume: 310, Issue:10

    Topics: Aged; alpha-2-Antiplasmin; Coronary Vessels; Drug Evaluation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase

1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
    Circulation, 1984, Volume: 70, Issue:4

    Topics: alpha-2-Antiplasmin; Animals; Coronary Angiography; Coronary Disease; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Fibrinogen; Fibrinolysis; Myocardial Infarction; Plasminogen; Plasminogen Activators

1984
[Aortocoronary venous bypass in dysfibrinogenemia].
    Die Medizinische Welt, 1983, Jan-28, Volume: 34, Issue:4

    Topics: Blood Coagulation Disorders; Coronary Artery Bypass; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

1983
Does qualitatively altered fibrinogen contribute to the increased heparin precipitable fraction (HPF) in acute myocardial infarction (AMI)?
    Thrombosis research, 1984, Jan-01, Volume: 33, Issue:1

    Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Blood Proteins; C-Reactive Protein; Fibrinogen; Fibronectins; Haptoglobins; Heparin; Humans; Myocardial Infarction; Neoplasms; Orosomucoid; Pulmonary Embolism; Sepsis

1984
Haemorheological investigations in patients with chronic ischaemic heart disease and acute myocardial infarction.
    Cor et vasa, 1983, Volume: 25, Issue:3

    Topics: Blood Proteins; Blood Viscosity; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction

1983
Plasma fibrinogen levels and the clinical course of acute myocardial infarction.
    Angiology, 1983, Volume: 34, Issue:11

    Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Thromboembolism

1983
Prognostic value of plasma fibrinogen in myocardial infarction.
    Journal of postgraduate medicine, 1983, Volume: 29, Issue:4

    Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis

1983
[Hemorrheological changes in ischemic heart disease].
    La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

    Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Erythrocytes; Exercise Test; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology

1983
[Erythrocyte filtration in acute myocardial infarction].
    La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

    Topics: Blood Sedimentation; Erythrocytes; Female; Fibrinogen; Humans; Leukocyte Count; Male; Myocardial Infarction; Polycarboxylate Cement; Time Factors; Ultrafiltration

1983
Evaluation of the haemorheological determinants in coronary heart disease.
    Advances in experimental medicine and biology, 1984, Volume: 164

    Topics: Blood Viscosity; Coronary Disease; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Physical Exertion

1984
Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
    Circulation, 1984, Volume: 69, Issue:4

    Topics: Aged; Antithrombin III; Creatine Kinase; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction

1984
Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.
    Journal of the American College of Cardiology, 1984, Volume: 4, Issue:1

    Topics: Antibodies, Bacterial; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase

1984
Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction.
    Thrombosis and haemostasis, 1980, Feb-29, Volume: 42, Issue:5

    Topics: Adenosine Diphosphate; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Platelets; Collagen; Epinephrine; Factor VIII; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Serotonin; Serum Globulins; Time Factors

1980
Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Thrombosis and haemostasis, 1980, Feb-29, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Animals; Blood Coagulation; Cerebrovascular Disorders; Chromatography, Gel; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Immunodiffusion; Infusions, Parenteral; Male; Molecular Weight; Myocardial Infarction; Polymers; Rabbits; Solubility; Thrombin; Thrombophlebitis

1980
Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction.
    Thrombosis and haemostasis, 1980, Feb-29, Volume: 43, Issue:1

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pregnancy; von Willebrand Factor

1980
Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
    Circulation, 1983, Volume: 67, Issue:5

    Topics: Adult; Aged; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Streptokinase; Time Factors

1983
Clinical and laboratory management of pulmonary embolism.
    Geriatrics, 1983, Volume: 38, Issue:4

    Topics: Anticoagulants; Blood Cell Count; Diagnosis, Differential; Electrocardiography; Fibrinogen; Humans; Iodine Radioisotopes; Lung; Myocardial Infarction; Physical Examination; Platelet Count; Plethysmography, Impedance; Pneumonia; Pulmonary Embolism; Radionuclide Imaging; Thrombosis; Ultrasonography

1983
Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
    Clinical cardiology, 1983, Volume: 6, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Whole Blood Coagulation Time

1983
Plasma hypercoagulability after termination of oral anticoagulants.
    Thrombosis research, 1983, Mar-15, Volume: 29, Issue:6

    Topics: 4-Hydroxycoumarins; Administration, Oral; Aged; Anticoagulants; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Phenprocoumon; Prothrombin Time; Thromboembolism; Time Factors

1983
Morphological variants of acute myocardial necrosis and their relationship to coronary artery thrombosis.
    Acta medica Scandinavica. Supplementum, 1980, Volume: 642

    Topics: Animals; Arteriosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Humans; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Rats

1980
[Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].
    Klinische Wochenschrift, 1981, May-04, Volume: 59, Issue:9

    Topics: Aged; alpha 1-Antitrypsin; Angina Pectoris; Blood Proteins; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Half-Life; Haptoglobins; Humans; Male; Myocardial Infarction; Prealbumin; Serum Albumin; Stress, Physiological; Transferrin

1981
Blood rheology in acute myocardial infarction.
    Acta cardiologica, 1982, Volume: 37, Issue:6

    Topics: Adult; Aged; Blood Viscosity; Diabetes Complications; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology

1982
Plasma fibrinogen levels as an indicator of myocardial necrosis.
    Journal of the Royal College of Physicians of London, 1982, Volume: 16, Issue:1

    Topics: Adult; Aged; Coronary Disease; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis

1982
Association of recurrent myocardial infarction with hemostatic factors: a prospective study.
    Chest, 1982, Volume: 81, Issue:5

    Topics: Adult; Aged; Cholesterol; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Prospective Studies; Prothrombin; Prothrombin Time; Recurrence

1982
Heparin effect on blood viscosity.
    Clinical cardiology, 1982, Volume: 5, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Hematocrit; Heparin; History, 17th Century; Humans; Male; Myocardial Infarction

1982
[Myocardial infarct: an acute dysmetabolic disease].
    Minerva medica, 1982, Sep-15, Volume: 73, Issue:35

    Topics: Adult; Antithrombin III; Female; Fibrinogen; Glycosaminoglycans; Heparin; Humans; Injections, Intravenous; Lipoprotein Lipase; Male; Middle Aged; Myocardial Infarction

1982
Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1982, Volume: 23, Issue:11

    Topics: Animals; Antibodies; Dogs; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Isotope Labeling; Mice; Myocardial Infarction; Myocardium; Myosins; Radionuclide Imaging; Technetium; Tissue Distribution

1982
Plasma fibrinolytic activity and fibrinogen: their relationship in cardiac injury.
    Journal of postgraduate medicine, 1982, Volume: 28, Issue:4

    Topics: Adult; Aged; Animals; Dogs; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Rats

1982
Fibrinogen derivatives and recurrent myocardial infarction.
    Acta medica Scandinavica, 1982, Volume: 212, Issue:5

    Topics: Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Prospective Studies; Recurrence; Risk

1982
Catabolism and excretion of fibrinopeptide-A.
    Blood, 1982, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Aged; Animals; Brain Abscess; Burns; Child; Circadian Rhythm; Dogs; False Positive Reactions; Female; Fibrinogen; Fibrinopeptide A; Hemoglobinuria; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Myocardial Infarction; Neoplasms; Thrombin

1982
[Evaluation of some hemo-rheological factors in a group of subjects with prior myocardial infarct submitted to exercise tests].
    Minerva cardioangiologica, 1981, Volume: 29, Issue:6

    Topics: Acid-Base Equilibrium; Adult; Blood Flow Velocity; Blood Viscosity; Exercise Test; Fibrinogen; Heart; Hematocrit; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardial Infarction

1981
Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Thrombosis and haemostasis, 1981, Jun-30, Volume: 45, Issue:3

    Topics: 4-Hydroxycoumarins; Administration, Oral; Anticoagulants; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction; Partial Thromboplastin Time; Phenprocoumon; Thrombin; Thrombophlebitis

1981
[Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1981, Jul-06, Volume: 36, Issue:27

    Topics: Acute Disease; Adult; Aged; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk; Thrombosis

1981
Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
    Angiology, 1981, Volume: 32, Issue:10

    Topics: Ancrod; Aspirin; Blood Viscosity; Chronic Disease; Erythrocyte Count; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Lipid Metabolism; Myocardial Infarction; Plasma Exchange; Rheology; Vascular Diseases; Vasodilator Agents

1981
[Lipid binding in blood clots in acute myocardial infarct].
    Acta medica Austriaca, 1981, Volume: 8, Issue:5

    Topics: Adult; Binding Sites; Blood Coagulation; Blood Platelets; Cholesterol; Cholesterol, HDL; Fibrinogen; Humans; Lipids; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Phospholipids; Triglycerides

1981
Changes in red cell deformability and other haemorrheological variables after myocardial infarction.
    British heart journal, 1980, Volume: 44, Issue:5

    Topics: Adult; Aged; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic

1980
[Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
    Giornale italiano di cardiologia, 1980, Volume: 10, Issue:1

    Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Humans; Hyperlipoproteinemias; Myocardial Infarction

1980
[Blood viscosimetric factors in cardiovascular pathology].
    Minerva cardioangiologica, 1980, Volume: 28, Issue:9

    Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases

1980
Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:5

    Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoimmune Diseases; Blood Coagulation Tests; Disease Susceptibility; Female; Fibrinogen; Hemostasis; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Thromboembolism; Thrombophlebitis; von Willebrand Factor

1995
The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:5

    Topics: Birefringence; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Enzyme Activation; Fibrin; Fibrinogen; Fibrinolysis; Gels; Hemophilia A; Humans; Myocardial Infarction; Plasma; Prothrombin; Thrombin; Thromboplastin

1995
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    The Journal of laboratory and clinical medicine, 1995, Volume: 125, Issue:2

    Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Fibrinogen; Flow Cytometry; Humans; Myocardial Infarction; P-Selectin; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Serotonin; Streptokinase; Thrombin; Thrombolytic Therapy; Thromboxane A2

1995
Complement components and fibrinogen: correlations and association with previous myocardial infarction.
    Cardiology, 1995, Volume: 86, Issue:3

    Topics: Adult; Antithrombin III; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Complement System Proteins; Confounding Factors, Epidemiologic; Fibrinogen; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Protein C; Protein S; Radioimmunoassay; Risk Factors; Tissue Plasminogen Activator

1995
[Relation between plasma fibrinogen and the function of collateral coronary vessels].
    Zeitschrift fur Kardiologie, 1995, Volume: 84, Issue:5

    Topics: Adult; Aged; Blood Viscosity; Cholesterol, LDL; Collateral Circulation; Coronary Circulation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Reference Values; Risk Factors; Stroke Volume; Ventricular Function, Left

1995
Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease.
    Coronary artery disease, 1995, Volume: 6, Issue:5

    Topics: Adult; Blood Platelets; Case-Control Studies; Cell Separation; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Platelet Function Tests; Risk Factors

1995
Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins.
    Annals of clinical biochemistry, 1993, Volume: 30 ( Pt 4)

    Topics: Acute-Phase Proteins; alpha 1-Antichymotrypsin; alpha-Macroglobulins; C-Reactive Protein; Female; Fibrinogen; Humans; Lipids; Male; Myocardial Infarction; N-Acetylneuraminic Acid; Nephelometry and Turbidimetry; Orosomucoid; Radioimmunoassay; Risk Factors; Sialic Acids

1993
[Fibrinogen and leukocyte number in coronary heart disease. Correlation with angiography and clinical degree].
    Zeitschrift fur Kardiologie, 1995, Volume: 84, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction

1995
Influence of circulating D-dimer levels on assays of fibrinogen.
    Annals of the Academy of Medicine, Singapore, 1994, Volume: 23, Issue:6

    Topics: Adult; Angina, Unstable; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Pregnancy; Pregnancy Complications; Streptokinase; Thrombelastography; Thrombolytic Therapy

1994
[Fibrinogen levels in ultra-high dosage streptokinase lysis].
    Deutsche medizinische Wochenschrift (1946), 1995, Jun-09, Volume: 120, Issue:23

    Topics: Fibrinogen; Heparin; Humans; Myocardial Infarction; Partial Thromboplastin Time; Streptokinase

1995
Outcome after thrombolytic therapy of nine cases of myopericarditis misdiagnosed as myocardial infarction.
    European heart journal, 1995, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Diagnostic Errors; Electrocardiography; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Pericardial Effusion; Pericarditis; Risk Factors; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

1995
Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5, Issue:5

    Topics: Aged; Blood Coagulation; Fibrinogen; Humans; Hydrogen-Ion Concentration; Iodoacetamide; Kinetics; Male; Middle Aged; Myocardial Infarction; Sodium Chloride

1994
Seasonal variations of plasma fibrinogen in elderly people.
    Lancet (London, England), 1994, Apr-16, Volume: 343, Issue:8903

    Topics: Adult; Aged; Aging; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Seasons

1994
Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.
    Circulation, 1994, Volume: 90, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Peptide Fragments; Prospective Studies; Prothrombin; Thromboplastin; Time Factors

1994
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).
    European journal of clinical investigation, 1994, Volume: 24, Issue:7

    Topics: Cholesterol, LDL; Cohort Studies; Fibrinogen; Humans; Incidence; Lipoprotein(a); Male; Middle Aged; Models, Statistical; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Risk Factors

1994
Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patency.
    International journal of cardiology, 1994, Jun-15, Volume: 45, Issue:2

    Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Coronary Angiography; Coronary Circulation; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Intravenous; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen; Treatment Outcome

1994
Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
    American journal of clinical pathology, 1994, Volume: 102, Issue:2

    Topics: Acute-Phase Reaction; Adult; Aged; C-Reactive Protein; Circadian Rhythm; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; von Willebrand Factor

1994
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study Group.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Alcohol Drinking; Antigens; Body Constitution; Body Mass Index; Case-Control Studies; Contraception; Disease Susceptibility; Europe; Factor VII; Fathers; Female; Fibrinogen; Humans; Lipids; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Smoking

1994
Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    European heart journal, 1994, Volume: 15, Issue:5

    Topics: Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors

1994
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Sangre, 1994, Volume: 39, Issue:2

    Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors

1994
[Changes in hemocoagulation during thrombolytic therapy of acute myocardial infarct in relation to risks of thrombotic complications].
    Vnitrni lekarstvi, 1994, Volume: 40, Issue:6

    Topics: Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Risk Factors; Thrombolytic Therapy; Thrombosis

1994
Tissue-type plasminogen activator and risk of myocardial infarction.
    Lancet (London, England), 1993, Jul-03, Volume: 342, Issue:8862

    Topics: alpha-2-Antiplasmin; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Inactivators; Recurrence; Risk Factors; Tissue Plasminogen Activator

1993
Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Angiology, 1994, Volume: 45, Issue:4

    Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Blood Coagulation; Fibrinogen; Fibrinolysin; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Prothrombin Time; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1994
The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.
    Thrombosis and haemostasis, 1993, Dec-20, Volume: 70, Issue:6

    Topics: Adult; Alleles; Fibrinogen; Genotype; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Reference Values; Survivors; Sweden

1993
[Evaluation of the fibrinolytic system in myocardial infarction].
    Sangre, 1994, Volume: 39, Issue:1

    Topics: Aged; alpha-2-Antiplasmin; Convalescence; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator

1994
Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.
    British heart journal, 1994, Volume: 71, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Heart; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors; Treatment Outcome

1994
Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
    Coronary artery disease, 1994, Volume: 5, Issue:3

    Topics: Aspirin; Blood Coagulation Tests; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy

1994
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:12

    Topics: Adult; Aged; Aging; Angina Pectoris; Body Mass Index; Coronary Disease; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; von Willebrand Factor

1993
[Importance of the fibrinogen concentration as an independent risk factor for ischemic heart disease].
    Wiener medizinische Wochenschrift (1946), 1993, Volume: 143, Issue:18

    Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Reference Values; Retrospective Studies; Risk Factors; Thrombolytic Therapy

1993
Fibrinogen and the albumin-globulin ratio in recurrent stroke.
    Stroke, 1993, Volume: 24, Issue:8

    Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Serum Globulins; Vascular Diseases

1993
Dental disease, fibrinogen and white cell count; links with myocardial infarction?
    Scottish medical journal, 1993, Volume: 38, Issue:3

    Topics: Adult; Female; Fibrinogen; Gingivitis; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Periodontitis; Risk Factors; Smoking; Social Class

1993
Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
    The American journal of cardiology, 1993, Jan-01, Volume: 71, Issue:1

    Topics: Aged; Anistreplase; Blood Coagulation Factors; Blood Viscosity; Cardiac Output; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Regression Analysis; Rheology; Thrombolytic Therapy; Vascular Patency

1993
[Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
    Schweizerische medizinische Wochenschrift, 1993, Jan-23, Volume: 123, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antigens; Child; Coronary Disease; Factor VII; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Protein C

1993
[Fibrinogen substitution in systemic defibrination because of thrombolysis in acute myocardial infarction].
    Ugeskrift for laeger, 1993, Mar-22, Volume: 155, Issue:12

    Topics: Fibrinogen; Humans; Myocardial Infarction; Risk Factors; Thrombolytic Therapy

1993
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
    British heart journal, 1993, Volume: 69, Issue:4

    Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors

1993
Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
    European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1993, Volume: 31, Issue:3

    Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Lipids; Lipoprotein(a); Lipoproteins, HDL; Myocardial Infarction; Risk Factors; Triglycerides

1993
Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.
    Thrombosis and haemostasis, 1993, Apr-01, Volume: 69, Issue:4

    Topics: Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Recombinant Proteins; Thrombolytic Therapy

1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:6

    Topics: Adult; Base Sequence; Case-Control Studies; Fibrinogen; Genetic Variation; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Risk Factors

1993
Bad teeth and myocardial infarction. Roles for white cells and fibrinogen.
    BMJ (Clinical research ed.), 1993, May-01, Volume: 306, Issue:6886

    Topics: Fibrinogen; Humans; Leukocyte Count; Myocardial Infarction; Oral Hygiene; Periodontal Diseases; Risk Factors

1993
Hemostatic risk factors of coronary artery disease in the Chinese.
    International journal of cardiology, 1995, Volume: 51, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Glucose; Case-Control Studies; China; Cholesterol; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Factor VII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Serine Proteinase Inhibitors; Taiwan; Triglycerides

1995
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.
    Circulation, 1996, Feb-01, Volume: 93, Issue:3

    Topics: Adult; Alleles; Base Sequence; Coronary Angiography; Coronary Disease; Fibrinogen; Genetic Linkage; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Myocardial Infarction; Polymorphism, Genetic; Smoking

1996
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Age of Onset; Angina Pectoris; Body Constitution; Comorbidity; Coronary Disease; Depression; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Hypertriglyceridemia; Lipids; Male; Motor Activity; Myocardial Infarction; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Smoking

1996
Lipid peroxidation, antioxidant defences and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease.
    Journal of cardiovascular risk, 1995, Volume: 2, Issue:6

    Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Erythrocyte Membrane; Female; Fibrinogen; Free Radical Scavengers; Humans; India; Lipid Peroxidation; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Count; Reference Values; Sterol Esterase

1995
Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Israel journal of medical sciences, 1996, Volume: 32, Issue:6

    Topics: Adult; Aged; Cholesterol, LDL; Death, Sudden, Cardiac; Factor VII; Fibrinogen; Humans; Lipids; Lipoproteins, LDL; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Risk Factors

1996
A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 1996, Volume: 44, Issue:4

    Topics: Adult; Aged; Alleles; Case-Control Studies; Chromosomes, Human, Pair 4; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Risk Factors

1996
A case-reference study on plasma fibrinogen concentrations and coronary atherosclerosis in Japanese.
    Journal of epidemiology, 1996, Volume: 6, Issue:2

    Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors

1996
Thrombotic markers during myocardial infarction.
    Panminerva medica, 1995, Volume: 37, Issue:3

    Topics: Adult; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Thrombosis

1995
Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Acute Disease; Adult; Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Thrombin; Time Factors; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor

1996
Von Willebrand factor in patients evolving Q-wave versus non-Q-wave acute myocardial infarction.
    International journal of cardiology, 1996, Oct-25, Volume: 56, Issue:3

    Topics: Aged; Analysis of Variance; Biomarkers; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; von Willebrand Factor

1996
Non-traditional risk factors for atherosclerosis in high risk children.
    Israel journal of medical sciences, 1996, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis

1996
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.
    Atherosclerosis, 1997, Mar-21, Volume: 129, Issue:2

    Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, LDL; Cohort Studies; Comorbidity; Death, Sudden, Cardiac; Disease Susceptibility; Fibrinogen; Germany; Humans; Incidence; Lipids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prevalence; Prospective Studies; Risk; Risk Factors; Smoking

1997
Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Thrombosis and haemostasis, 1997, Volume: 77, Issue:6

    Topics: Acute-Phase Reaction; Alleles; Biomarkers; Coronary Disease; Fibrinogen; Homozygote; Humans; Male; Myocardial Infarction

1997
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
    Circulation, 1997, Sep-02, Volume: 96, Issue:5

    Topics: Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Risk Factors

1997
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
    Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:12

    Topics: Adult; Aged; Apolipoproteins B; Austria; Cholesterol, HDL; Comorbidity; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Phenotype; Prevalence; Renal Dialysis; Risk Factors; Smoking

1997
Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:12

    Topics: Case-Control Studies; Deoxyribonucleases, Type II Site-Specific; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk

1997
Association of a common polymorphism in the factor XIII gene with myocardial infarction.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:1

    Topics: Case-Control Studies; Factor XIII; Female; Fibrinogen; Humans; Leucine; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Risk Factors; Valine

1998
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:1

    Topics: Case-Control Studies; Cholesterol; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Factor VII; Factor XIIa; Female; Fibrinogen; Humans; Insulin; Male; Myocardial Infarction; Risk Factors; Survivors; Tissue Plasminogen Activator; Triglycerides

1998
Antipeptide monoclonal antibodies to defined fibrinogen Aalpha chain regions: anti-Aalpha 487-498, a structural probe for fibrinogenolysis.
    Blood, 1998, Mar-01, Volume: 91, Issue:5

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Enzyme-Linked Immunosorbent Assay; Epitopes; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immunoblotting; Mice; Mice, Inbred BALB C; Myocardial Infarction; Peptide Fragments; Species Specificity; Thrombolytic Therapy

1998
[Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
    Zeitschrift fur Kardiologie, 1997, Volume: 86, Issue:12

    Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors

1997
Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Journal of the American College of Cardiology, 1998, Mar-01, Volume: 31, Issue:3

    Topics: alpha-2-Antiplasmin; Angina, Unstable; Antithrombin III; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Peptide Hydrolases; Plasminogen; Prospective Studies; Time Factors; Tissue Plasminogen Activator

1998
Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
    The American journal of cardiology, 1998, Apr-01, Volume: 81, Issue:7

    Topics: Aged; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Prospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator

1998
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?
    Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:4

    Topics: Aged; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking

1998
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
    European heart journal, 1998, Volume: 19, Issue:4

    Topics: Angina, Unstable; Antibodies, Anti-Idiotypic; Anticoagulants; Biomarkers; C-Reactive Protein; Chlamydia Infections; Chronic Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pneumonia, Bacterial; Prevalence; Prognosis; Risk Factors

1998
[Role of biochemical and fibrinolytic parameters on cardiac events associated with Hanshin-Awaji earthquake-induced stress].
    Rinsho byori. The Japanese journal of clinical pathology, 1998, Volume: 46, Issue:6

    Topics: Blood Pressure; Blood Viscosity; Disasters; Endothelium, Vascular; Fibrinogen; Humans; Japan; Myocardial Infarction; Stress, Physiological; Stress, Psychological

1998
Monocyte tissue factor-like activity in post myocardial infarction patients.
    British journal of haematology, 1998, Volume: 102, Issue:2

    Topics: Blood Cell Count; Blood Coagulation; Case-Control Studies; Factor VII; Fibrinogen; Homeostasis; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Neutrophils; Plasminogen; Plasminogen Activators; Thromboplastin; Tumor Necrosis Factor-alpha

1998
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Thrombosis and haemostasis, 1998, Volume: 80, Issue:5

    Topics: Alcohol Drinking; Cardiovascular Diseases; Comorbidity; Factor VII; Fibrinogen; France; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires

1998
[Etiopathogenesis of acute myocardial infarction: role of early leukocytosis].
    Cardiologia (Rome, Italy), 1998, Volume: 43, Issue:9

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Female; Fibrinogen; Hemodynamics; Humans; Leukocytosis; Male; Middle Aged; Myocardial Infarction; Platelet Count; Stents; Thrombolytic Therapy; Time Factors

1998
Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.
    Clinical biochemistry, 1998, Volume: 31, Issue:8

    Topics: Chi-Square Distribution; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Statistics as Topic

1998
Relationship between plasma fibrinogen and coronary heart disease in women.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Body Mass Index; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Hospitalization; Humans; Lipids; Logistic Models; Menopause; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Smoking

1999
Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:1

    Topics: Fibrinogen; Humans; Myocardial Infarction; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors

1999
Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Aged; Angina Pectoris; Angina, Unstable; Animals; Blood Proteins; Body Temperature; C-Reactive Protein; Cardiac Catheterization; Coronary Artery Disease; Coronary Vessels; Disease Progression; Energy Metabolism; Female; Fibrinogen; Humans; Lipids; Macrophage Activation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Rupture, Spontaneous; Swine; Thermography

1999
Arterial thrombosis in heart failure.
    Lancet (London, England), 1998, May-23, Volume: 351, Issue:9115

    Topics: Adenosine Diphosphate; Coronary Thrombosis; Epinephrine; Fibrinogen; Heart Failure; Hemorheology; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Vasoconstrictor Agents; von Willebrand Factor

1998
Thrombogenic factors and recurrent coronary events.
    Circulation, 1999, May-18, Volume: 99, Issue:19

    Topics: Adult; Aged; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; Thrombosis; von Willebrand Factor

1999
Saruplase versus other fibrinolytic agents.
    International journal of clinical practice. Supplement, 1998, Volume: 99

    Topics: Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator

1998
Infection and myocardial infarction.
    Helicobacter, 1999, Volume: 4, Issue:2

    Topics: Adult; Aged; Antigens, Bacterial; Bacterial Infections; Bacterial Proteins; Chlamydia Infections; Cytomegalovirus Infections; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Herpesviridae Infections; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Serologic Tests; Virus Diseases

1999
Association between job characteristics and plasma fibrinogen in a normal working population: a cross sectional analysis in referents of the SHEEP Study. Stockholm Heart Epidemiology Program.
    Journal of epidemiology and community health, 1999, Volume: 53, Issue:6

    Topics: Aged; Cross-Sectional Studies; Employment; Female; Fibrinogen; Humans; Life Style; Logistic Models; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Sex Factors; Social Class; Stress, Physiological; Surveys and Questionnaires; Sweden

1999
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:1

    Topics: Adult; Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors

1999
Carotid intima-media thickness of young coronary patients.
    Coronary artery disease, 1999, Volume: 10, Issue:6

    Topics: Adult; Blood Glucose; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, HDL; Coronary Artery Disease; Fibrinogen; Humans; Iron; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Transferrin; Tunica Intima; Ultrasonography

1999
Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    The American journal of cardiology, 1999, Sep-01, Volume: 84, Issue:5

    Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Recombinant Proteins; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator

1999
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    European heart journal, 1999, Volume: 20, Issue:20

    Topics: Adult; Angina Pectoris; Aorta, Abdominal; Arteriosclerosis; Biomarkers; Blood Viscosity; C-Reactive Protein; Carotid Arteries; Cerebral Arteries; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Prognosis; Severity of Illness Index; Stroke Volume; Ultrasonography, Doppler, Duplex; Ultrasonography, Doppler, Transcranial; Ventricular Function, Left

1999
Lower cardiac mortality in smokers following thrombolysis.
    QJM : monthly journal of the Association of Physicians, 1999, Volume: 92, Issue:11

    Topics: Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Smoking; Thrombolytic Therapy; Treatment Outcome

1999
Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:5

    Topics: Aged; Biomarkers; Convalescence; Coronary Thrombosis; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Phosphorus; Phosphorylation; Protein Processing, Post-Translational; Recurrence

1999
Development and evaluation of a new canine myocardial infarction model using a closed-chest injection of thrombogenic material.
    Japanese circulation journal, 1999, Volume: 63, Issue:11

    Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Blood Transfusion, Autologous; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Heart Rate; Hydroxybutyrate Dehydrogenase; Injections, Intra-Arterial; Isoenzymes; Myocardial Infarction; Organ Size; Pulmonary Wedge Pressure; Stroke Volume; Thrombin; Vascular Patency

1999
C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:1

    Topics: Adult; Aged; Alleles; C-Reactive Protein; Cholesterol; Cohort Studies; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Triglycerides

2000
[Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Circadian Rhythm; Coronary Angiography; Echocardiography, Doppler; Electrocardiography; Fibrinogen; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy; Treatment Outcome

1999
Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:12

    Topics: Acute Disease; Aged; Analysis of Variance; Angina, Unstable; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Syndrome; Time Factors

1999
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
    Journal of clinical epidemiology, 2000, Volume: 53, Issue:1

    Topics: Adult; Angina Pectoris; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Logistic Models; Male; Myocardial Infarction; Predictive Value of Tests; Risk Factors

2000
Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment.
    Thrombosis research, 2000, Apr-15, Volume: 98, Issue:2

    Topics: Adult; Aged; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Phosphorylation; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

2000
The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
    Blood, 2000, Apr-01, Volume: 95, Issue:7

    Topics: Animals; Blood Coagulation; Blotting, Western; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Mice; Myocardial Infarction; Peptide Fragments; Polymers; Thrombin; Transglutaminases

2000
c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy co
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:2

    Topics: Abciximab; Adenosine Diphosphate; Adsorption; Adult; Antibodies, Monoclonal; Anticoagulants; Blood Flow Velocity; Blood Platelets; Cell Culture Techniques; Endothelium, Vascular; Fibrinogen; Glass; Hemorheology; Humans; Immunoglobulin Fab Fragments; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Time Factors; Umbilical Veins; von Willebrand Factor

2000
Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Coronary Circulation; Factor VIIa; Fibrinogen; Hemodynamics; Hemostatics; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Recombinant Proteins; Thromboplastin

2000
Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
    The Journal of biological chemistry, 2000, Jul-07, Volume: 275, Issue:27

    Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Enzyme Activation; Factor XIII; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Kinetics; Myocardial Infarction; Peptide Fragments; Peptides; Thrombin

2000
Elevation of plasma fibrinogen in silent myocardial ischaemia.
    Acta biochimica Polonica, 1999, Volume: 46, Issue:4

    Topics: Adult; Arteriosclerosis; Case-Control Studies; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis

1999
Modifications of whole blood filterability during acute myocardial infarction.
    Clinical hemorheology and microcirculation, 2000, Volume: 22, Issue:2

    Topics: Acute Disease; Aged; Blood Viscosity; Diabetes Complications; Erythrocyte Deformability; Female; Fibrinogen; Fibrinolytic Agents; Filtration; Humans; Hyperlipidemias; Hypertension; Male; Membranes, Artificial; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Polycarboxylate Cement; Thrombolytic Therapy

2000
Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.
    Microvascular research, 2000, Volume: 60, Issue:1

    Topics: Animals; Blood Viscosity; Capillaries; Cobalt Radioisotopes; Coronary Circulation; Dogs; Drug Evaluation, Preclinical; Erythrocyte Count; Fibrinogen; Fibrinolytic Agents; Hematocrit; Hemoglobins; Image Processing, Computer-Assisted; Microcirculation; Microspheres; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Radionuclide Imaging; Streptokinase; Thrombolytic Therapy; Tin Radioisotopes

2000
Plasma fibrinogen and coronary heart disease in urban Japanese.
    American journal of epidemiology, 2000, Sep-01, Volume: 152, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Urban Population

2000
Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction.
    The American journal of cardiology, 2000, Oct-15, Volume: 86, Issue:8

    Topics: Aged; Apolipoproteins B; Cholesterol; Female; Fibrinogen; Humans; Lipids; Logistic Models; Male; Middle Aged; Myocardial Infarction; Smoking; Time Factors

2000
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hypercholesterolemia; Inflammation; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Risk Factors; Triglycerides

2000
Fibrinogen polymorphisms are not associated with the risk of myocardial infarction.
    British journal of haematology, 2000, Volume: 110, Issue:4

    Topics: Analysis of Variance; Case-Control Studies; Chi-Square Distribution; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk

2000
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
    Journal of internal medicine, 2000, Volume: 248, Issue:4

    Topics: Aged; Analysis of Variance; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; P-Selectin; Pilot Projects; Platelet Activation; Prospective Studies; Streptokinase; Thrombomodulin; Vitamin E; von Willebrand Factor

2000
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.
    The American journal of pathology, 2000, Volume: 157, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Antithrombins; Cell Movement; Chemokines; Fibrin; Fibrinogen; Hirudins; Microscopy, Electron; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocarditis; Myocardium; Neutrophils; Rabbits; Thrombin; Thromboplastin

2000
Role of monocytes in the early phase of acute myocardial infarction.
    Panminerva medica, 2000, Volume: 42, Issue:3

    Topics: Acute Disease; Aged; Creatine Kinase; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Monocytes; Myocardial Infarction

2000
Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:3

    Topics: Adult; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Orosomucoid; Survival Rate; Sweden; Time Factors

2001
Parameters of red blood cell aggregation as correlates of the inflammatory state.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:5

    Topics: Acute-Phase Reaction; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Bacterial Infections; Biomarkers; C-Reactive Protein; Cell Aggregation; Erythrocytes; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Stress, Mechanical

2001
C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.
    Annals of medicine, 2001, Volume: 33, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; C-Reactive Protein; Coronary Disease; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Interleukin-6; Male; Myocardial Infarction; Prognosis; Retrospective Studies; Risk Assessment; Syndrome; Tumor Necrosis Factor-alpha

2001
Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction.
    Japanese circulation journal, 2001, Volume: 65, Issue:4

    Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Biomarkers; Comorbidity; Coronary Thrombosis; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Female; Fibrinogen; Hemorheology; Heparin; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Factors; Stress, Mechanical

2001
Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    The Israel Medical Association journal : IMAJ, 2001, Volume: 3, Issue:1

    Topics: Angina Pectoris; Antithrombin III; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Serine Proteinase Inhibitors; Smoking

2001
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Coronary artery disease, 2001, Volume: 12, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index

2001
Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study.
    Thrombosis research, 2001, May-15, Volume: 102, Issue:4

    Topics: Body Mass Index; Cholesterol; Cholesterol, HDL; Dietary Fats; Erythrocytes; Factor VII; Fatty Acids; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Smoking; Tissue Plasminogen Activator; von Willebrand Factor

2001
Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study.
    Journal of internal medicine, 2001, Volume: 249, Issue:6

    Topics: Female; Fibrinogen; Follow-Up Studies; Humans; Lipids; Logistic Models; Male; Middle Aged; Myocardial Infarction; Norway; Predictive Value of Tests; Prognosis; Prospective Studies; Statistics, Nonparametric; Stroke Volume; Surveys and Questionnaires

2001
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
    Circulation, 2001, Jun-26, Volume: 103, Issue:25

    Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor

2001
Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction.
    Atherosclerosis, 2001, Volume: 157, Issue:1

    Topics: Acute Disease; Adult; Aged; Angioplasty; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Prognosis

2001
A hypothesis to explain the reported association of the alpha-fibrinogen A312 allele with thromboembolic disease.
    Thrombosis and haemostasis, 2001, Volume: 85, Issue:6

    Topics: Alleles; Amino Acid Substitution; Case-Control Studies; Fibrin; Fibrinogen; Humans; Male; Myocardial Infarction; Polymorphism, Genetic; Thromboembolism

2001
Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:9

    Topics: Adult; Aged; Brain Infarction; Case-Control Studies; Cathepsin G; Cathepsins; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Promoter Regions, Genetic; Serine Endopeptidases; Transcriptional Activation; Tumor Cells, Cultured

2001
Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    American heart journal, 2001, Volume: 142, Issue:4

    Topics: Adult; Age of Onset; Antibodies, Bacterial; Antibodies, Viral; Biomarkers; C-Reactive Protein; Chlamydia Infections; Chlamydophila pneumoniae; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrinogen; Humans; Immunoglobulin G; Inflammation; Leukocytes; Male; Middle Aged; Myocardial Infarction; Risk Factors; Serologic Tests

2001
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
    European heart journal, 2001, Volume: 22, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Coronary Artery Disease; DNA Primers; Fibrinogen; Genotype; Germany; Humans; Male; Massachusetts; Middle Aged; Mutation; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Stroke; Venous Thrombosis; White People

2001
Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.
    Thrombosis research, 2001, Dec-15, Volume: 104, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Recurrence; Retrospective Studies; Thrombophilia

2001
Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting.
    Heart and vessels, 2000, Volume: 15, Issue:6

    Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Recurrence; Risk Factors; Stents; Thrombosis

2000
Fibrinogen: associations with cardiovascular events in an outpatient clinic.
    American heart journal, 2002, Volume: 143, Issue:2

    Topics: Biomarkers; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Regression Analysis

2002
C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study.
    Atherosclerosis, 2002, Volume: 160, Issue:2

    Topics: C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Smoking; Stroke Volume; Survival Rate

2002
Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:3

    Topics: Blood Viscosity; Cerebral Infarction; Cohort Studies; Fibrinogen; Follow-Up Studies; Humans; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies

2002
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:3

    Topics: Acute-Phase Proteins; Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Blood Proteins; C-Reactive Protein; Chronic Disease; Death, Sudden, Cardiac; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Neoplasm Proteins; Peptide Fragments; Peroxidases; Peroxiredoxin III; Peroxiredoxins; Physical Exertion; Prognosis; Protein Isoforms; Prothrombin; Risk Factors; Treatment Outcome; Troponin I

2002
[Indicators of plaque stability].
    Herz, 2002, Volume: 27, Issue:1

    Topics: Acute Disease; Adult; Angina, Unstable; C-Reactive Protein; Chest Pain; Clinical Trials as Topic; Coronary Angiography; Electrocardiography; Fibrinogen; Humans; Interleukin-6; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Prognosis; Risk Assessment; Risk Factors; Syndrome; Thrombolytic Therapy; Thrombosis; Time Factors; Tomography, X-Ray Computed; Troponin T; Tumor Necrosis Factor-alpha

2002
Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina.
    International journal of cardiology, 2002, Volume: 83, Issue:1

    Topics: Acute Disease; Adult; Aged; Angina Pectoris; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Poland; Rest; Statistics as Topic; Syndrome; Troponin I

2002
[Biohemorheologic factors and cardiovascular events curve in survivors of transmural acute myocardial infarct--24-month follow-up].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2002, Volume: 21, Issue:2

    Topics: Blood Viscosity; Carrier Proteins; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Survivors

2002
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.
    Circulation, 2002, Jun-04, Volume: 105, Issue:22

    Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Ceruloplasmin; Cholesterol; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypercholesterolemia; Incidence; Inflammation; Male; Middle Aged; Mortality; Myocardial Infarction; Orosomucoid; Risk Factors; Stroke; Sweden

2002
Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
    Thrombosis research, 2002, Mar-15, Volume: 105, Issue:6

    Topics: Aged; Biomarkers; Blood Coagulation; Case-Control Studies; Exercise; Female; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; von Willebrand Factor; Women's Health

2002
Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction.
    Haematologica, 2002, Volume: 87, Issue:7

    Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Thrombin

2002
Observations on blood viscosity changes after acute myocardial infarction.
    Circulation, 1975, Volume: 51, Issue:6

    Topics: Alpha-Globulins; Blood Proteins; Blood Viscosity; Fibrinogen; Hematocrit; Mathematics; Myocardial Infarction; Plasma; Polycythemia; Serum Albumin; Time Factors

1975
Heparin cofactor activity measured with an amidolytic method.
    Thrombosis research, 1975, Volume: 6, Issue:4

    Topics: Acute Disease; Alpha-Globulins; Antithrombin III; Antithrombins; Biological Assay; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Heparin; Hexadimethrine Bromide; Humans; Liver Cirrhosis; Methods; Myocardial Infarction; Spectrophotometry; Thrombin

1975
[Changes in the content of finbrinolysis activating and inhibiting factors and of fibrinogen in patients with thrombosis and prethrombotic conditions].
    Folia haematologica (Leipzig, Germany : 1928), 1975, Volume: 102, Issue:2

    Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Plasminogen Activators; Thrombosis

1975
Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
    Thrombosis et diathesis haemorrhagica, 1975, Nov-15, Volume: 34, Issue:2

    Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Platelets; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Factor 3; Platelet Factor 4; Sex Factors; Thrombophlebitis

1975
Changes in protease inhibitors after acute myocardial infarction.
    Journal of clinical pathology, 1976, Volume: 29, Issue:7

    Topics: Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Complement C1 Inactivator Proteins; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Protease Inhibitors

1976
Plasma-fibrinogen and thromboemboli after myocardial infarction.
    Lancet (London, England), 1976, Nov-27, Volume: 2, Issue:7996

    Topics: Adult; Aged; Aspartate Aminotransferases; Circadian Rhythm; Creatine Kinase; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Thromboembolism; Time Factors

1976
Plasma-fibrinogen and thromboemboli after myocardial infarction.
    Lancet (London, England), 1977, Jan-29, Volume: 1, Issue:8005

    Topics: Ancrod; Fibrinogen; Humans; Myocardial Infarction; Thromboembolism

1977
[Myocardial infarct repair in the light of clinico-biochemical and morphological studies].
    Kardiologiia, 1977, Volume: 17, Issue:1

    Topics: Adult; Aged; alpha-Macroglobulins; Asparagine; Creatine Kinase; Erythrocyte Count; Female; Fibrinogen; Haptoglobins; Humans; Hydroxyproline; Leukocyte Count; Male; Middle Aged; Mucoproteins; Myocardial Infarction; Myocardium; Transaminases; Wound Healing

1977
The great circulatory paradox.
    Lancet (London, England), 1977, Jul-02, Volume: 2, Issue:8027

    Topics: Autoradiography; Coronary Disease; Fibrinogen; Humans; Iodine Radioisotopes; Isotope Labeling; Myocardial Infarction

1977
Fibrinolysis in patients with ischemic heart disease (in relation to the etiologic factor of myocardial infarction).
    Japanese circulation journal, 1975, Volume: 39, Issue:5

    Topics: Acute Disease; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipids; Middle Aged; Myocardial Infarction; Plasminogen; Serum Globulins; Streptokinase

1975
Effect of myocardial infarction on components of fibrinolytic system.
    British heart journal, 1977, Volume: 39, Issue:1

    Topics: Adult; Aged; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Time Factors

1977
[Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods].
    Kardiologiia, 1977, Volume: 17, Issue:1

    Topics: Adult; Blood Coagulation Tests; Chromatography, Paper; Factor XIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen Activators; Plasminogen Inactivators; Serum Globulins; Thromboembolism; Thromboplastin; Time Factors; Urokinase-Type Plasminogen Activator

1977
The esterification of cholesterol in plasma after acute myocardial infarction.
    Scandinavian journal of clinical and laboratory investigation, 1975, Volume: 35, Issue:2

    Topics: Acute Disease; Adult; Aged; alpha 1-Antitrypsin; C-Reactive Protein; Cholesterol; Esters; Fibrinogen; Haptoglobins; Humans; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Serum Albumin; Time Factors

1975
Intensive plasmapheresis as a risk factor for arteriosclerotic cardiovascular disease?
    Vox sanguinis, 1977, Volume: 33, Issue:1

    Topics: Arteriosclerosis; Blood Viscosity; Erythrocyte Aggregation; Fibrinogen; Humans; Hyperlipidemias; Hypoproteinemia; Lipoproteins, LDL; Lipoproteins, VLDL; Myocardial Infarction; Nephrotic Syndrome; Plasmapheresis; Risk

1977
Blood coagulation system pathophysiology in acute myocardial infarction: the influence of anticoagulant treatment on laboratory findings.
    The Journal of laboratory and clinical medicine, 1979, Volume: 93, Issue:6

    Topics: Anticoagulants; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Heparin; Humans; Myocardial Infarction; Warfarin

1979
[State of hemostasis and blood rheology in congestive circulatory insufficiency].
    Kardiologiia, 1979, Volume: 19, Issue:4

    Topics: Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Fibrinogen; Heart Failure; Hematocrit; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Thromboembolism

1979
Rheological factors in circulatory disorders.
    Angiology, 1979, Volume: 30, Issue:7

    Topics: Blood Viscosity; Cerebral Infarction; Cinnarizine; Erythrocyte Membrane; Fibrinogen; Humans; Intermittent Claudication; Myocardial Infarction; Physical Exertion; Vascular Diseases

1979
The relation of coronary thrombosis to ischaemic myocardial necrosis.
    The Journal of pathology, 1979, Volume: 127, Issue:2

    Topics: Cardiomyopathies; Coronary Disease; Coronary Vessels; Death, Sudden; Fibrinogen; Humans; Myocardial Infarction; Necrosis; Radioisotopes

1979
[The clinical significance of blood viscosity in degenerative angiopathies].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1979, May-01, Volume: 34, Issue:9

    Topics: Blood Proteins; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Lipids; Male; Myocardial Infarction; Vascular Diseases

1979
[Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Kardiologiia, 1979, Volume: 19, Issue:8

    Topics: Adult; Aged; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Solubility

1979
[Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
    Vrachebnoe delo, 1979, Issue:9

    Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Binding; Sterols

1979
On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
    Indian journal of experimental biology, 1979, Volume: 17, Issue:6

    Topics: Animals; Cardiomyopathies; Female; Fibrinogen; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necrosis; Prognosis; Propranolol; Rats

1979
Fibrinopeptide a (FPA) in patients with acute myocardial infarction.
    Thrombosis research, 1979, Volume: 16, Issue:1-2

    Topics: Acute Disease; Blood Coagulation; Electrocardiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Time Factors

1979
Myocardial damage vis-a-vis plasma fibrinolytic activity and fibrinogen level--an experimental study.
    The Indian journal of medical research, 1979, Volume: 70

    Topics: Animals; Blood Coagulation Tests; Dogs; Female; Fibrinogen; Fibrinolysis; Male; Myocardial Infarction

1979
Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in myocardial infarction.
    The Journal of the Association of Physicians of India, 1979, Volume: 27, Issue:9

    Topics: Adult; Aged; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Platelet Adhesiveness

1979
[Significance of the nitroblue-tetrazolium test in myocardial infarction].
    Arquivos brasileiros de cardiologia, 1979, Volume: 33, Issue:4

    Topics: Adult; Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Nitroblue Tetrazolium; Tetrazolium Salts

1979
[Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua xin xue guan bing za zhi, 1979, Volume: 7, Issue:1

    Topics: Adenosine Diphosphate; Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Aggregation

1979
A study of the catabolism of fibrinogen after myocardial infarction.
    Cor et vasa, 1977, Volume: 19, Issue:4-5

    Topics: Acute Disease; Fibrinogen; Half-Life; Heparin; Humans; Myocardial Infarction; Phenindione; Time Factors

1977
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
    Bollettino della Societa italiana di cardiologia, 1977, Volume: 22, Issue:7

    Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility

1977
Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction.
    British heart journal, 1978, Volume: 40, Issue:5

    Topics: Adult; Aged; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Serum Globulins

1978
[Nonenzymatic fibrinolysis in ischemic heart disease].
    Kardiologiia, 1978, Volume: 18, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction

1978
[Changes in blood and plasma viscosity in patients with myocardial infarct].
    Orvosi hetilap, 1979, Jan-28, Volume: 120, Issue:4

    Topics: Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction; Plasma Cells

1979
Decreased myocardial fibrinolytic activity following temporary ischaemia and reperfusion.
    Thrombosis et diathesis haemorrhagica, 1975, Sep-30, Volume: 34, Issue:1

    Topics: Animals; Coronary Circulation; Endocardium; Fibrin; Fibrinogen; Fibrinolysis; Haplorhini; Ischemia; Myocardial Infarction; Papio

1975
[Influence of acute exertion and physical training on platelet function of the coronary patient].
    Archives des maladies du coeur et des vaisseaux, 1976, Volume: 69, Issue:3

    Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Adhesiveness; Platelet Aggregation

1976
Affinity chromatography and quantitation of soluble fibrin from plasma.
    Thrombosis research, 1977, Volume: 10, Issue:3

    Topics: Chromatography, Affinity; Disseminated Intravascular Coagulation; Electrophoresis, Disc; Fibrin; Fibrinogen; Fractional Precipitation; Humans; Myocardial Infarction; Solubility

1977
[Urokinase treatment of threatened and acute myocardial infarct].
    Annales de medecine interne, 1977, Volume: 128, Issue:2

    Topics: Adult; Aged; Endopeptidases; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Urokinase-Type Plasminogen Activator

1977
[Diagnosis of thromboembolic diseases].
    Wiener medizinische Wochenschrift (1946), 1977, May-30, Volume: 127, Issue:10

    Topics: Aortic Aneurysm; Arterial Occlusive Diseases; Diagnosis, Differential; Embolism; Erysipelas; Fibrinogen; Humans; Myocardial Infarction; Phlebography; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis; Ultrasonography

1977
[Blood viscosity measurements in coronary infarct patients].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jun-15, Volume: 32, Issue:12

    Topics: Blood Viscosity; Cholesterol; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Risk

1977
[Blood and plasma viscosity during the various phases of the acute myocardial infarction (AMI). Preliminary study (author's transl)].
    Giornale italiano di cardiologia, 1977, Volume: 7, Issue:8

    Topics: Acute Disease; Blood Viscosity; Cholesterol; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Prognosis; Rheology

1977
Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy.
    Thrombosis research, 1977, Volume: 11, Issue:3

    Topics: Chromatography, Affinity; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Genital Neoplasms, Female; Humans; Myocardial Infarction; Solubility

1977
Relationship between fibrinogen and blood viscosity.
    Thrombosis research, 1976, Volume: 8, Issue:2 suppl

    Topics: Adult; Aged; Aging; Blood Viscosity; Brain; Fibrinogen; Humans; Infarction; Kidney; Middle Aged; Myocardial Infarction

1976
Attempted diagnosis of ventricular mural thrombi in acute mycardial infarction using 125I-labelled fibrinogen.
    Acta medica Scandinavica, 1976, Volume: 200, Issue:1-2

    Topics: Acute Disease; Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis

1976
Proceedings: I-Labelled fibrinogen, autoradiography, and stereoarteriography in identification of coronary thrombotic occlusion in fatal myocardial infarction.
    British heart journal, 1976, Volume: 38, Issue:8

    Topics: Angiography; Autoradiography; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction

1976
Changes in coagulation factors following acute myocardial infarction in man.
    Haemostasis, 1976, Volume: 5, Issue:4

    Topics: Acute Disease; Adult; Blood Coagulation; Blood Coagulation Tests; Factor IX; Factor V; Factor VII; Factor X; Factor XI; Factor XII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Time Factors

1976
[Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1976, Sep-15, Volume: 31, Issue:18

    Topics: Acute Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Protamines; Pulmonary Embolism; Thromboembolism

1976
[Improvement of flow properties using Arwin in acute experimental infarct].
    Zeitschrift fur Kardiologie, 1976, Volume: 65, Issue:11

    Topics: Angina Pectoris; Animals; Anticoagulants; Blood Pressure; Blood Viscosity; Dogs; Female; Fibrinogen; Heart Rate; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Snakes; Venoms

1976
[Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
    Kardiologiia, 1976, Volume: 16, Issue:12

    Topics: Adult; Blood Coagulation; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Kallikreins; Kininogens; Male; Microcirculation; Middle Aged; Myocardial Infarction; Thrombosis

1976
[Disseminated intravascular coagulation in myocardial infarct].
    Kardiologiia, 1976, Volume: 16, Issue:4

    Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Cell Count; Cell Survival; Disseminated Intravascular Coagulation; Factor V; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

1976
[Rheologic properties of blood in patients with complicated and uncomplicated course of acute myocardial infarct].
    Kardiologiia, 1976, Volume: 16, Issue:4

    Topics: Adult; Aged; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Rheology

1976
Identifying patients at risk for thromboembolism. Use of 125I-labeled fibrinogen in patients with acute myocardial infarction.
    JAMA, 1976, Dec-13, Volume: 236, Issue:24

    Topics: Acute Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Risk; Thromboembolism; Thrombophlebitis

1976
[An experimental model of electrically-induced coronary thrombosis in the closed chest].
    Zeitschrift fur experimentelle Chirurgie, 1975, Volume: 8, Issue:4

    Topics: Animals; Aspartate Aminotransferases; Blood Gas Analysis; Blood Pressure; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Electric Injuries; Fibrinogen; Fibrinolysis; Myocardial Infarction; Myocardium; Platelet Count; Time Factors

1975
Cardiac heterotransplantation. Morphological and immunohistological studies.
    Transplantation, 1975, Volume: 19, Issue:2

    Topics: Animals; Antigens; Complement System Proteins; Cyclophosphamide; Fibrinogen; Fluorescent Antibody Technique; Graft Rejection; Heart Transplantation; Immunoglobulin G; Inflammation; Mice; Microscopy, Fluorescence; Myocardial Infarction; Myocardium; Necrosis; Rats; Transplantation, Heterologous

1975
Effect of fibrinogen on aggregation of red cells and on apparent viscosity of artificial thrombi in haemophilia, myocardial infarction, thyroid disease, cancer and control systems: effect of ABO blood groups.
    Microvascular research, 1975, Volume: 9, Issue:1

    Topics: ABO Blood-Group System; Blood Coagulation Tests; Blood Group Antigens; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Erythrocytes; Fibrinogen; Hemophilia A; Humans; Microcirculation; Myocardial Infarction; Neoplasms; Regression Analysis; Rheology; Thyroid Diseases

1975
Decision theory in the prevention of thrombo-embolism after myocardial infarction.
    Journal of the Royal College of Physicians of London, 1975, Volume: 9, Issue:3

    Topics: Aged; Decision Making; Fibrinogen; Heparin; Humans; Mathematics; Middle Aged; Myocardial Infarction; Probability; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis

1975
[Survival and state of patients during the 1st year after myocardial infarct (according to data of epidemiological study - myocardial infarct register)].
    Kardiologiia, 1975, Volume: 15, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Blood Glucose; Cholesterol; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Thrombelastography; Thromboembolism; Time Factors

1975
[Influence of a streptokinase-induced fibrinolysis on the extent of the acute experimental myocardial infarction (author's transl)].
    Klinische Wochenschrift, 1975, Aug-15, Volume: 53, Issue:16

    Topics: Animals; Arteries; Blood Cell Count; Blood Platelets; Blood Pressure; Coronary Vessels; Dogs; Female; Fibrinogen; Fibrinolysis; Heart; Heart Rate; Hemostasis; Humans; Ligation; Male; Myocardial Infarction; Streptokinase

1975
[Incidence of venous thrombosis in acute myocardial infarct diagnosed using 125 I-fibrinogen].
    Casopis lekaru ceskych, 1976, Volume: 115, Issue:10

    Topics: Acute Disease; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Radionuclide Imaging; Thrombophlebitis

1976
Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. A clinical and autoradiographic study.
    American heart journal, 1976, Volume: 91, Issue:5

    Topics: Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis

1976
Fibrinolytic effects of pro-urokinase combined with low-dose urokinase compared to high-dose urokinase in patients with acute myocardial infarction.
    Thrombosis research, 1992, Jul-15, Volume: 67, Issue:2

    Topics: Aged; alpha-Macroglobulins; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Recombinant Proteins; Thrombin Time; Urokinase-Type Plasminogen Activator

1992
[Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
    Kardiologia polska, 1992, Volume: 37, Issue:11

    Topics: Adult; Blood Coagulation; Cholesterol; Coronary Thrombosis; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Triglycerides

1992
[Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1992, Volume: 11, Issue:11

    Topics: Aged; Female; Fibrinogen; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Thrombosis

1992
Platelet size and outcome after myocardial infarction.
    Lancet (London, England), 1992, Mar-07, Volume: 339, Issue:8793

    Topics: Blood Platelets; Fibrinogen; Humans; Myocardial Infarction; Platelet Count; Prognosis

1992
Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.
    Journal of the American College of Cardiology, 1992, Volume: 19, Issue:5

    Topics: Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Female; Fibrin; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Substrate Specificity; Time Factors; Tissue Plasminogen Activator

1992
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
    Thrombosis and haemostasis, 1992, Aug-03, Volume: 68, Issue:2

    Topics: Acute-Phase Proteins; Adult; Coronary Artery Disease; Coronary Disease; Fibrin; Fibrinogen; Gels; Humans; In Vitro Techniques; Lipoproteins; Male; Molecular Structure; Myocardial Infarction; Polymers

1992
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology].
    Annales de biologie clinique, 1992, Volume: 50, Issue:1

    Topics: Angina Pectoris; Biomarkers; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; von Willebrand Factor

1992
Hageman factor and risk of myocardial infarction in middle-aged men.
    Atherosclerosis, 1992, Volume: 97, Issue:1

    Topics: Aged; Antigens; Cholesterol; Factor VII; Factor XII; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Risk Factors

1992
Plasma sialic acid in myocardial infarction.
    Biochemical Society transactions, 1992, Volume: 20, Issue:4

    Topics: C-Reactive Protein; Electrocardiography; Fibrinogen; Humans; Lipids; Myocardial Infarction; Orosomucoid; Sialic Acids

1992
Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age.
    American heart journal, 1992, Volume: 123, Issue:3

    Topics: Adult; Age Factors; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Electrocardiography, Ambulatory; Fibrinogen; Follow-Up Studies; Heart Rate; Humans; Male; Myocardial Infarction; Regression Analysis; Risk Factors

1992
Fibrinogen: the plot thickens.
    Journal of clinical epidemiology, 1992, Volume: 45, Issue:5

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Risk Factors

1992
Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
    The American journal of cardiology, 1992, Jun-01, Volume: 69, Issue:17

    Topics: Adult; Aged; Electrocardiography; Female; Fibrinogen; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency

1992
Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1992, Volume: 3, Issue:1

    Topics: Aged; Blood Coagulation Tests; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myocardial Infarction; Nephelometry and Turbidimetry; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator

1992
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Journal of the American College of Cardiology, 1990, Volume: 15, Issue:6

    Topics: alpha-2-Antiplasmin; alpha-Macroglobulins; Complement C1 Inactivator Proteins; Drug Administration Schedule; Fibrinogen; Fibrinolysin; Humans; In Vitro Techniques; Myocardial Infarction; Plasminogen; Streptokinase; Tissue Plasminogen Activator

1990
Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction.
    Thrombosis research, 1990, May-01, Volume: 58, Issue:3

    Topics: Adult; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Blood Cell Count; Blood Coagulation Tests; Creatine Kinase; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Thrombin Time; Thrombolytic Therapy; Tissue Plasminogen Activator

1990
Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction.
    Journal of molecular and cellular cardiology, 1990, Volume: 22, Issue:5

    Topics: Animals; Antibodies; Antibodies, Monoclonal; Arteries; Chronic Disease; Coronary Aneurysm; Coronary Vessels; Epitopes; Fibrin; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Granulation Tissue; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains

1990
Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:2

    Topics: alpha-Macroglobulins; Ancrod; Animals; Blood Pressure; Coronary Circulation; Dogs; Fibrinogen; Fibrinolysin; Heart Rate; Leukocyte Count; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Peroxidase; Tissue Plasminogen Activator; Ventricular Fibrillation

1991
[When will fibrinogen screening become available?].
    Deutsche medizinische Wochenschrift (1946), 1991, Dec-06, Volume: 116, Issue:49

    Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rabbits; Risk Factors

1991
Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 1991, Volume: 6, Issue:3

    Topics: Aged; Fibrinogen; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator

1991
Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis?
    Thrombosis and haemostasis, 1991, Oct-01, Volume: 66, Issue:4

    Topics: Diagnostic Tests, Routine; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hematologic Tests; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Risk Factors

1991
[The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
    Arquivos brasileiros de cardiologia, 1991, Volume: 57, Issue:1

    Topics: Administration, Oral; Female; Fibrinogen; Humans; Injections, Intravenous; Lipoproteins; Male; Myocardial Infarction; Radioimmunoassay; Thrombolytic Therapy; Tissue Plasminogen Activator

1991
Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
    The American journal of cardiology, 1991, Jun-15, Volume: 67, Issue:16

    Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Humans; Lipoprotein(a); Lipoproteins; Middle Aged; Myocardial Infarction; Plasminogen Activators; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1991
A method for enzyme- and immunohistochemical staining of large frozen specimens.
    Histochemistry, 1991, Volume: 95, Issue:5

    Topics: Animals; Fibrinogen; Fibronectins; Frozen Sections; Gelatin; Histocytochemistry; Immunohistochemistry; Mice; Microwaves; Myocardial Infarction; Myocardium; Swine

1991
Histidine-rich glycoprotein in thrombolytic therapy: has it clinical relevance?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1991, Volume: 2, Issue:2

    Topics: Anistreplase; Coronary Vessels; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Proteins; Streptokinase; Thrombolytic Therapy

1991
How soon after quitting smoking does risk of heart attack decline?
    Journal of clinical epidemiology, 1991, Volume: 44, Issue:11

    Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Time Factors

1991
Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation.
    Lancet (London, England), 1990, Feb-24, Volume: 335, Issue:8687

    Topics: Blood Coagulation; Drug Therapy, Combination; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator

1990
[The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Vnitrni lekarstvi, 1991, Volume: 37, Issue:3

    Topics: Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy

1991
[Systemic lytic state as marker of therapeutic success after rt-PA in bolus in myocardial infarction].
    Arquivos brasileiros de cardiologia, 1990, Volume: 55, Issue:5

    Topics: Adult; Aged; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy

1990
[The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Terapevticheskii arkhiv, 1990, Volume: 62, Issue:11

    Topics: Adult; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Male; Myocardial Infarction; Myoglobin; Physical Exertion; Thrombolytic Therapy; Time Factors

1990
Fibrinogen, factor VII clotting activity and coronary artery disease severity.
    Atherosclerosis, 1990, Volume: 85, Issue:2-3

    Topics: Cholesterol; Coronary Angiography; Coronary Disease; Coronary Vessels; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Triglycerides

1990
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
    Chest, 1990, Volume: 97, Issue:4 Suppl

    Topics: Bleeding Time; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Tests; Hemorrhage; Humans; Myocardial Infarction; Platelet Function Tests; Streptokinase; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

1990
Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Angiology, 1990, Volume: 41, Issue:8

    Topics: Adult; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

1990
Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
    Cardiovascular research, 1990, Volume: 24, Issue:9

    Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Fibrinogen; Infusions, Intravenous; Male; Microcirculation; Myocardial Infarction; Myocardial Reperfusion; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vascular Patency

1990
Correlations between fibrinolytic function and acute myocardial infarction.
    The American journal of cardiology, 1990, Nov-06, Volume: 66, Issue:16

    Topics: Adult; Case-Control Studies; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Myocardial Infarction; Plasminogen Inactivators; Prospective Studies; Recurrence; Tissue Plasminogen Activator

1990
Fibrinogen proteolysis and coagulation system activation during thrombolytic therapy.
    Advances in experimental medicine and biology, 1990, Volume: 281

    Topics: Double-Blind Method; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator

1990
Bishop lecture. Contribution of the Framingham Study to preventive cardiology.
    Journal of the American College of Cardiology, 1990, Volume: 15, Issue:1

    Topics: Blood Glucose; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cholesterol; Electrocardiography; Fibrinogen; Humans; Life Style; Massachusetts; Myocardial Infarction; Prospective Studies; Risk Factors

1990
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
    British heart journal, 1990, Volume: 64, Issue:6

    Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Blood Coagulation; Blood Coagulation Tests; Drug Resistance; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Retrospective Studies; Thrombolytic Therapy

1990
Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina.
    European heart journal, 1990, Volume: 11, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction

1990
Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin.
    Cancer, 1990, Feb-15, Volume: 65, Issue:4

    Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Fibrinogen; Fibrinopeptide A; Fluorouracil; Humans; Male; Myocardial Infarction; Prospective Studies; Protein C; Tongue Neoplasms

1990
Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.
    Thrombosis research, 1990, Mar-01, Volume: 57, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin

1990
Plasma HMW fibrinogen in patients with ischaemic heart disease.
    Scandinavian journal of clinical and laboratory investigation, 1990, Volume: 50, Issue:3

    Topics: Aged; Aged, 80 and over; Coronary Disease; Fibrinogen; Humans; Middle Aged; Molecular Weight; Myocardial Infarction; Prospective Studies

1990
Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
    Circulation, 1985, Volume: 72, Issue:1

    Topics: Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction

1985
[Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction].
    Quaderni Sclavo di diagnostica clinica e di laboratorio, 1985, Volume: 21, Issue:2

    Topics: Beta-Globulins; beta-Thromboglobulin; False Negative Reactions; False Positive Reactions; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Myocardial Infarction; Time Factors

1985
[Clinical experiences with systemic high-dosage short-term fibrinolysis in acute myocardial infarct].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1986, May-01, Volume: 41, Issue:9

    Topics: Adult; Aged; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Fibrinogen; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin Time

1986
[Thrombolytic therapy with urokinase--indications and results].
    Folia haematologica (Leipzig, Germany : 1928), 1986, Volume: 113, Issue:1-2

    Topics: Coronary Artery Bypass; Factor XIII; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Risk; Thrombosis; Urokinase-Type Plasminogen Activator

1986
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
    Circulation, 1986, Volume: 74, Issue:5

    Topics: Adult; Aged; alpha-2-Antiplasmin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Plasminogen Activators; Recombinant Proteins; Urokinase-Type Plasminogen Activator

1986
Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
    Thrombosis and haemostasis, 1987, Oct-28, Volume: 58, Issue:3

    Topics: Acute-Phase Proteins; C-Reactive Protein; Complement C1 Inactivator Proteins; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Thrombophlebitis; Tissue Plasminogen Activator

1987
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.
    Thrombosis and haemostasis, 1988, Apr-08, Volume: 59, Issue:2

    Topics: Amino Acid Chloromethyl Ketones; Aprotinin; Blood Specimen Collection; Citrates; Citric Acid; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Myocardial Infarction; Tissue Plasminogen Activator

1988
Alterations of antithrombin III after acute myocardial infarction.
    Folia haematologica (Leipzig, Germany : 1928), 1988, Volume: 115, Issue:3

    Topics: Antithrombin III; C-Reactive Protein; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction; Prealbumin; Retinol-Binding Proteins

1988
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction.
    The American journal of cardiology, 1989, May-01, Volume: 63, Issue:15

    Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Enzyme Activation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Prospective Studies; Recurrence; Urokinase-Type Plasminogen Activator; Vascular Patency

1989
Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
    Circulation, 1989, Volume: 79, Issue:5

    Topics: Coronary Angiography; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Radioimmunoassay; Recombinant Proteins; Recurrence; Time Factors; Tissue Plasminogen Activator

1989
A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
    Journal of the American College of Cardiology, 1989, Volume: 14, Issue:3

    Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pilot Projects; Recurrence; Streptokinase; Stroke Volume; Tissue Plasminogen Activator; Vascular Patency

1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.
    Circulation, 1989, Volume: 80, Issue:5

    Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Humans; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator

1989
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.
    Journal of the American College of Cardiology, 1989, Nov-15, Volume: 14, Issue:6

    Topics: Adult; Aged; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Tissue Plasminogen Activator; Vascular Patency

1989
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
    The American journal of cardiology, 1989, Dec-01, Volume: 64, Issue:19

    Topics: Arteries; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator; Vascular Patency

1989
[Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Archives des maladies du coeur et des vaisseaux, 1989, Volume: 82, Issue:11

    Topics: Adult; Angina Pectoris; Angina, Unstable; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Tissue Plasminogen Activator; von Willebrand Factor

1989
Fibrinolytic activity in coronary heart disease.
    Chinese medical journal, 1989, Volume: 102, Issue:9

    Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen

1989
Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory.
    Chinese medical journal, 1989, Volume: 102, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Myocardial Infarction; Periodicity; Platelet Adhesiveness; Time Factors

1989
Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.
    Clinica chimica acta; international journal of clinical chemistry, 1989, Sep-15, Volume: 184, Issue:1

    Topics: Blood Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Heparin; Humans; Immunoelectrophoresis; Molecular Weight; Myocardial Infarction; Streptokinase; Urokinase-Type Plasminogen Activator

1989
[Fibrinogen, a cardiovascular risk factor].
    Minerva cardioangiologica, 1989, Volume: 37, Issue:11

    Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors

1989
[Fibronectin and fibrinogen/fibrin at the focus of an experimental myocardial infarct].
    Arkhiv patologii, 1989, Volume: 51, Issue:9

    Topics: Animals; Fibrin; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Granulation Tissue; Heart Aneurysm; Myocardial Infarction; Rats

1989
Bleeding after thrombolysis in acute myocardial infarction.
    European heart journal, 1989, Volume: 10, Issue:1

    Topics: Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Streptokinase; Urokinase-Type Plasminogen Activator

1989
Plasma fibrinogen in unstable coronary artery disease.
    Scandinavian journal of clinical and laboratory investigation, 1989, Volume: 49, Issue:1

    Topics: Angina Pectoris; Angina, Unstable; Body Weight; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Smoking

1989
[Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].
    Deutsche medizinische Wochenschrift (1946), 1989, Jun-16, Volume: 114, Issue:24

    Topics: Blood Viscosity; Coronary Circulation; Coronary Disease; Drug Evaluation; Erythrocyte Aggregation; Exercise Test; Fenofibrate; Fibrinogen; Heart; Humans; Lipids; Microcirculation; Myocardial Infarction; Propionates; Radionuclide Imaging; Thallium Radioisotopes

1989
Fibrinopeptide A levels in patients with acute ischaemic heart disease.
    Haemostasis, 1989, Volume: 19, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction

1989
[Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
    Rinsho byori. The Japanese journal of clinical pathology, 1989, Volume: 37, Issue:3

    Topics: Aged; Blood Coagulation; Cerebral Infarction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Peptide Fragments

1989
Urinary fibrinopeptide A levels in ischemic heart disease.
    Journal of the American College of Cardiology, 1989, Volume: 14, Issue:3

    Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies

1989
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
    Lancet (London, England), 1987, Jul-04, Volume: 2, Issue:8549

    Topics: Adult; Fibrinogen; Follow-Up Studies; Glycoproteins; Hemostasis; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Methods; Middle Aged; Myocardial Infarction; Plasminogen Activators; Plasminogen Inactivators; Prospective Studies; Recurrence; Risk; Triglycerides

1987
Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction.
    Thrombosis and haemostasis, 1988, Aug-30, Volume: 60, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Blood Platelets; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Obesity; Platelet Function Tests; Sex Factors; Smoking

1988
[Characteristics of hemostasis, fibrinolysis and lipid indicators in children and their fathers with a history of myocardial infarction at a young age].
    Kardiologiia, 1986, Volume: 26, Issue:5

    Topics: Adolescent; Adult; Antithrombin III Deficiency; Blood Coagulation; Child; Cholesterol; Cholesterol, HDL; Coronary Disease; Disease Susceptibility; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Triglycerides

1986
Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Annals of internal medicine, 1986, Volume: 104, Issue:3

    Topics: Aged; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Urokinase-Type Plasminogen Activator

1986
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation.
    Circulation, 1986, Volume: 73, Issue:6

    Topics: Adult; Aged; Arterial Occlusive Diseases; Computers; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Tissue Plasminogen Activator

1986
[Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Haemostasis, 1986, Volume: 16 Suppl 4

    Topics: Anistreplase; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Metabolic Clearance Rate; Molecular Weight; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase; Urokinase-Type Plasminogen Activator

1986
Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator.
    Journal of the American College of Cardiology, 1987, Volume: 10, Issue:3

    Topics: Aged; Blood Coagulation; Coronary Circulation; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator

1987
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.
    The American journal of medicine, 1988, Volume: 85, Issue:3

    Topics: Age Factors; Aged; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Tissue Plasminogen Activator

1988
[Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].
    Archives des maladies du coeur et des vaisseaux, 1988, Volume: 81, Issue:9

    Topics: Adult; Aged; Anticoagulants; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Retrospective Studies; Streptokinase

1988
Do different doses of intravenous streptokinase alter the frequency of coronary reperfusion in acute myocardial infarction?
    The American journal of cardiology, 1988, Nov-01, Volume: 62, Issue:13

    Topics: Aged; Coronary Circulation; Creatine Kinase; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase

1988
[Fibrinopeptide A and protein C in heart patients with acute coronary syndromes].
    Vutreshni bolesti, 1988, Volume: 27, Issue:6

    Topics: Acute Disease; Aged; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Protein C

1988
[Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
    Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:12

    Topics: Creatine Kinase; Fibrinogen; Fibrinopeptide A; Humans; Injections, Intravenous; Myocardial Infarction; Streptokinase

1988
[Detection of left ventricular thrombi after acute myocardial infarction using Ga-67-DFO-DAS-fibrinogen].
    Journal of cardiology, 1988, Volume: 18, Issue:4

    Topics: Adult; Deferoxamine; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Starch; Thrombosis

1988
Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy.
    Drugs, 1987, Volume: 33 Suppl 3

    Topics: Anistreplase; Coronary Circulation; Coronary Vessels; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Myocardial Infarction; Plasminogen; Streptokinase

1987
[Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?].
    Deutsche medizinische Wochenschrift (1946), 1988, Jul-29, Volume: 113, Issue:30

    Topics: Angina Pectoris; Angina, Unstable; Blood Viscosity; Cardiac Catheterization; Coronary Angiography; Erythrocyte Aggregation; Fibrinogen; Hemodynamics; Humans; Myocardial Infarction

1988
Streptokinase and reduced plasma viscosity: a second benefit.
    European journal of haematology, 1988, Volume: 41, Issue:1

    Topics: Blood Cell Count; Blood Viscosity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Microcirculation; Myocardial Infarction; Plasminogen; Prothrombin Time; Streptokinase

1988
[Study of proteolytic systems of the blood in patients with myocardial infarction].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Apr-18, Volume: 43, Issue:16

    Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Protease Inhibitors

1988
Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection.
    Annals of internal medicine, 1986, Volume: 104, Issue:3

    Topics: Anistreplase; Cardiac Catheterization; Coronary Angiography; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Time Factors

1986
Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.
    International journal of cardiology, 1986, Volume: 11, Issue:1

    Topics: Adult; Aged; Anistreplase; Fibrinogen; Follow-Up Studies; Half-Life; Heart; Hemostasis; Humans; Infusions, Parenteral; Kinetics; Middle Aged; Myocardial Infarction; Plasminogen; Recurrence; Streptokinase; Time Factors

1986
Distribution of fibrinogen and albumin in normal, ischaemic, and necrotic myocardium during the evolution of myocardial infarction: an immunohistochemical study.
    Cardiovascular research, 1986, Volume: 20, Issue:1

    Topics: Albumins; Animals; Coronary Vessels; Dogs; Fibrinogen; Immunologic Techniques; Ischemia; Myocardial Infarction; Myocardium; Necrosis

1986
Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Circulation, 1986, Volume: 74, Issue:5

    Topics: Aged; Anistreplase; Coronary Vessels; Electrophoresis, Agar Gel; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prognosis; Streptokinase

1986
Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction.
    Journal of the American College of Cardiology, 1987, Volume: 9, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiography; Coronary Circulation; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Streptokinase; Subtraction Technique

1987
Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Circulation, 1987, Volume: 75, Issue:6

    Topics: Blood Coagulation; Electrophoresis, Agar Gel; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Polymers; Thrombosis; Time Factors

1987
[Coronary thrombolysis after intracoronary and intravenous administration of streptokinase to myocardial infarct patients].
    Kardiologiia, 1987, Volume: 27, Issue:3

    Topics: Adult; Aged; Coronary Vessels; Fibrinogen; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Myocardial Infarction; Streptokinase

1987
[Fibrinolytic activity and coronary heart disease].
    Zhonghua nei ke za zhi, 1987, Volume: 26, Issue:2

    Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators

1987
Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Thrombosis and haemostasis, 1987, Aug-04, Volume: 58, Issue:2

    Topics: Collagen Diseases; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Thromboembolism

1987
[Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
    Giornale italiano di cardiologia, 1987, Volume: 17, Issue:7

    Topics: Female; Fibrinogen; Hemorrhage; Humans; Male; Myocardial Infarction; Prothrombin Time; Streptokinase

1987
Serum amyloid A concentrations during the course of acute ischaemic heart disease.
    Journal of clinical pathology, 1986, Volume: 39, Issue:6

    Topics: Aged; Amyloid; Coronary Disease; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Serum Amyloid A Protein; Time Factors

1986
Usefulness of residual plasma fibrinogen after intravenous streptokinase for predicting delay or failure of reperfusion in acute myocardial infarction.
    The American journal of cardiology, 1986, Oct-01, Volume: 58, Issue:9

    Topics: Coronary Circulation; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Streptokinase

1986
Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction.
    The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:9

    Topics: Adult; Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis

1986
[Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:12

    Topics: Adult; Angina Pectoris; Blood Protein Electrophoresis; Chromatography, Gel; Coronary Artery Disease; Coronary Disease; Exercise Therapy; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion

1986
Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    The Journal of the Association of Physicians of India, 1985, Volume: 33, Issue:12

    Topics: Angina Pectoris; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Prognosis

1985
Bypass surgery following thrombolytic therapy.
    Zeitschrift fur Kardiologie, 1985, Volume: 74 Suppl 6

    Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coronary Artery Bypass; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Recurrence; Risk

1985
[Treatment of profuse gastroduodenal hemorrhages in peptic ulcer and myocardial infarction].
    Vestnik khirurgii imeni I. I. Grekova, 1985, Volume: 135, Issue:10

    Topics: Aged; Aminocaproic Acid; Blood Transfusion; Critical Care; Duodenal Ulcer; Evaluation Studies as Topic; Fibrinogen; Gastrectomy; Hemostatic Techniques; Humans; Male; Middle Aged; Myocardial Infarction; Peptic Ulcer Hemorrhage; Serum Albumin; Stomach Ulcer

1985
Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction.
    Thrombosis research, 1985, Mar-01, Volume: 37, Issue:5

    Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase

1985
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study.
    Annals of internal medicine, 1985, Volume: 103, Issue:6 ( Pt 1)

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Fibrinolysis; Humans; In Vitro Techniques; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Tissue Plasminogen Activator

1985
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Archives of internal medicine, 1986, Volume: 146, Issue:4

    Topics: Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Recurrence; Streptokinase

1986
Fibrinopeptide A: a marker of acute coronary thrombosis.
    Circulation, 1985, Volume: 71, Issue:5

    Topics: Coronary Disease; Creatine Kinase; Female; Fibrinogen; Fibrinopeptide A; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Time Factors

1985
[Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct].
    Kardiologiia, 1985, Volume: 25, Issue:2

    Topics: Adult; Aged; Blood Coagulation Tests; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Haptoglobins; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Phenotype; Risk

1985
Measurement of antistreptokinase antibodies.
    Journal of the American College of Cardiology, 1985, Volume: 5, Issue:6

    Topics: Antibodies, Bacterial; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Streptokinase

1985
Left ventricular thrombosis, wall motion abnormalities, and blood viscosity changes after first transmural anterior myocardial infarction.
    Chest, 1985, Volume: 88, Issue:1

    Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Echocardiography; Female; Fibrinogen; Heart; Humans; Male; Middle Aged; Movement; Myocardial Infarction

1985
Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
    Thrombosis research, 1985, Jul-15, Volume: 39, Issue:2

    Topics: Aortic Aneurysm; Arteriosclerosis; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction; Radioimmunoassay

1985
Discrepant fibrinogen values during thrombolytic therapy. Comparison of aca and Data-Fi results using immunofixation. Electrophoresis as a reference.
    American journal of clinical pathology, 1985, Volume: 84, Issue:4

    Topics: Adult; Blood Protein Electrophoresis; Fibrinogen; Fibrinolysis; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Streptokinase; Thrombophlebitis

1985
The measurement of fibrinogen by the DuPont aca and Dade methods in patients receiving streptokinase infusions.
    American journal of clinical pathology, 1985, Volume: 84, Issue:4

    Topics: Coronary Vessels; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Injections, Intravenous; Methods; Myocardial Infarction; Streptokinase

1985
Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.
    Circulation, 1985, Volume: 71, Issue:1

    Topics: Adult; Aged; alpha-2-Antiplasmin; Blood Coagulation; DNA, Recombinant; Female; Fibrinogen; Fibrinolysis; Half-Life; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Radioimmunoassay

1985
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:5

    Topics: Adult; Aged; Aspirin; Coronary Angiography; Dipyridamole; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Perfusion; Plasminogen; Streptokinase

1985
Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF).
    Thrombosis research, 1985, Aug-15, Volume: 39, Issue:4

    Topics: Acute Disease; Chemical Precipitation; Fibrinogen; Fibronectins; Heparin; Hip Prosthesis; Humans; Molecular Weight; Myocardial Infarction

1985
[Immunologic diagnosis of intravascular blood clotting and intravascular thrombus formation among patients with ischemic heart disease].
    Kardiologiia, 1985, Volume: 25, Issue:9

    Topics: Adult; Angina, Unstable; Autoantibodies; Coronary Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemagglutination Tests; Humans; Male; Middle Aged; Myocardial Infarction; Thrombin

1985
Frequency of venous thrombosis after myocardial infarction.
    Lancet (London, England), 1971, Dec-25, Volume: 2, Issue:7739

    Topics: Aged; Anticoagulants; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Varicose Veins

1971
Venous thrombosis after myocardial infarction.
    Lancet (London, England), 1972, Jan-15, Volume: 1, Issue:7742

    Topics: Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Radionuclide Imaging; Thrombophlebitis; Time Factors

1972
Venous thrombosis after myocardial infarction.
    Lancet (London, England), 1972, Jan-29, Volume: 1, Issue:7744

    Topics: Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis

1972
Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    Lancet (London, England), 1972, Apr-29, Volume: 1, Issue:7757

    Topics: Aspartate Aminotransferases; Blood Sedimentation; Fibrin; Fibrinogen; Humans; L-Lactate Dehydrogenase; Myocardial Infarction; Time Factors

1972
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
    Lancet (London, England), 1972, Sep-16, Volume: 2, Issue:7777

    Topics: Adult; Age Factors; Blood Platelets; Cholesterol; Drug Synergism; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Potassium; Recurrence; Time Factors

1972
Incorporation of 125 I-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man.
    Lancet (London, England), 1973, Feb-24, Volume: 1, Issue:7800

    Topics: Acute Disease; Aged; Arteries; Autopsy; Coronary Vessels; Dicumarol; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Isotopes; Isotope Labeling; Male; Myocardial Infarction; Thrombosis; Time Factors

1973
Long-term blood abnormalities in thrombosis.
    Lancet (London, England), 1973, Jul-21, Volume: 2, Issue:7821

    Topics: Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis; Thrombosis

1973
Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    Lancet (London, England), 1972, Mar-25, Volume: 1, Issue:7752

    Topics: Acute Disease; Age Factors; Aged; Fibrin; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Serologic Tests; Thrombophlebitis

1972
Letter: Fibrinolytic activity and postoperative deep-vein thrombosis.
    Lancet (London, England), 1974, May-04, Volume: 1, Issue:7862

    Topics: Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Postoperative Complications; Preoperative Care; Thrombophlebitis

1974
Acute phase reaction following intravenous administration of streptokinase.
    Thrombosis et diathesis haemorrhagica, 1974, Jun-30, Volume: 31, Issue:3

    Topics: Adult; Aged; alpha 1-Antitrypsin; Beta-Globulins; C-Reactive Protein; Ceruloplasmin; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Middle Aged; Myocardial Infarction; Orosomucoid; Plasminogen; Streptokinase; Thrombophlebitis; Time Factors

1974
[Autoimmune reactions and blood coagulation status in patients with myocardial infarct].
    Kardiologiia, 1974, Volume: 14, Issue:6

    Topics: Aged; Antibody Formation; Autoantibodies; Blood Coagulation; Complement Fixation Tests; Fibrinogen; Fibrinolysis; gamma-Globulins; Humans; Middle Aged; Myocardial Infarction; Myocardium; Time Factors

1974
Therapeutic defibrination in the treatment of thrombotic disease.
    Lancet (London, England), 1968, Mar-09, Volume: 1, Issue:7541

    Topics: Adult; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Immunoassay; Male; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Plasminogen; Thrombophlebitis; Thrombosis; Urticaria; Venoms

1968
A new approach to anticoagulant therapy.
    Lancet (London, England), 1968, Mar-09, Volume: 1, Issue:7541

    Topics: Anticoagulants; Fibrinogen; Humans; Myocardial Infarction; Thrombosis; Venoms

1968
Fibrinolytic activity and coronary-artery disease.
    Lancet (London, England), 1968, May-11, Volume: 1, Issue:7550

    Topics: Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Phenformin

1968
[Coagulation spectrum in coronary sclerosis and infarct].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1968, Apr-01, Volume: 23, Issue:7

    Topics: Aged; Blood Coagulation; Blood Platelets; Coronary Disease; Dicumarol; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction

1968
Apparent resistance to oral anticoagulant therapy and influence of hypnotics on some coagulation factors.
    Acta medica Scandinavica, 1968, Volume: 184, Issue:4

    Topics: Anticoagulants; Barbiturates; Blood Coagulation; Blood Coagulation Tests; Dicumarol; Factor VII; Female; Fibrinogen; Humans; Hypnotics and Sedatives; Male; Middle Aged; Myocardial Infarction; Prothrombin

1968
Leg-vein thrombosis following myocardial infarction.
    Lancet (London, England), 1970, Oct-17, Volume: 2, Issue:7677

    Topics: Adult; Female; Fibrinogen; Humans; Iodine Isotopes; Leg; Male; Middle Aged; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis

1970
[Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Archives des maladies du coeur et des vaisseaux, 1973, Volume: 66, Issue:4

    Topics: Age Factors; Aged; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Iodine Isotopes; Middle Aged; Myocardial Infarction; Prognosis; Thrombosis

1973
[Proposal for the therapy of myocardial infarct in its initial stage].
    MMW, Munchener medizinische Wochenschrift, 1974, Mar-08, Volume: 116, Issue:10

    Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Blood Vessels; Edema; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Prednisolone; Sulfates; Sulfur Radioisotopes; Thromboembolism; Thymidine; Time Factors; Tritium

1974
[State of the blood coagulation system in patients with myocardial infarct and chest pain and the changes in it during the use of anticoagulants and fibrinolysin].
    Kardiologiia, 1967, Volume: 7, Issue:9

    Topics: Aged; Angina Pectoris; Anticoagulants; Blood Coagulation; Factor V; Factor VII; Female; Fibrinogen; Fibrinolysin; Heparin; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography

1967
Studies in cryofibrinogenemia.
    Acta haematologica, 1969, Volume: 42, Issue:1

    Topics: Aminocaproates; Blood Protein Disorders; Blood Proteins; Blood Sedimentation; Carcinoma; Cold Temperature; Collagen Diseases; Cryoglobulins; Electrophoresis; Fibrinogen; Fibrinolysin; Heparin; Hodgkin Disease; Humans; Immune Sera; Immunoelectrophoresis; Leukemia, Lymphoid; Myocardial Infarction; Neoplasm Metastasis; Paper; Waldenstrom Macroglobulinemia

1969
[A study of the mucopolysaccharide-thrombogenic mechanism predisposing to myocardial infarct].
    Terapevticheskii arkhiv, 1969, Volume: 41, Issue:7

    Topics: Adult; Aged; Blood Coagulation Factors; Fibrinogen; Glycosaminoglycans; Heparin; Humans; Middle Aged; Myocardial Infarction

1969
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    The New England journal of medicine, 1970, Sep-24, Volume: 283, Issue:13

    Topics: Adult; Agglutination Tests; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral; Erythrocytes; False Negative Reactions; False Positive Reactions; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemagglutination Inhibition Tests; Hodgkin Disease; Humans; Immunoassay; Immunodiffusion; Kidney Diseases; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Male; Methods; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Staphylococcus

1970
Changes in platelet adhesiveness, blood coagulation and fibrinolysis before and after the development of myocardial infarction. Investigation in 3 cases.
    Japanese heart journal, 1970, Volume: 11, Issue:5

    Topics: Aged; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Factor V; Factor X; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Prothrombin Time; Trypsin Inhibitors

1970
Detection of hypercoagulable states with protamine sulphate tests.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 52

    Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Disorders; Chlorides; Densitometry; Disseminated Intravascular Coagulation; Dogs; Endotoxins; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Mercury; Methods; Myocardial Infarction; Protamines; Rabbits; Sulfates; Thromboembolism

1972
[Fibrinolytic activity of the blood in the human coronary vessels].
    Kardiologiia, 1974, Volume: 14, Issue:4

    Topics: Arteriosclerosis; Blood Specimen Collection; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Electric Countershock; Enzyme Activation; Enzyme Repression; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Hypertension; Myocardial Infarction; Plasminogen; Radiography

1974
[Nonenzymatic fibrinolysis in patients with ischemic heart disease].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Adult; Aged; Blood Coagulation Tests; Blood Platelets; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Prothrombin; Thrombin

1974
[Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Blood Coagulation Tests; Drug Evaluation; Ethyl Biscoumacetate; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Plasminogen; Thrombin; Time Factors

1974
[Correlation between indices of hemocoagulation and lipid metabolism in patients with myocardial infarct].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Cholesterol; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipid Metabolism; Lipids; Lipoproteins, LDL; Middle Aged; Myocardial Infarction; Triglycerides

1974
About increase of aggregation of red cells with an increase of temperature in normal and abnormal blood (i.e. cancer). Effect of ABO blood groups and proteins.
    Biorheology, 1973, Volume: 10, Issue:3

    Topics: ABO Blood-Group System; Anticoagulants; Blood Donors; Blood Group Antigens; Blood Proteins; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Edetic Acid; Erythrocytes; Fibrinogen; Hematocrit; Hot Temperature; Humans; Myocardial Infarction; Neoplasms; Serum Albumin; Vascular Diseases

1973
Intravascular coagulation in acute renal failure after myocardial infarction.
    Annals of internal medicine, 1974, Volume: 81, Issue:4

    Topics: Acute Kidney Injury; Aged; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Heparin; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic

1974
[Study of hemostasis in patients with myocardial infarct and its prognostic significance].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Age Factors; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Globulins; Humans; Leukocytes; Myocardial Infarction; Prognosis

1974
[Pathogenetic aspects of cellular hemostasis in ischemic heart disease].
    Kardiologiia, 1974, Volume: 14, Issue:11

    Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Basophils; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation

1974
[The phenomenon of oblique frequency distribution as exemplified by blood clotting factors. A neglected problem].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1974, Oct-07, Volume: 29, Issue:40

    Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Fibrinogen; Humans; Kidney Diseases; Myocardial Infarction; Probability; Prothrombin; Pulmonary Embolism; Thrombin

1974
Fibrin degradation products and the 125I-labeled fibrinogen test in patients with myocardial infarction.
    European journal of cardiology, 1974, Volume: 2, Issue:1

    Topics: Adult; Aged; Animals; Antibodies; Aspartate Aminotransferases; Bronchitis; Bronchopneumonia; Erythrocytes; Female; Fibrin; Fibrinogen; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Sheep; Thrombophlebitis

1974
[Animal experiments on the effect of mechanical assistance of circulation with the intra-aortal balloon pump on the coagulation system].
    Thoraxchirurgie, vaskulare Chirurgie, 1972, Volume: 20, Issue:3

    Topics: Adult; Aged; Animals; Aorta, Thoracic; Assisted Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Dogs; Factor IX; Factor V; Factor VIII; Factor X; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Prothrombin Time; Time Factors

1972
Immunologic study of fibrinogen and its split products in venous thrombosis.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 52

    Topics: Adult; Anticoagulants; Blood Cell Count; Blood Platelets; Ethyl Biscoumacetate; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Phagocytosis; Phenformin; Phlebography; Platelet Adhesiveness; Pulmonary Embolism; Pyrazoles; Thrombophlebitis; Time Factors

1972
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
    Biorheology, 1973, Volume: 10, Issue:4

    Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous

1973
The use of anticoagulants in the prevention of venous thrombosis after myocardial infarction.
    The Medical journal of Australia, 1972, Nov-11, Volume: 2, Issue:20

    Topics: Adult; Aged; Anticoagulants; Catheterization; False Positive Reactions; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Warfarin

1972
Density gradient separation of human platelets from plasma and the role of plasma in adenosine diphosphate induced platelet electrophoretic mobility changes.
    Thrombosis et diathesis haemorrhagica, 1972, Jul-31, Volume: 27, Issue:3

    Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Centrifugation, Density Gradient; Electrophoresis; Fibrinogen; Humans; Myocardial Infarction; Phosphatidylcholines; Plasma; Platelet Adhesiveness

1972
Early determination of serum fibrin-fibrinogen degradation products in an intensive care unit.
    Acta clinica Belgica, 1972, Volume: 27, Issue:1

    Topics: Arrhythmias, Cardiac; Burns; Diabetic Coma; Fibrin; Fibrinogen; Heart Failure; Humans; Intensive Care Units; Lung Diseases, Obstructive; Myocardial Infarction; Poisoning; Shock, Cardiogenic; Tetanus

1972
The 125I fibrinogen test and its uses.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 52

    Topics: Adult; Age Factors; Aged; Dextrans; Female; Fibrinogen; Humans; Injections, Intravenous; Iodine Radioisotopes; Methods; Middle Aged; Myocardial Infarction; Occlusive Dressings; Phlebography; Physical Exertion; Pregnancy; Puerperal Disorders; Surgical Procedures, Operative; Thrombophlebitis

1972
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1972, Volume: 35, Issue:5

    Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms

1972
[Plasmatic haptoglobin in chronic coronary disease and in myocardial infarct. Physiopathological significance. Diagnostic importance].
    Medicina interna, 1973, Volume: 25, Issue:1

    Topics: Arteriosclerosis; Chronic Disease; Coronary Disease; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction

1973
[Mechanisms of stimulating effect of alcohol in the development of myocardial infarct].
    Klinicheskaia meditsina, 1973, Volume: 51, Issue:4

    Topics: Adult; Alcoholic Intoxication; Blood Coagulation; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

1973
The diagnosis of acute fibrinous pericarditis using 125 I labelled fibrinogen.
    The British journal of radiology, 1973, Volume: 46, Issue:543

    Topics: Acute Disease; Aged; Female; Fibrinogen; Heart Auscultation; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis; Radionuclide Imaging

1973
Venous thromboses in myocardial infarction. Comparison in heparin dosage.
    British heart journal, 1973, Volume: 35, Issue:5

    Topics: Acute Disease; Female; Fibrinogen; Heart Failure; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Thrombophlebitis

1973
The clinical significance of the plasminogen level.
    American journal of clinical pathology, 1973, Volume: 60, Issue:2

    Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries

1973
Prognostic value of serum fibrinogen-related antigen levels after myocardial infarction.
    British heart journal, 1973, Volume: 35, Issue:10

    Topics: Antigens; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Thrombophlebitis; Time Factors

1973
[Differential sex-dependent biomorphosis of fibrinogen metabolism].
    Zeitschrift fur Alternsforschung, 1973, Volume: 27, Issue:3

    Topics: Adult; Age Factors; Aged; Female; Fibrinogen; Hepatitis A; Humans; Male; Middle Aged; Myocardial Infarction; Pneumonia; Sex Factors

1973
Viscosity of blood in patients with myocardial infarction, haemophilia and thyroid diseases. Effect of fibrinogen, albumin and globulin.
    Biorheology, 1973, Volume: 10, Issue:3

    Topics: Blood Coagulation; Blood Viscosity; Fibrinogen; Hemophilia A; Humans; Hyperthyroidism; Hypothyroidism; Myocardial Infarction; Serum Albumin; Serum Globulins; Stress, Mechanical; Thrombosis; Thyroid Diseases

1973
[Blood lipid content and the coagulation system in coronary insufficiency in young persons].
    Kardiologiia, 1973, Volume: 13, Issue:9

    Topics: Adult; Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Myocardial Infarction

1973
Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
    Annals of clinical research, 1973, Volume: 5, Issue:6

    Topics: Acute Disease; Adult; Age Factors; Aged; Anticoagulants; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Methods; Middle Aged; Myocardial Infarction; Sex Factors; Tachycardia; Thrombophlebitis; Time Factors; Ventricular Fibrillation

1973
Quantitation of plasma fibrinogen in the presence of fibrinogen degradation products.
    Scandinavian journal of haematology, 1973, Volume: 11, Issue:3

    Topics: Animals; Barbiturates; Buffers; Cattle; Chromatography, Gel; Clot Retraction; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Hydrogen-Ion Concentration; Immune Sera; Immunoelectrophoresis; Methods; Myocardial Infarction; Phosphates; Prothrombin Time; Rabbits

1973
The influence of fibrinogen degradation products on the reptilase-time of plasma.
    Scandinavian journal of haematology, 1973, Volume: 11, Issue:5

    Topics: Animals; Blood Coagulation; Chromatography, DEAE-Cellulose; Fibrin; Fibrinogen; Fibrinolytic Agents; Glycine; Heparin; Humans; Hydrogen-Ion Concentration; Myocardial Infarction; Peptide Hydrolases; Prothrombin Time; Rabbits; Snakes; Thrombin; Venoms

1973
Quantitative biochemical changes in rats following isoproterenol-induced myocardial infarction.
    Arzneimittel-Forschung, 1973, Volume: 23, Issue:11

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; Densitometry; Fibrinogen; Iron; Isoproterenol; L-Lactate Dehydrogenase; Lactates; Lipids; Male; Myocardial Infarction; Necrosis; Neuraminic Acids; Pentaerythritol Tetranitrate; Rats; Time Factors

1973
[Fibrinolysis in acute myocardial infarct with increased risk].
    Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1973, Volume: 54, Issue:10

    Topics: Acute Disease; Adult; Aged; Austria; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Streptokinase

1973
A novel approach to evaluate the validity of thrombolytic treatment in acute myocardial infarction.
    Thrombosis et diathesis haemorrhagica. Supplementum, 1973, Volume: 56

    Topics: Acid-Base Equilibrium; Acute Disease; Blood Pressure; Blood Viscosity; Cardiac Output; Catecholamines; Central Venous Pressure; Coronary Care Units; Echocardiography; Electrocardiography; Fatty Acids, Nonesterified; Fibrinogen; Heart Ventricles; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Kymography; Lactates; Myocardial Infarction; Myocardium; Pulmonary Artery; Radionuclide Imaging; Streptokinase; Time Factors; Vascular Resistance

1973
The frequency of deep venous thrombosis in patients with acute myocardial infarction judged by the 125-I-tagged human fibrinogen technique.
    European journal of cardiology, 1973, Volume: 1, Issue:1

    Topics: Acute Disease; Aged; Denmark; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis

1973
Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia.
    American heart journal, 1974, Volume: 87, Issue:2

    Topics: Blood Flow Velocity; Blood Pressure; Blood Viscosity; Coronary Circulation; Coronary Disease; Fibrinogen; Heart Ventricles; Hematocrit; Humans; Mathematics; Models, Theoretical; Myocardial Infarction

1974
Value of determination of serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    American journal of clinical pathology, 1974, Volume: 61, Issue:2

    Topics: Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrin; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Prognosis

1974
Editorial: The cause-effect relationship between recent coronary artery occlusion and acute myocardial infarction.
    American heart journal, 1974, Volume: 87, Issue:3

    Topics: Autopsy; Coronary Disease; Fibrinogen; Iodine Radioisotopes; Myocardial Infarction

1974
Letter: Thrombosis and myocardial infarction.
    Circulation, 1974, Volume: 49, Issue:6

    Topics: Acidosis; Death, Sudden; Fibrinogen; Humans; Hypoxia; Myocardial Infarction; Thrombosis; Time Factors

1974
[Coronary thrombosis in acute myocardial infarct, is it a primary or secondary phenomenon?].
    Kardiologiia, 1974, Volume: 14, Issue:4

    Topics: Acute Disease; Aged; Autopsy; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Necrosis; Thrombosis; Time Factors

1974
Influence of smoking on deep vein thrombosis after myocardial infarction.
    British medical journal, 1974, Jul-27, Volume: 3, Issue:5925

    Topics: Age Factors; Aged; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Smoking; Thrombophlebitis; Varicose Veins

1974
Increased incidence of deep vein thrombosis after myocardial infarction in non-smokers.
    British medical journal, 1974, Jul-27, Volume: 3, Issue:5925

    Topics: Age Factors; Aged; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Middle Aged; Myocardial Infarction; Smoking; Thrombophlebitis; Varicose Veins

1974
The possible use of 125I-labeled fibrinogen for the detection of mural thrombosis following myocardial infarction.
    American heart journal, 1974, Volume: 88, Issue:3

    Topics: Aged; Autopsy; Cardiac Tamponade; Electrocardiography; Fibrinogen; Hemiplegia; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis; Thrombophlebitis; Thrombosis; Time Factors; Ventricular Fibrillation

1974
Thrombolytic therapy with streptokinase.
    The Medical journal of Australia, 1970, Oct-31, Volume: 2, Issue:18

    Topics: Embolism; Fibrinogen; History, 20th Century; Myocardial Infarction; Plasminogen; Prothrombin Time; Pulmonary Embolism; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis

1970
[Fibrinolytic therapy in severe angina pectoris].
    Deutsche medizinische Wochenschrift (1946), 1971, Apr-30, Volume: 96, Issue:18

    Topics: Adult; Aged; Angina Pectoris; Blood Platelets; Blood Viscosity; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Streptokinase; Time Factors

1971
The diagnosis of deep vein thrombosis using the 125 I fibrinogen test.
    Archives of surgery (Chicago, Ill. : 1960), 1972, Volume: 104, Issue:2

    Topics: Abdomen; Adult; Aged; Cesarean Section; Female; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Phlebography; Pregnancy; Prostatectomy; Puerperal Disorders; Thrombophlebitis; Vagina; Veins

1972
[Sexual differences in fibrinogen during aging].
    Casopis lekaru ceskych, 1972, Mar-17, Volume: 111, Issue:12

    Topics: Adolescent; Adult; Aged; Aging; Child; Female; Fibrinogen; Hepatitis A; Humans; Male; Middle Aged; Myocardial Infarction; Pneumonia; Regeneration; Sex Factors

1972
[Use of anticoagulants in myocardial infarct].
    Klinicheskaia meditsina, 1972, Volume: 50, Issue:2

    Topics: Adult; Aged; Anticoagulants; Blood Pressure; Evaluation Studies as Topic; Female; Fibrinogen; Heart Aneurysm; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Rupture; Thrombelastography

1972
The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis.
    The Milbank Memorial Fund quarterly, 1972, Volume: 50, Issue:1

    Topics: Adult; Delivery, Obstetric; Female; Fibrinogen; Fractures, Bone; Genital Diseases, Female; Humans; Iodine Radioisotopes; Leg; Male; Methods; Middle Aged; Myocardial Infarction; Phlebography; Postoperative Complications; Prostatectomy; Thrombophlebitis; Time Factors

1972
Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
    British heart journal, 1972, Volume: 34, Issue:6

    Topics: Adult; Arteriosclerosis; Coronary Disease; Diagnosis, Differential; Fibrin; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Protamines; Serum Globulins

1972
Sequential changes of plasma proteins after myocardial infarction.
    Scandinavian journal of clinical and laboratory investigation. Supplementum, 1972, Volume: 124

    Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Ceruloplasmin; Female; Fibrinogen; Haptoglobins; Humans; Immunoglobulins; L-Lactate Dehydrogenase; Male; Middle Aged; Mucoproteins; Myocardial Infarction; Trypsin Inhibitors

1972
Plasma 125 I-labelled fibrinogen clearance in diagnosis of deep venous thrombosis after myocardial infarction.
    British heart journal, 1972, Volume: 34, Issue:7

    Topics: Fibrinogen; Humans; Iodine Radioisotopes; Leg; Metabolic Clearance Rate; Myocardial Infarction; Myocardium; Thrombophlebitis

1972
Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
    Thrombosis et diathesis haemorrhagica, 1972, Aug-31, Volume: 28, Issue:1

    Topics: Blood Coagulation; Blood Glucose; Blood Pressure; Body Constitution; Body Weight; Cholesterol; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Plasminogen; Prothrombin; Sampling Studies; Skinfold Thickness; Smoking; Spirometry; Thromboplastin; Triglycerides; Vital Capacity

1972
[Diagnostic value of some blood indices in myocardial infarct].
    Voenno-meditsinskii zhurnal, 1971, Volume: 8

    Topics: C-Reactive Protein; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

1971
Blood hypercoagulability, thrombosis, and acute myocardial infarction.
    The Journal of laboratory and clinical medicine, 1971, Volume: 78, Issue:5

    Topics: Acute Disease; Blood Coagulation Disorders; Chromatography; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Thrombosis

1971
Blood rheological abnormalities complicating blood hypercoagulable-thrombotic states.
    The Journal of laboratory and clinical medicine, 1971, Volume: 78, Issue:5

    Topics: Blood Coagulation; Blood Viscosity; Chromatography; Fibrinogen; Humans; Myocardial Infarction; Rheology; Thrombosis

1971
[The value of some humoral indices in the differential diagnosis of micro- and macrofocal myocardial infarcts].
    Kardiologiia, 1971, Volume: 11, Issue:11

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Cholesterol; Clinical Enzyme Tests; Diagnosis, Differential; Fibrinogen; Focal Infection; Fructose-Bisphosphate Aldolase; Humans; Leukocyte Count; Myocardial Infarction

1971
Study of plasma fibrinogen and fibrinolytic activity in acute myocardial infarction.
    Journal of the Indian Medical Association, 1971, Aug-16, Volume: 57, Issue:4

    Topics: Aspartate Aminotransferases; Blood Sedimentation; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction

1971
[Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Acta medica Iugoslavica, 1970, Volume: 24, Issue:1

    Topics: Adult; Aged; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ethyl Biscoumacetate; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction

1970
Diffusion of plasma proteins into cells: a manifestation of cell injury in human myocardial ischemia.
    The American journal of pathology, 1967, Volume: 50, Issue:4

    Topics: Adult; Aged; Blood Proteins; Child, Preschool; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Infant; Male; Middle Aged; Mortality; Myocardial Infarction; Serum Albumin; Serum Globulins

1967
Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.
    Journal of clinical pathology, 1969, Volume: 22, Issue:6

    Topics: Adult; Electroshock; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Serum Globulins; Stress, Physiological; Surgical Procedures, Operative

1969
Plasma protein electrophoretic pattern and blood viscosity in arteriosclerotic heart disease.
    Journal of the American Geriatrics Society, 1970, Volume: 18, Issue:5

    Topics: Aged; Anticoagulants; Blood Protein Electrophoresis; Blood Viscosity; Cholesterol; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction

1970
[Functional state of the thrombocytes and blood coagulation in patients with myocardial infarct complicated by shock].
    Kardiologiia, 1970, Volume: 10, Issue:7

    Topics: Adult; Aged; Blood Cell Count; Blood Coagulation; Blood Platelets; Capillaries; Cell Adhesion; Cell Aggregation; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Thrombelastography; Thrombosis; Time Factors

1970
[Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency].
    Kardiologiia, 1970, Volume: 10, Issue:10

    Topics: Adult; Aged; Aging; Angina Pectoris; Antithrombins; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography; Thrombin

1970
A study of plasma fibrinogen content and its fibrinolytic activity following acute myocardial infarction.
    The Journal of the Association of Physicians of India, 1970, Volume: 18, Issue:10

    Topics: Acute Disease; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction

1970
The rheology of red blood cell aggregates.
    Microvascular research, 1970, Volume: 2, Issue:3

    Topics: Anemia, Sickle Cell; Blood Proteins; Blood Viscosity; Elasticity; Erythrocyte Aggregation; Fibrinogen; Humans; Microcirculation; Myocardial Infarction; Osmotic Pressure

1970
[Observations on the fibrinogen consumption rate in thrombotic and hemorrhagic disorders].
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1970, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fibrinogen; Hemophilia A; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Myocardial Infarction; Raynaud Disease; Thrombophlebitis; Thrombosis

1970
[State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
    Kardiologiia, 1971, Volume: 11, Issue:2

    Topics: Blood Coagulation; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Prothrombin; Thrombin; Thrombosis

1971
Fibrinogen degradation products.
    The New England journal of medicine, 1971, Jun-24, Volume: 284, Issue:25

    Topics: Cerebrovascular Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Pulmonary Embolism; Vascular Diseases

1971
[Behavior of the blood compensating system in patients with cardiac infarction in the light of recent studies. I. Behavior of fibrinogen and fibrinolytic activity].
    Przeglad lekarski, 1967, Dec-28, Volume: 23, Issue:12

    Topics: Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction

1967
[Some indices of coagulograms and thrombelastograms in person having sustained myocardial infarction under 40 years of age].
    Vestnik Akademii meditsinskikh nauk SSSR, 1967, Volume: 22, Issue:7

    Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Humans; Myocardial Infarction; Thrombelastography

1967
[Whole-blood viscosity and myocardial infarction].
    Ugeskrift for laeger, 1967, Nov-02, Volume: 129, Issue:44

    Topics: Aged; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology

1967
[Statistical and clinical study of the significance of fibrinogenemia in the course of myocardial infarct].
    Cardiologia pratica, 1967, Volume: 18, Issue:1

    Topics: Adult; Aged; Anticoagulants; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Pulmonary Embolism; Thromboembolism; Thrombophlebitis

1967
[Problem of the differential diagnosis and therapy of climacteric cardiopathy].
    Kardiologiia, 1967, Volume: 7, Issue:8

    Topics: Adult; Aged; Aging; Angina Pectoris; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; C-Reactive Protein; Climacteric; Coronary Disease; Diagnosis, Differential; Electrocardiography; Estradiol; Female; Fibrinogen; Heart Diseases; Humans; Leukocyte Count; Male; Menopause; Methyltestosterone; Middle Aged; Myocardial Infarction; Pain; Serum Globulins; Testosterone

1967
Hemorrheologic observations in acute myocardial infarction.
    Angiology, 1968, Volume: 19, Issue:4

    Topics: Blood Proteins; Blood Viscosity; Dextrans; Erythrocyte Aggregation; Fibrinogen; Glucose; Hematocrit; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Rheology

1968
Failure of safflower oil hyperlipemia to inhibit limitation of the size of experimental streptokinase-treated myocardial infarction.
    American heart journal, 1968, Volume: 75, Issue:6

    Topics: Animals; Blood Coagulation Tests; Coronary Disease; Dogs; Fatty Acids, Essential; Fibrinogen; Fibrinolysis; Hyperlipidemias; Myocardial Infarction; Myocardium; Prothrombin Time; Streptokinase; Thrombelastography

1968
[On closed heart injuries].
    Kardiologiia, 1968, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Child; Fibrinogen; Heart Injuries; Heart Septum; Heart Valves; Humans; Male; Middle Aged; Myocardial Infarction; Rupture

1968
[Hydrocortisone, nonesterified fatty acids and the blood coagulation system in acute myocardial infarct].
    Kardiologiia, 1968, Volume: 8, Issue:1

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Cholesterol; Fatty Acids, Nonesterified; Fibrinogen; Fibrinolysis; Heparin; Humans; Hydrocortisone; Middle Aged; Myocardial Infarction; Prothrombin Time

1968
[On some clinical and humoral changes during the 3d week of disease with myocardial infarct].
    Vnitrni lekarstvi, 1968, Volume: 14, Issue:4

    Topics: 17-Ketosteroids; Adult; Aged; Angina Pectoris; Blood Sedimentation; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies

1968
[The prognostic value of certain humoral changes in myocardial infarct].
    Kardiologiia, 1968, Volume: 8, Issue:7

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Cholesterol; Fibrinogen; Fructose-Bisphosphate Aldolase; Humans; Leukocyte Count; Myocardial Infarction; Prothrombin

1968
[Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1968, Dec-02, Volume: 23, Issue:49

    Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Fibrinogen; Heparin; Humans; Middle Aged; Myocardial Infarction

1968
[Clinical significance of plasma fibrinogen].
    Naika. Internal medicine, 1968, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Afibrinogenemia; Aged; Animals; Dextrans; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Rabbits

1968
A study of myocardial infarction. Procedures of important laboratory investigations.
    The Indian journal of medical research, 1968, Volume: 56, Issue:7 Suppl

    Topics: Blood Viscosity; Erythrocytes; Fibrinogen; Humans; Methods; Myocardial Infarction

1968
[Thrombogenesis in atherosclerosis of the coronary arteries].
    Terapevticheskii arkhiv, 1968, Volume: 40, Issue:1

    Topics: Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction

1968
Diagnosis of suspected or occult pulmonary embolus.
    British medical journal, 1969, May-31, Volume: 2, Issue:5656

    Topics: Adult; Female; Fibrin; Fibrinogen; Humans; Immunoassay; Myocardial Infarction; Pulmonary Embolism

1969
[Cryofibrinogenemia in endangiitis obliterans with myocardial infarct and multiple thromboses].
    Die Medizinische Welt, 1966, Aug-13, Volume: 33

    Topics: Blood Protein Disorders; Fibrinogen; Humans; Myocardial Infarction; Thromboangiitis Obliterans; Thromboembolism

1966
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.
    Journal of clinical pathology, 1966, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen

1966
[The diagnostic significance of plasma fibrinogen in myocardial infarct and the angina pectoris syndrome].
    Vnitrni lekarstvi, 1966, Volume: 12, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction

1966
[Qualitative changes in fibrinogen in rheumatism and coronary insufficiency].
    Terapevticheskii arkhiv, 1966, Volume: 38, Issue:4

    Topics: Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rheumatic Fever

1966